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CHAPTER 1 
Introduction 
Persons with a chronic neuromuscular disease [NMD] may experience a host 
of problems in daily occupations and may be more or less severely restricted 
in activities and participation in life roles. They continuously have to deal 
with changes in their health condition as a result of the chronic progressive 
nature of the disease. Since there is no cure for most NMDs, it is important to 
provide support and care on a regular basis, both to the persons with NMD 
and their families, helping them to cope with the disease and continue to 
participate in meaningful roles1. The aim of the current thesis is to develop a 
better understanding of how allied health professionals, specifically 
occupational therapists (OT), physical therapists (PT) and speech therapists 
[ST] can help to achieve these objectives. 
There is wide variety in referral, content and duration of OT, PT and ST 
for persons with NMD. Referral largely depends on the knowledge and 
experience of the referring physician with OT, PT and ST. Most frequently, 
persons are referred to PT in primary care. The content and duration of PT 
vary and not only depend on the type and severity of the impairments in 
body functions and restrictions in activities and participation, but also on the 
expertise of the PT. It is not unusual for persons with a NMD to have PT 
continuously for many years, the costs of which are fully reimbursed in the 
Netherlands. For OT and ST, the situation is different. In general, there is 
limited knowledge among referring physicians, among persons with NMD 
and even among professionals themselves regarding the treatment options of 
OT and ST for persons with NMD. 
In current thesis we aim to increase this knowledge for all involved. A 
way to gain knowledge, experience and new insights is by regularly seeing 
persons with a NMD and by explicit and conscious professional reasoning, 
often referred to as clinical reasoning. Within this reasoning process, the 
professional integrates knowledge regarding the client situation, the therapy 
context, theory and research, and personal beliefs and ideas about therapy 
outcomes2. 
The premise that service provision of OT, PT and ST for persons with 
NMD has been inefficient was the starting point of our thesis. This premise 
led to a comparative cohort study in which current allied health care 
utilization was compared with allied health care advice from a 
neuromuscular expert centre. This advice was based on single OT, PT and ST 
consultations and multidisciplinary meetings. In these consultations client 
expertise, professional expertise and scientific evidence were combined, as in 
8 
GENERAL INTRODUCTION 
evidence based practice (EBP). These elements of EBP are key elements in 
current thesis. Following a brief introduction on NMD, the elements of EBP 
are further elaborated on. 
Neuromuscular diseases 
Neuromuscular diseases (NMD) can be classified anatomically, making clear 
in which part of the peripheral nervous system the consequences of the 
disease are present. Four categories are distinguished3: 1) Motor neuron 
disorders such as amyotrophic lateral sclerosis (ALS) and spinal muscular 
atrophy (SMA), which may involve motor neurons in the brain, spinal cord, 
and periphery, and ultimately weaken the muscles; 2) Motor nerve root 
disorders and peripheral neuropathies such as Charcot-Marie-Tooth disease 
(CMT) and Guillain Barré Syndrome, that not only affect motor but also 
sensory nerves; 3) Neuromuscular transmission disorders in which the 
neuromuscular junction may also be directly involved in diseases such as 
myasthenia gravis; and 4) Muscle disorders such as Duchenne and Becker 
muscular dystrophies, myotonic muscular dystrophy (MD), 
facioscapulohumeral muscular dystrophy (FSHD), inflammatory myopathies 
or limb-girdle muscular dystrophy (LCD). Most of these conditions are slowly 
progressive and involve several impairments in functions such as muscle 
weakness, sensory loss, pain, fatigue and autonomic dysfunction in varying 
combinations. Some types of neuromuscular diseases, like myotonic 
dystrophy, are in fact multisystem disorders with involvement of many 
organs, including impairments in the muscular, respiratory, cardiac, central 
nervous, endocrine and ocular functions and structures4. The impairments in 
various functions and structures may result in a variety of limitations in 
activities and restrictions in participation. 
In the Netherlands there are about 100.000 persons living with an 
inherited or acquired NMD, sometimes for a restricted period of time, but 
often throughout their whole life5. There are over 600 different NMD with a 
wide diversity of symptoms, prevalence, hereditary, aetiology, progression 
and treatment6. The majority is rare and these are mainly the hereditary 
NMD. A survey of the world literature on population frequencies of various 
inherited NMD affecting children and adults resulted in 1991 in a 
conservative estimate of 1 in 3500 of the population to have a disabling 
inherited NMD7. Most likely this prevalence has increased due to the 
increased longevity of persons with NMDs. Myotonic dystrophy and 
hereditary motor and sensory neuropathy (HMSN), also known as Charcot-
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Marie-Tooth [CMT) disease are most common with prevalence's of 
respectively 1/20.000 and 1/1.0006. 
Evidence based practice 
Since the introduction of evidence-based medicine, it has evolved to evidence 
based practice (EBP), emphasizing that it is not only applicable to medical 
professions but also to many other health care services8. The most widely 
used definition is from Sackett et al. (2000] who describe EBP as 'the 
conscientious, explicit and judicious use of current best evidence in making 
decisions about the care of individual patients89. Most definitions of EBP 
distinguish three elements: 1} professional expertise, defined as the 
proficiency and judgment that individual clinicians acquire through clinical 
experience and clinical practice; 2) best available external scientific evidence 
from systematic research; 3) predicaments, rights, preferences, norms and 
values of individual clients8 " . Although persons with chronic illnesses 
become experts in managing their disease, their knowledge and experience 
have long been an untapped resource12. There are situations in which the 
clients know more about their diseases than the professionals13. It is 
therefore justified to distinguish both, client expertise as well as professional 
expertise. Also, for health care professionals it is important that they are 
aware of their own beliefs and values when providing services as these 
influence the way support is provided14. Expertise of clients and 
professionals thus both comprise knowledge, expertise, norms and values. As 
all these elements are context-specific, the context is also an important 
element in EBP8. The next paragraphs will describe aspects related to client 
expertise, professional expertise, scientific evidence and the context, which 
includes the practice context for OT, PT and ST for persons with NMD as well 
as the societal context (Figure 1). 
Client expertise 
In a practice context, many health care providers focus on diseases and their 
management, rather than on people, their lives and their health issues 15. For 
evidence based decision making in OT, PT and ST, information on the disease 
and its course is important, but using client expertise involves much more 
than that. Each client attending OT, PT and/or ST has unique physical, 
psychological, emotional, environmental and personal perspectives, 
knowledge and experience influencing their activities and participation. 
Gaining insight and understanding of these perspectives can be obtained by 
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using observations and tests and, above all, by using a narrative approach 
asking persons to tell about their lives. Client-centered practice and 
qualitative research both explicitly make use of client expertise and aim to 
increase understanding of the client perspective. 
Figure 1. Elements of evidence based practice (EBP] in a practice context and societal 
context. 
Client-centered practice 
A range of definitions and related concepts can be found to describe client-
centered practice1416. Also many terms have been used to describe concepts 
centered on people being partners in health care. These terms include client-
centered, patient-centered, patient-focused or family-centered14. An early 
definition described patient-centered medicine as an approach whereby the 
health care provider uses the patient's knowledge and expertise to guide the 
interaction within the consultation15. This shows how evidence based 
practice and client-centered practice are congruent with and complementary 
to each other for shared decision making17. A later definition described the 
patient-centered approach as one whereby the health care providers try to 
enter the patient's world, to see the illness through the patient's eyes15;16. Six 
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interacting components of the patient-centered process have been described: 
1) exploring both the disease and the illness experience; 2] understanding 
the whole person; 3] finding common ground regarding management; 4) 
incorporating prevention and health promotion; 5} enhancing the patient-
professional relationship and 6] establishing realistic goals16. The various 
models stress the important contributions that both the client and the 
practitioner bring to the intervention and the strength of combining these16. 
Other components of being patient-centered include taking the patient and 
his or her problems, ideas and expectations seriously, involving the patient in 
decisions, giving information to enable patients to take responsibility for 
their own health, and feeling responsible for non-medical aspects of the 
presented problem16:18. 
In a review on interventions to promote a patient-centered approach 
in clinical consultations, two main features were identified as part of a broad 
definition of patient-centered care15: 1} healthcare providers share control of 
consultations, decisions about interventions or the management of the health 
problems with patients; and/or 2] health care providers focus on the patient 
as a person, rather than solely on the disease, in consultations. Within this 
definition, shared treatment decision making is an indicator of patient-
centered care15. The Dutch advisory board for health care [Raad voor 
Volksgezondheid en Zorg [RvZ]} recommends an even more central role for 
the client in their health care management13. In the advice report Health 2.0, 
the client participates in communities that support him/her to stay or 
become healthy or to manage their chronic illness. In Health 2.0 clients are 
seen as persons and partners in care and they have autonomy regarding their 
lives and health care interventions13. 
Client perspective from qualitative studies 
Several qualitative studies have investigated the illness experience of persons 
with a NMD and how they have dealt with it11924. Most obvious were 
restrictions in mobility and increased fatigue and feebleness. The persons 
described psychosocial consequences of muscular dystrophy as well as 
stigma when the disability had become more obvious. In spite of reported 
distress, several persons experienced better psychological adaptation over 
time20. All studies stressed the importance to gain insight in the illness 
experience of persons with a NMD in order to offer the best possible 
support11924. 
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One study aimed to elucidate the next of kin's experiences when an 
adult member has muscular dystrophy. This study revealed the need for 
health care professionals to understand the next of kin narrated meaning of 
changes when an family member has a progressive disease22. One other study 
described conceptions and experiences of the hereditary aspect of muscular 
dystrophy from both the patients' and the next of kin's' perspective. It was 
found that heredity has a prominent place in the thoughts and feelings of the 
family and that families with a muscular dystrophy need medical information 
and the opportunity for genetic testing as well as support and counseling in 
coming to terms with living with a hereditary disease21. 
Professional expertise 
Professional expertise is based on knowledge and experience, norms and 
values and is influenced by the professional domain2. A profession's domain 
articulates its sphere of knowledge, societal contribution, and intellectual or 
scientific activity. Defining the knowledge and skills needed for optimal allied 
health care services for persons with NMD appears difficult and therapists 
often lack expertise in the treatment of persons with NMD2526. In this 
paragraph the professional domains of OT, PT and ST are described and an 
attempt is made to describe specific skills and experience required for the 
assessment and management of persons with NMD. Finally, the professional 
expertise in EBP or professional reasoning is explained. 
Occupational therapy 
The OT profession's domain centers on enabling occupation27. The World 
Federation of Occupational Therapists2" has defined OT as a client-centered 
health profession concerned with promoting health and well being through 
occupation. The primary goal of OT is to enable people to participate in 
activities of everyday and societal life. OTs achieve this outcome by working 
with people and communities to enhance their ability to engage in the 
occupations they want to, need to, or are expected to do, or by modifying the 
occupation or the environment to better support their occupational 
engagement. OTs believe that participation can be supported or restricted by 
the physical, affective or cognitive abilities of the individual, the 
characteristics of the occupation, or the physical, social, cultural, attitudinal 
and legislative environments. Therefore, OT practice is focused on enabling 
individuals to change aspects of their person, the occupation, the 
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environment, or some combination of these to enhance occupational 
participation28. 
Hill and Phillips have described the specific experience required for OT 
in NMD as experience with long/term chronic conditions and knowledge of 
their particular needs with reference to education, work and education, 
living, family life, and social and leisure activities26. In current thesis, the OT 
assessment and interventions for NMD are described as follows: The OT 
assessment consists of a client-centered interview in which the client is asked 
to describe an ordinary day and highlight the problems encountered in 
occupational performance. In addition, the OT observes the performance of a 
daily task looking at safety, efficiency aspects and discusses these with the 
client. The following OT interventions for persons with NMD have been 
distinguished in this thesis: training of activities of daily living (including self 
care, mobility, work, household tasks, leisure) or training of skills, including 
(fine) motor skills, advice and instruction in the use of assistive devices, 
provision of splints and slings, counseling on energy conservation strategies, 
educating patient, family and caregivers or a combination of the above. 
Physical therapy 
The definition of PT according to the World Confederation for Physical 
Therapy (WCPT)29: PT provides services to individuals and populations to 
develop, maintain and restore maximum movement and functional ability 
throughout the lifespan. This includes providing services in circumstances 
where movement and function are threatened by ageing, injury, disease or 
environmental factors. Functional movement is central to what it means to be 
healthy. PT is concerned with identifying and maximizing quality of life and 
movement potential within the spheres of promotion, prevention, 
treatment/intervention, habilitation and rehabilitation. This encompasses 
physical, psychological, emotional, and social well being. PT involves the 
interaction between physical therapist, patients/clients, other health 
professionals, families, care givers, and communities in a process where 
movement potential is assessed and goals are agreed upon, using knowledge 
and skills unique to PTs29. 
Hill and Phillips have described the specific expertise of PT for people 
with muscle disease as requiring skills in both neurological and 
musculoskeletal PT, experience in treating muscle conditions and the 
confidence to treat patients with rare disorders26. In current thesis, the PT 
assessment and interventions for NMD are described as follows: The PT 
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assessment focuses on muscle strength, mobility and balance and its relation 
to activities like walking, transferring and lifting and carrying. In a semi-
structured interview problems in performing these activities are elicited, as 
well as any prior attempts to deal with them. Based on the problems 
expressed, a set of functional tests for balance and walking and functional 
observations like performing transfers and stair climbing are recorded. At the 
level of impairment, an overview of muscle strength, muscle length, joint 
mobility and stability, pain and tenderness is obtained. The following PT 
modalities for persons with NMD have been distinguished: exercise therapy 
such as muscle strengthening exercises, mobilizing exercises, aerobic 
exercises, breathing exercises; and other interventions which could be 
training of skills such as transfers or taking stairs or a combination of these 
interventions. 
Speech and language therapy 
The domain of ST includes human communication behaviors and disorders as 
well as swallowing. The overall objective of ST services is to optimize 
individuals' ability to communicate and/or swallow in natural environments, 
and thus improve their quality of life. This objective is best achieved through 
the provision of integrated services in meaningful life contexts30. A ST's 
occupation entails the development, improvement and recovery of four vital 
aspects of human communication: speech, the human voice, language and 
hearing, including the primary functions at the basis of these aspects, i.e. 
swallowing31. The ST is the professional responsible for the prevention, 
assessment, treatment and scientific study of human communication and 
related disorders. In this context human communication encompasses all 
those processes associated with the comprehension and production of oral 
and written language, as well as appropriate forms of non-verbal 
communication32. 
According to Hill and Phillips, STs in muscle diseases need skills and 
expertise in the assessment and management of dysphagia26. In current 
thesis, the assessment and interventions for ST in NMD are described as 
follows: The assessment focuses on swallowing and communication. 
Following an interview, a standardized assessment of oral motor functioning 
and speech is conducted. Also swallowing tests are used to obtain 
information about swallowing abilities. In this thesis we distinguished 
various ST interventions for persons with NMD: information and advice or 
teaching compensatory strategies. Information and advice incorporated 
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dietary modification, augmentative and alternative communication or 
instruction of the patient and relatives. Compensatory strategies included 
teaching swallowing maneuvers and/or strategies to improve intelligibility. 
Professional reasoning and shared decision-making 
Professional reasoning about decisions regarding the care for clients is about 
how therapists put science and art of practice together2. During professional 
reasoning, etiology of diseases, insight in the client situation, diagnostic and 
therapy options, theory and research are integrated with professional 
expertise. The professional expertise, acquired through practical experience, 
is used in the various stages of the therapy process9:33;34. The professional 
uses interview skills, assessments and theoretical knowledge to gather 
information on the client perspective. This involves several ways of 
professional reasoning including narrative reasoning to understand the life 
history of the client and the meaning of the illness for the client and their 
aims for the future2. This is combined with scientific reasoning in which the 
professional uses knowledge and experience regarding the diagnosis, 
prognosis, course of the disease and current health status with the desired 
situation regarding abilities and restrictions in activities and participation. 
For scientific reasoning the available scientific evidence regarding the 
assessments and interventions is used. The problems identified are 
translated into research questions, preferably from a client's perspective33. 
After framing the question, research evidence is searched and appraised or 
professional practice guidelines examined and the applicability of the results 
to a particular client determined. Pragmatic reasoning is also applied to find 
out what is feasible in the context2. And finally, in the care for NMD, aspects of 
ethical reasoning may arise when desires of persons are in conflict with their 
physical capabilities and prognosis. This all leads to the collaborative process 
with the client in shared decision making. The professional expertise has 
influence on the quality of both the discussion of client and research 
evidence, and the shared decision making. Finally, professional expertise and 
client expertise are used to evaluate the effect of therapy, which may result in 
new goals and researchable questions and the therapist's and client's 
accumulation of expertise, which has the potential to affect future decision 
making33. 
Professionals have acknowledged that they lack expertise in research 
retrieval and analysis, which is a barrier to the integration of research 
evidence into practice35. A helpful tool to bridge the gap between scientific 
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evidence and clinical practice is the development of evidence based and 
consensus based guidelines. Evidence based guidelines regarding OT, PT and 
ST for persons with NMD are lacking and it is one of the future challenges for 
professionals and clients to develop such guidelines. 
Scientific evidence 
Ideally, each decision regarding the professional analysis of the problem, 
testing and choice of intervention is based on the best available scientific 
evidence36. This requires formulation of the right questions and translating 
these into searchable questions, often with the use of the PICO method [P: 
Patient, Population or Problem; 1: Intervention or exposure; C; Comparison 
and 0: Outcome) followed by a search in the appropriate databases. In 
current thesis, literature searches have been carried out for the population 
with a NMD (P), for OT, PT and ST interventions (I and C] and outcome 
measures at the level of body functions, activities and participation or quality 
of life (0). 
Initially, the Cochrane database was searched for systematic reviews 
of randomized clinical trials (RCTs) and controlled clinical trials (CCTs), as 
these are considered the golden standard in EBP. However, no Cochrane 
reviews existed regarding OT for persons with NMD. Three Cochrane reviews 
investigated specific PT interventions for persons with specific types of NMD 
and all three concluded that there was insufficient evidence to establish the 
benefit of exercise therapy3739. For ST, one Cochrane review on interventions 
for swallowing difficulties [dysphagia) in persons with chronic muscle 
disease also concluded that there is insufficient evidence40. 
The majority of NMD are rare, which makes it difficult to carry out 
RCTs and CCTs with large enough groups of participants. Observational 
designs with a long term follow-up might be more suitable. Therefore, the 
systematic reviews carried out in current thesis, also included studies other 
than RCTs and CCTs. 
The applicability of scientific evidence depends on factors related to the 
client, the professional as well as the context34. To know whether an 
intervention might be effective for an individual, it is important that the client 
matches the in- and exclusion criteria defined in the study. Most studies have 
strict in- and exclusion criteria, which may be the reason for professionals to 
dismiss findings from an RCT when their clients are different from those in a 
trial41. For the professional, it is important to know which skills or 
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knowledge is needed for assessment and management of persons with NMD 
and whether additional education or training is necessary. There may be 
barriers such as the availability of therapeutic material, finances, health care 
systems, opinion or culture within a (professional] organization34. In a 
research context, standardized treatment protocols are often required with 
extensive quality control to decrease errors in treatment delivery. Hence, a 
research context may not reflect the clinical practice environment41. 
Moreover, the clinical practice environment does not reflect the context in 
which persons live and were they have to cope with the problems as a result 
of their chronic condition. 
Context 
Two contexts are distinguished (Figure 1): practice context and societal 
context. These contexts are also described in the Canadian Practice Process 
Framework (CPPF], a framework for evidence-based, client-centered 
occupational enablement42. The practice context is where the client and the 
professional meet. Both the practice context and societal context have 
physical, social, cultural and institutional characteristics, such as the models 
of service delivery and the health care system42. 
Persons with NMD may receive OT, PT and ST in primary care i.e. 
community or in an expert centre for NMD. Although the community context 
is most preferable for persons to be treated in, the provision of OT, PT and ST 
in the community is highly variable and has been described as fragmented, 
inadequate and even deficient264345. In the Netherlands, a general 
practitioner has a mean number of 15 persons with a NMD in practice 5. A 
community practice for OT, PT or ST will have even less persons per year, 
which means that it is impossible to gain and built expertise regarding the 
assessment and management of persons with NMD. 
Integrated approaches have been advocated incorporating all aspects 
of NMD including genetic and medical resources as well as rehabilitation and 
community services for persons and family members, not just at discrete 
moments but across the continuum4345. Such approach may work well for 
prevalent diagnoses like Parkinson's disease and multiple sclerosis, but is 
difficult for NMD, as there are only few centres of expertise in NMD, for which 
it is less easy to have close links with the many different communities46. 
In the Netherlands there are several diagnostic centers and 
rehabilitation centers with teams specialized in the treatment for persons 
with NMD5. In these centers integrated medical care and rehabilitation 
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services are available. As most persons with a NMD receive community 
services26:43:4S:47, ways need to be found to transfer expertise from specialized 
teams to professionals in the community. 
The Dutch patient support organization (Vereniging Spierziekten 
Nederland [VSN]} has initiated and supports a network for OTs and PTs with 
expertise NMD with the aim to increase and share their knowledge and 
experience548. The therapists of this network work in the diagnostic centers 
or specialized rehabilitation centers. Although this network aims to support 
therapists in community, community therapists are often unaware of this 
network. Several strategies have been used to increase awareness, such as a 
website (www.vsn.nl) including a list of expert professionals for each region, 
regional meetings with community professionals, articles and 
presentations48. A website for health professionals 
[www.hulpverleners.vsn.nl] is being developed48. Participation in 
professional networking including the use of internet communities are 
increasingly promoted to exchange and increase professional knowledge and 
experience13. 
As the government encourages taking own responsibility and 
increasing self-management skills in persons with chronic diseases and their 
health care professionals, they have allowed for direct access to OT, ST and 
FT without medical referral in 2011. This stresses the importance to share 
knowledge and experience in the field of NMD. 
Current studies were carried out from the Neuromuscular Centre of 
Nijmegen [NMCN] in the Radboud University Nijmegen Medical Centre. In 
this centre different professionals with expertise in the field of NMD work 
together in a multidisciplinary team consisting of medical and allied health 
care professionals, including OT, PT and ST. Most persons visiting the NMCN 
are from outside the region. Following multidisciplinary assessments, these 
persons may be referred to OT, PT and ST within the NMCN, a rehabilitation 
centre or to OT, PT and ST in the community. All persons receive a written 
report and advice regarding the treatment goals, and suggestions for the 
volume (duration) of therapy. So far, it was unclear whether this advice was 
received, appreciated and implemented by persons with NMD and their OTs, 
PTs and STs in the various contexts. 
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Aims and outline of this thesis 
This thesis is divided into three parts reflecting the elements of evidence 
based practice as well as the chronological process by which the knowledge 
and experience regarding OT, PT and ST for persons with NMD was built. 
Part I: Professional perspective 
Part I was based on the premise that referral to and utilization of PT, OT and 
ST was not efficient and that a multidisciplinary approach with expert 
consultations would result in more efficient referral to and utilization of OT, 
PT and ST for persons with NMD. Chapter 2 presents a comparative cohort 
study in which the usual volume of OT, PT and ST is compared with the 
volume of therapy suggested by OT, PT and ST of the NMCN based on one-off 
consultations and a multidisciplinary meeting and advice. A cost analyses was 
carried out to get insight into the costs and possible savings of such 
multidisciplinary approach. Chapter 3 explores the extent to which the OT, PT 
and ST advices were implemented with regard to the volume of therapy 
suggested. This study also explores whether factors at the level of the advice, 
the person with NMD, the allied health professional of the context might have 
influenced implementation of the advice. 
Part II: Scientific perspective 
Three systematic reviews were conducted to summarize scientific evidence 
for OT, PT and ST for persons with NMD. These reviews not only included 
evidence from RCTs and CCTs, but also from uncontrolled pre-post designs. 
Chapter 4 presents the results of the systematic review on the efficacy of OT 
for adults with NMD, Chapter 5 summarizes the effectiveness of exercise 
therapy and other types of PT for persons with NMD, and in Chapter 6 the 
evidence for ST for persons with NMD is presented. 
Part III: Client perspective 
Because a single consultation within limited time frame and within a practice 
context differs from the context where persons live, it does not provide full 
understanding of the illness experience of persons. Therefore, it was felt that 
the client perspective was not well understood. This was especially the case 
for persons with the most prevalent and most complex disease myotonic 
dystrophy type 1. It was also felt that the perspective of partners should be 
incorporated because a chronic NMD also affects the lives of partners and 
also of both of them as a couple. Chapter 7 provides better insight and 
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understanding of experiences of couples living with myotonic dystrophy type 
1 with a qualitative study using in-depth interviews. 
General discussion 
Chapter 8 reflects on the findings from the various studies representing the 
professional perspective, the scientific perspective and client perspective. 
The perspective regarding service delivery for chronic conditions was added 
using the Chronic Care Model. This model includes determinants of effective 
chronic illness care and the nature of practice systems that facilitate good 
care and good patient outcomes. These elements may assist in Improving 
service delivery of OT, PT and ST in persons with NMD. The discussion 
concludes with recommendations for future service delivery and research 
regarding OT, PT and ST in NMD. 
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Abstract 
Purpose: To compare the volume of occupational therapy (OT], physical 
therapy (PT) and speech therapy (ST) as currently received by patients with 
neuromuscular diseases with the volume of OT, PT and ST recommended by a 
multidisciphnary team. 
Method: The use of OT, PT and ST was studied retrospectively and 
prospectively in a reference group (n=106) receiving usual care and in an 
intervention group (n=102) receiving advice based on multidisciphnary 
assessments. A cost analysis was made and the implementation of the advice 
was evaluated at 6 months. 
Intervention: Multidisciphnary assessments consisted of a single consultation 
by OT, PT and ST each, followed by a multidisciphnary meeting and 
integrated advice. 
Outcome variables: volume (frequency times duration) of therapy, relative 
over- and underuse of therapy and costs of therapy and intervention. 
Results: Compared to the multidisciphnary advice, there was 40% underuse 
of OT among patients with neuromuscular disease. For PT, there was 32% 
overuse and 22% underuse; for ST, there was neither over- nor underuse. 
Some 40% percent of patients received once-only advice regarding ST 
compared to 27% regarding OT and 19% regarding PT. The costs of the 
multidisciphnary advice were estimated at €245 per patient. If fully 
implemented, our multidisciphnary approach would result in a mean cost 
savings of €85.20 per patient. The recommended therapy had, however, been 
implemented only partially at 6 months follow up. 
Conclusions: Some patients with a neuromuscular disease do not receive any 
form of allied health care, whereas they should. Among patients with 
neuromuscular disease who do receive some form of allied health care, quite 
a few receive these treatments for too long periods of time. Ways need to be 
developed to improve implementation of the multidisciphnary advice and to 
obtain a more favourable balance between its costs and benefits. 
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Introduction 
The prevalence of neuromuscular disease (NMD) in the Netherlands is 
estimated at 6.25 per 1,000 (100,000 patients in total). Patients with NMD 
constitute a highly heterogeneous group in terms of incidence, heredity, 
aetiology, prognosis and functional impairments13. As a result, it is difficult to 
identify which patients will benefit from allied health services, such as 
physiotherapy (PT), occupational therapy (OT) and speech therapy (ST). 
Patients who suffer from a rapidly progressive NMD such as amyotrophic 
lateral sclerosis (ALS), need multidisciplinary assessment and treatment4. 
Most adult patients suffer from a mildly progressive NMD, and may require 
some form of allied health therapy in primary care. Our impression is that in 
current practice, many patients receive PT but only few patients receive OT 
or ST. Obviously, referral patterns play a key role in this respect. 
To our knowledge, no guidelines or criteria exist for referral of 
patients with NMD to PT, OT or ST in primary care. As a result, current 
referral practices seem arbitrary and show considerable variation. The issue 
is further complicated by the paucity of data on outcome of OT, PT or ST in 
this heterogeneous group of patients. Regarding PT, one review examined the 
efficacy and safety of strength training and aerobic exercise training in 
patients with muscle diseases, based on two randomised trials. Its major 
conclusion is that there is insufficient evidence of its effectiveness in these 
patients5. There are no controlled clinical trials of OT in patients with NMD. 
Two uncontrolled trials have been conducted, evaluating the effect of a hand-
training programme for patients with myotonic dystrophy type I6 and 
Welander distal myopathy7. Both studies showed a positive treatment effect, 
but the number of patients in these trials was low (5 and 12 respectively), 
and only a limited part of OT was evaluated. Also with respect to ST in 
patients with NMD, no evidence exists of its effectiveness0. 
Results from exploratory studies describing experiences and functional 
abilities in patients with different types of NMD, such as muscular dystrophy9 
or critical illness polyneuropathy10, may assist in establishing the best 
possible treatment and support in these patients. From such studies, it may 
be concluded that a coordinated team approach is essential for achieving 
optimal outcomes in complicated or complex illness involving multiple 
extremities and/or multiple organ systems, or an illness that creates 
disability in the performance of basic activities of daily life (ADL)1011. 
To ensure that patients with NMD receive appropriate OT, PT or ST, we 
adopted a multidisciplinary approach, involving expertise from the fields of 
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neurology, rehabilitation medicine, PT, OT and ST. Apart from the medical 
diagnosis and prognosis, an assessment was made of the patients' limitations 
in activities and participation. Upon completion of the assessment, some 
patients received advice and did not need further treatment. If further 
treatment was advised, the objectives, content, and expected duration were 
stated explicitly. In this paper, we describe our experience with such a 
multidisciplinary assessment of patients with NMD who attended the 
Neuromuscular Centre Nijmegen. Current utilization of OT, PT and ST [usual 
care] was documented and compared with the utilisation of OT, PT and ST as 
recommended by the multidisciplinary team (experimental care). 
Specifically, the following questions were addressed: 
- Did recommendations regarding content and duration of allied healthcare 
given by the multidisciplinary team differ from actual allied healthcare 
utilization? 
- How frequently was only a single consultation, consisting of assessment 
and counselling, considered appropriate? 
How did the patients rate the assessment and the recommendations for 
allied health care? 
- Were the recommendations implemented at six months follow up? 
How is the balance between costs and savings of the intervention? 
Methods 
Study design 
A comparative cohort study was carried out with patients attending the 
Neuromuscular Centre Nijmegen. One cohort served as a reference group and 
received usual care. A second cohort served as the intervention group and 
received multidisciplinary assessment and advice (Figure 1]. The cohorts 
were compared at baseline regarding patient characteristics and OT, PT and 
ST received during the previous six months (Figure 1: comparison 1). In the 
reference group, OT, PT and ST at baseline and at 6 months follow up were 
compared to monitor changes over time in case of usual care (Figure 1: 
comparison 2). In the intervention group, actual OT, PT and ST utilization at 
baseline were compared with recommendations from the multidisciplinary 
team (Figure 1: comparison 3). To evaluate changes as a result of the 
multidisciplinary assessment and advice, OT, PT and ST at baseline and at 6 
months follow up were compared (Figure 1: comparison 4]. Approval for this 
study was obtained from the Medical Ethics Committee of the Radboud 
University Nijmegen Medical Centre. 
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Cohort 1: 
Reference group 
July 2002 -
December 2002 
Cohort 2: 
Intervention group 
December 2002 -
June 2003 
Baseline: 
Patient characteristics 
and volume of OT. PT 
and ST in the 
previous six months 
Comparison 1* 
Baseline: 
Patient characteristics I 
and volume of OT, PT 
and ST in the previous \ 
six months 
Companson 2 t -
Intervention: 
Multidisciplinary 
assessment and 
advice 
At six months 
follow up: 
volume of OT, PT f 
and ST in the 
previous six 
months 
At six months 
follow up: 
volume of OT, PT ( 
and ST in the 
previous six 
months 
-Comparison 3t 
Figure 1. Design of the study 
* Companson 1: Comparison of the two cohorts at baseline in terms of patient 
characteristics and volume of OT, PT and ST received in the previous six months 
{amount of OT, PT and ST at baseline). Purpose: To check for comparability of the two 
cohorts at baseline. 
t Comparison 2: Comparison of the volume of OT, PT and ST at baseline with the volume 
at six months follow up, when usual care is given. Purpose: To check for any changes in 
the volume of allied care in the absence of a specific intervention. 
φ Comparison 3: Companson of the amount of OT, PT and ST at baseline with the 
amount advised by the multidisciplinary team. Purpose: To assess appropriateness of 
current service provision, by reference to expert opinion. 
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 Comparison 4: Comparison of the volume of OT, PT and ST at baseline with the volume 
at six months follow-up, following the multidisciplinary advice. Purpose: To assess 
extent of implementation of recommendations. 
Patients 
Consecutive patients visiting the Neuromuscular Centre Nijmegen from July 
2002 to June 2003 were approached for participation. Inclusion criteria 
were: 1] probable or definite NMD according to the medical records; 2) age 
18 years or older; and 3) sufficient command of the Dutch language. Patients 
of the reference group were recruited from July 2002 until December 2002. 
Patients of the intervention group were recruited from December 2002 until 
lune 2003. 
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Intervention: multidisciplinary assessment and advice 
The multidisciplinary assessment comprised consultation of the OT, PT and 
ST (in random order] of the Neuromuscular Centre Nijmegen. The OT 
assessment focused on problems in the performance of daily activities. The 
OT conducted a client-centred interview in which the patient was asked to 
describe an ordinary day and highlight the problems encountered in 
occupational performance. In addition, the OT observed the patient while 
performing a daily task (making a hot drink and a sandwich). 
The PT assessment focused on muscle strength, mobility and balance 
and its relation to activities like walking, transferring and lifting and carrying. 
In a semi-structured interview problems in performing these activities were 
elicited, as well as any prior attempts to deal with them. Based on the 
problems expressed, a set of functional tests like a Berg Balance scale12, 6 
minute walking distance13, analysis of the gait pattern and functional 
observations like performing transfers and stair climbing were recorded. At 
the level of impairment, an overview of muscle strength, muscle length, joint 
mobility, pain and tenderness was obtained. In the analysis the Rehabilitation 
Problem Solving (RPS] form14 was used to relate disease, impairments and 
activities and to decide if PT might be beneficial to the patient. 
The ST assessment focused on swallowing and communication. 
Following an interview, a standardized assessment of oral motor functioning 
and speech was conducted. Also, two quantitative swallowing tests, the 
dysphagia limit and the timed test, were used to obtain information about 
swallowing abilities15;16. 
After the assessment, all therapists registered whether there was an 
indication for further therapy. If advice was given during the assessment, but 
there was no need for further treatment, this was registered by the therapist 
as a single advice. When further treatment was deemed necessary, treatment 
goals, treatment modality, and expected duration were specified. 
The findings and recommendations were summarised and discussed 
during a multidisciplinary meeting with a neurologist, rehabilitation 
physician, occupational therapist, physiotherapist, and speech therapist. This 
resulted in an integrated multidisciplinary advice regarding appropriate OT, 
PT and ST. This advice was sent to the patient and relevant health care 
professionals (general practitioner, neurologist, rehabilitation physician and 
allied health professionals). 
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Outcome measures 
- The 36-item short-form (SF-36)17 and Euroqol 5D18 were used to describe 
functional health status and valuation of individual health state, 
respectively. The SF-36 is composed of 36 questions and standardized 
response choices, organized into eight multi-item scales; physical 
functioning, social functioning, role limitations due to physical problems, 
role limitations due to emotional problems, mental health, vitality, bodily 
pain and general health. The scores of the SF-36 scales can range between 
0 and 100, with a higher score indicating a better functional health status. 
The Euroqol 5D is composed of 5 questions on different dimensions of 
quality of life: mobility, self-care, usual activities, pain/discomfort, 
anxiety/depression. Response options vary from 1 to 3, higher scores 
indicating worse quality of life. On an additional VAS score [0-100], 
patients rate their current health status, higher scores indicating better 
health status. 
- Volume of OT, PT and ST utilization. Frequency of allied healthcare visits χ 
total treatment duration was used to calculate volume. The procedure for 
obtaining these data is described in more detail below. 
- Relative Overuse' or 'underuse' of OT, PT and ST. The difference between 
actual allied healthcare utilization and the utilization as recommended by 
the multidisciplinary team, where the latter is considered the gold 
standard. 
- Costs of PT, OT and ST. These were calculated using standard cost prices 
for allied health services (€ 23.60 per 30-min session] and consultant care 
(€98 per hour] in 2003, in accordance with national guidelines for cost 
calculation of health services19. 
- Patients' rating of the assessments and advice was evaluated with 
questionnaires (described in more detail below]. 
Volume ofOT,PT and ST 
In both groups the volume (number and duration of treatment sessions] of 
OT, PT and ST received was registered using patient questionnaires. At 
baseline, patients were asked to register the amount of OT, PT and ST 
received during the previous 6 months. In addition, patients in the reference 
group were asked to register the amount of OT, PT or OT during the 
subsequent 8 weeks prospectively. This amount was extrapolated to 6 
months (26 weeks] to obtain comparable time periods. At six months follow 
up, the patients in the intervention group retrospectively registered the 
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amount of therapy received in the preceding 6 months. The number of allied 
healthcare visits was categorised as follows: no sessions, 1 to 10 sessions, 11 
to 25 sessions, 26 to 52 sessions, and more than 52 sessions. The choice for 
the two latter categories was related to a treatment frequency of once a week 
(26 sessions in half a year) or twice a week (52 sessions in half a year). 
To calculate the number of treatment sessions as recommended in the 
multidisciplinary reports, the following assumptions were made: 
- The OT often advised one to five or five to ten sessions of OT, as it was 
difficult to know exactly how many sessions were needed. These were 
rated as five or ten sessions of 30 min, respectively; 
- The PT regularly suggested to gradually decrease the PT to a lower 
frequency e.g. from twice a week to once a week or in some cases to once 
a month. In such cases, a gradual decrease of one session per month was 
assumed; 
- If the PT advised a certain number of PT sessions followed by a re-
evaluation, only the number of recommended sessions was used in the 
calculation; 
- If hydrotherapy was suggested, this was counted as PT only if the need for 
PT coaching was specified. 
Patients' rating of the assessments and advice 
Patients in the intervention group were asked for their opinion on the 
assessments and advice for OT, PT and ST separately. They were asked 
whether the assessment had been valuable for them and why (not). The 
reasons for a valuable assessment included 'attention was paid to my 
problems and needs', 'new information or advice was given' or both. If the 
assessment was not considered valuable, the patient could specify why. 
These specifications included 'I do not experience problems or needs', 'I did 
not receive new information or advice' or other reasons. Patients were also 
asked whether or not they agreed with the advice given by the OT, PT and ST 
respectively. 
Statistical analysis 
An independent t-test was used to test whether there were significant 
differences in age between the two groups. A Mann-Whitney Test was used to 
test whether there were significant differences between the groups in 
medical diagnosis, duration of the complaints, generic health status and 
quality of life. Descriptive statistics (percentages) were used to describe the 
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amount of OT, PT or ST received, and differences between groups were tested 
using a Mann-Whitney test. A Wilcoxon test was used to test for significant 
differences between the amount of therapy received at baseline and at 6 
months for both groups. 
Results 
Patients 
For the reference group, medical records of 250 eligible patients were 
reviewed; 144 patients did not meet the inclusion criteria (Figure 2]. The 
main reason was the absence of a probable or definite neuromuscular 
disease. Many patients were still in the diagnostic phase. Other reasons 
included age (younger than 18] or communication problems (insufficient 
command of the Dutch Language]. Of the 106 patients included in the 
reference group, 87 returned the health care diary. For the intervention 
group, medical records of 257 eligible patients were reviewed; 155 patients 
were excluded for the same reasons as in the reference group. Of the 102 
patients who participated, 88 returned the questionnaire reporting the 
amount of therapy received in the previous 6 months. 
Baseline characteristics revealed no significant differences between 
the two groups in age, medical diagnosis, duration of the complaints, generic 
health status, quality of life or amount of OT, PT and ST received during the 
previous 6 months (p>0.05] (Tables I and II]. The mean age was 47 years (SD 
15] and 49 years (sd 13] for the reference group and intervention group 
respectively. The male/female distribution was 57/49 in the reference group 
51/51 in the intervention group. In both groups all NMD categories 
(disorders of the motor neuron, motor nerve root, peripheral nerve, 
neuromuscular transmission and muscles] were included, with the majority 
suffering from a muscle disease (54% in the reference group and 67% in the 
intervention group]. The duration of the complaints lasted a year or more in 
the majority of the patients in both groups (>95%]. The SF-36 dimensions 
Physical functioning, Role limitations due to physical problems and General 
health had the lowest scores (mean scores below 50 with high standard 
deviations], indicating substantial, though variable physical problems in both 
groups. 
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COHORT 1 : Reference group 
July 2002-December 2002 
COHORT 2: Intervention group 
December 2002- June 2003 
Assessed for eligibility in 
medical records (n=250) 
Excluded (n= 144) 
- Failed inclusion 
criteria (n= 91) 
- Did not respond (n=13) 
- Refused to participate 
(n=25) 
- Other reasons (n=15) 
Assessed for eligibility in 
medical records (n=257) 
Allocated to reference group 
(n=106) 
Excluded (n= 155) 
- Failed inclusion 
criteria (n=80) 
- Did not respond (n=14) 
- Refused to participate 
(n= 53) 
- Other reasons(n=8) 
Allocated to intervention group 
(n=102) 
Lost to follow up (n=19) 
- did not return health care diary 
(n=19) 
Lost to follow up (n=31 ) 
- did not return satisfaction questionnaire 
(n=15) 
- satisfaction questionnaire not completed 
(n=2) 
- did not return questionnaire on 
the volume following 6 months (n=11) 
- deceased(n=2) 
- address unknown (n=1) 
Analysed (n=87) Analysed {n=88) 
Figure 2. Inclusion and follow-up of patients. 
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Table I. Characteristics of the reference group and the intervention group 
Age (years) 
Mean / standard deviation / range 
Gender 
Male / female 
Medical diagnosis 
Motor neuron disorders 
Motor nerve root disorders 
Peripheral nerve disorders 
Neuromuscular transmission disorders 
Muscle disorders 
muscular dystrophy / myopathy / myositis 
Duration of complaints 
0-6 months / 6-12 months / >12 months 
Generic health status (SF36) mean (SD) 
Physical Functioning 
Social Functioning 
Role limitations - physical 
Role limitations - emotional 
Mental health 
Vitality 
Bodily pain 
General Health 
Quality of Life (EQ-5D) mean (SD) 
Mobility 
Self-care 
Usual activities 
Pain/discomfort 
Anxiety/depression 
Health status 
Reference 
group, n=106 
4 7 / 1 5 / 2 0 - 8 3 
5 7 / 4 9 
9 
11 
20 
9 
57 
3 2 / 1 9 / 6 
2 / 5 / 9 9 
37 (26) 
70 (24) 
48 (41) 
78 (39) 
74(17) 
55(18) 
70 (28) 
45 (21) 
1,9 (0,4) 
1,5 (0,6) 
1,8 (0,5) 
1,8 (0,5) 
1,2 (0,4) 
62 (17) 
Intervention 
group, n=102 
49 / 13 / 20-73 
5 1 / 5 1 
8 
4 
15 
7 
68 
3 9 / 2 1 / 8 
3 / 4 / 9 5 
33 (27) 
68 (25) 
39 (39) 
69 (42) 
72 (18) 
51 (20) 
65 (30) 
42 (22) 
1,9 (0,4) 
1,5 (0,6) 
1,9 (0,4) 
1,9 (0,5) 
1,2 (0,5) 
60 (18) 
*p<0.05 
The problems In mental health or Role limitations due to emotional problems 
had the highest scores, indicating least problems in these areas. The Euroqol 
5D showed similar results with problems in all dimensions, but the least in 
the dimension Anxiety/depression [Table I). The mean health status in the 
Euroqol was 62 (SD 17) and 60 (SD 18] for the reference group and 
intervention group, respectively. 
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The volume of OT, PT and ST at baseline was similar in both groups: 
Less than 10% had received a short period of OT; 32% (reference group) and 
40% (intervention group) of the patients had received PT, most of them more 
than once a week; and there were hardly any patients that had had ST in the 
past 6 months (Table II). 
Table II. Amount of therapy at baseline for the reference group and intervention group 
Baseline Occupational Therapy 
0 sessions 
1 - 1 0 sessions 
11 - 25 sessions 
26 - 52 sessions 
> 52 sessions 
Baseline Physical Therapy 
0 sessions 
1 - 1 0 sessions 
1 1 - 2 5 sessions 
26 - 52 sessions 
> 52 sessions 
Baseline Speech Therapy 
0 sessions 
1 - 1 0 sessions 
11 - 2 5 sessions 
26 - 52 sessions 
> 52 sessions 
Reference group 
n=106 
96 
7 
2 
1 
0 
72 
1 
13 
17 
3 
101 
5 
0 
0 
0 
Intervention group 
n=102 
93 
8 
1 
0 
0 
61 
5 
11 
21 
4 
101 
0 
1 
0 
0 
*p<0.05 
Multidiscipiinary assessment and advice 
After the OT assessments (n=102), 44 patients (43%) received advice for 
further treatment and 28 patients (27%) received a single advice. The PT 
assessments (n=102) resulted in an indication for further treatment in 46 
patients (45%) and an indication for a single advice in 19 patients (19%). 
After the ST assessments (n=102), six patients (6%) were advised to have 
further ST and 41 patients (40%) received a single advice. 
Patients' rating of the assessments and advice 
Most patients valued the OT, PT or ST assessments highly (Table III), giving 
as main reason that they appreciated the attention paid to their specific 
problems and needs, or that they were given new information or advice. 
36 
USUAL PRACTICE VERSUS MULT1DISC1PL1NARY ADVICE 
Patients often mentioned both reasons. Other reasons for a positive 
assessment were that patients were pleased for having been examined so 
thoroughly and that they were relieved for still doing reasonably well. 
Reasons for not appreciating the assessment were that the advice was 
difficult to implement or patients did not feel that their problems were taken 
seriously. At least 95% of the patients agreed with the advice given for OT 
(99%), PT (95%) and ST (100%]. 
Table III. Patient appreciation of their assessment 
Valuable 
• Because attention was paid to 
my problems and needs 
• Because new information or 
advice was given 
• Because of both of the 
foregoing reasons 
• For other reasons 
Total 
Not valuable 
• No problems nor needs 
• No new information nor advice 
• For other reasons 
Total 
Occupational 
Therapy 
{n=89) 
40.4% 
10.1% 
32.6% 
0% 
83.1% 
12.4% 
1.1% 
3.4% 
16.9% 
Physical 
Therapy 
(n=86) 
44.2% 
11.6% 
29.1% 
4.7% 
89.5% 
2.3% 
3.5% 
4.7% 
10.5% 
Speech 
Therapy 
(n=88) 
28.4% 
12.5% 
28.4% 
3.4% 
72.7% 
25% 
2.3% 
0% 
27.3% 
Volume ofOT,PT and ST 
In the reference group, the volume of OT, PT or ST received during the 6 
months before inclusion in the study (baseline] and at 6 months follow up 
were not significantly different (Table IV]. In the intervention group, there 
was a significant underuse of OT in 40% of the patients and hardly any 
overuse of OT. The mean difference between the usual and recommended 
amount of OT was 2 sessions per patient in 6 months (underuse]. There was 
a significant underuse of PT in 22% of patients and overuse in 32%, with a 
net mean difference of 6 sessions per patient (overuse]. There was limited 
underuse and overuse of ST (Table V]. 
37 
CHAPTER 2 
Table IV. OT, PT and ST received by the reference group in the 6 months preceding the 
study and in the subsequent 6 months 
Number of treatment 
sessions 
Occupational Therapy* 
0 
1-10 
11-25 
26-52 
>52 
Physical Therapy f 
0 
1-10 
11-25 
26-52 
>52 
Speech Therapyt 
0 
1-10 
11-25 
26-52 
>52 
Reference group 
Previous 6 months 
(n=106) 
90.6% 
6.6% 
1.9% 
0.9% 
0% 
67.9% 
0.9% 
12.3% 
16.0% 
2.8% 
95.3% 
4.7 % 
0% 
0% 
0% 
Reference group 
Following 6 months 
Cn=87) 
93.1% 
5.7% 
1.1% 
0% 
0% 
59.8% 
2.3% 
12.6% 
25.3% 
0% 
97.7% 
1.1% 
0% 
1.1% 
0% 
*p>0.1 for the volume of OT; tp>0.05 for PT ; φρ>0.7 for ST. 
Table VI shows the number and distribution of therapy sessions received 
over 6 months in the intervention group. It was recommended that more 
patients should have a short course of OT, PT and ST. Compared with the 
amount of PT received at baseline, the multidisciplinary advice was 
amounted to a reduction of the number of PT sessions. Comparison of 
therapy received at baseline with that at 6 months follow up revealed a non­
significant reduction of PT and a significant increase of OT and ST (Table VI). 
At baseline, fewer than 10% of patient had had a short course of OT; at 6 
months, this number exceeded 25%. The number of patients receiving 1 to 10 
sessions of PT increased from nearly 5% at baseline to more than 11% at 6 
months. For ST, only 1% of patients had received a short course of ST at 
baseline, whereas this number rose to more than 10% at 6 months. The data 
for the 6-month follow-up showed that the therapy advice was only poorly 
implemented (Table VI). 
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Table V. Percentage of overuse and underuse of OT, PT and ST and the overall mean 
difference between amount of therapy received at baseline and the amount advised by 
OT, PTandST(n=102) 
Overuse 
Neutral 
Underuse 
Mean difference 
(Standard 
deviation) 
Occupational 
Therapy 
2% 
58% 
40% 
2.1 (4.0) 
Under-use 
Physical 
Therapy 
32% 
46% 
22% 
6.1 (15.2) 
Over-use 
Speech 
Therapy 
1% 
94% 
5% 
0.4 (2.6) 
Under-use 
Impact of the multidisciplinary advice on health care costs 
The costs of the multidisciplinary assessments and integrated advice were 
assumed to consist of personnel costs only, and were estimated at €245 per 
patient. Each PT and OT assessment lasted an hour and the mean duration of 
the ST assessment was half an hour. Reports took about half an hour to write. 
Using the cost price of €23.60 for half an hour, the cost of the allied health 
assessment and reporting were 8 χ 23.60 = €188.80. The multidisciplinary 
meeting lasted 10 minutes per patient, leading to a cost of €23.60 for the 
allied health professionals (OT, PT and ST) and €32.67 for the consultants 
(neurologist and rehabilitation physician). 
Comparing the costs of current practice (OT, PT and ST at baseline) 
and the costs of the recommended therapy showed that recommended 
practice could lead to mean cost savings of €85.20 per patient (mean increase 
of 2.1 OT sessions and 0.4 ST sessions and mean decrease of 6.1 PT sessions 
per patient). However, at 6 months the recommendations were only partially 
implemented. While the mean amount of OT received had increased by 1.60 
sessions per patient, the mean amount of ST received had increased by 0.1 
sessions per patient and that of PT had decreased by 0.8 sessions per patient. 
The actual amount of OT, PT and ST received at 6 months increased costs by 
€21.24 per patient in addition of the costs of the multidisciplinary 
assessment and advice. 
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Table VI. Volume of OT, PT and ST in the intervention group during the 6 months 
preceding study entry, based on the advice and at 6 months 
Number of 
treatment 
sessions 
OTsessions 
0 
1 - 1 0 
1 1 - 2 5 
2 6 - 5 2 
>52 
PT sessions 
0 
1 - 1 0 
1 1 - 2 5 
2 6 - 5 2 
>52 
ST sessions 
0 
1 - 1 0 
1 1 - 2 5 
2 6 - 5 2 
>52 
Intervention group 
at baseline 
(n=102) 
63 
91.2% 
7.8% 
1.0% 
0% 
0% 
1333 
59.8% 
4.9% 
10.8% 
20.6% 
3.9% 
12 
9 9 % 
0% 
1.0% 
0% 
0% 
Intervention group 
based on advice 
(n=102) 
281* 
55.9% 
44 .1% 
0% 
0% 
0% 
708* 
51% 
24.5% 
13.7% 
9.8% 
1.0% 
48 
94 .1% 
3.9% 
2.0% 
0% 
0% 
Intervention group 
at 6 months 
(n=88) 
177t 
72.7% 
22.7% 
2.3% 
2.3% 
0% 
1011 
58.0% 
11.4% 
9.1% 
19.3% 
2.3% 
23t 
88.6% 
10.2% 
1.1% 
0% 
0% 
* p<0.01 for the volume of OT (p=0.00], PT (p=0.00] and ST (p=0.17) retrospectively measured 
compared to the volume based on the advice, t ?< 0.05 for the volume of OT (0.01), PT (0.55) 
and ST (0.05] retrospectively measured at baseline compared to the volume retrospectively 
measured at 6 months follow up. 
Discussion 
In this study we compared the volume of OT, PT and ST in NMD currently 
received with the volume recommended by an expert multidisciplinary team. 
In the absence of scientific and solid empirical evidence (a gold standard] 
regarding the most appropriate volume of allied health care for patients with 
NMD, this 'expert advice' was considered as 'next-best' standard of reference. 
Our results show that the expert advice regarding the volume of OT, 
PT and ST differed considerably from the actual service provision among 
patients with NMD. According to the expert advice, far more patients would 
need a short course of therapy or advice during a single consultation. In this 
article we use the terms 'overuse' of 'underuse' to describe the difference 
between the actual volume of OT, PT and ST and the recommended volume. 
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For sake of brevity, we have used these terms in our paper, although these 
terms imply a standard of care that is presently unavailable. 
Regarding OT, there was a substantial 'underuse' of OT in current 
practice compared to the recommended volume of OT. This underuse is 
confirmed in an inventory of allied health care for chronically disabled in the 
Netherlands20. An unmet need for OT among patients with diseases of the 
nervous system is reported. Reasons for this unmet need include: 1) lack of 
awareness in patients and referring physicians of what OT has to offer; 2) 
problems with referral (too late or not at all) in one third of the patients; 3] 
problematic OT funding by health insurance companies for about 46% of 
chronic conditions; and 4) the poor availability of OT in primary care20. These 
reasons may also explain the difficulties experienced to implement the expert 
advice. 
Compared to the recommended volume of PT, there was Overuse' as 
well as 'underuse' of PT in current practice. PT overuse was often the result 
of a higher frequency and duration of PT in current practice than suggested in 
the expert advice. Instead of continuous PT, a short course of PT was advised 
to address specific treatment goals, such as instructions to the patient how to 
maintain an optimal physical condition with an individual exercise 
programme. It appears that patients are insufficiently aware that they can 
continue exercises on an individual basis, not necessarily requiring 
professional supervision20. In our study often 6-8 PT sessions were advised, 
after which patients were encouraged to further carry out the exercises by 
themselves. A comparable PT approach, with 6-8 sessions, was described in a 
study on the implementation of clinical guidelines for patients with low back 
pain21. 
In current practice there was also 'underuse' of PT. This was the case 
when patients did not have PT, but the multidisciplinary team recommended 
that they received instruction and advice within a single consultation or 
within a short episode of PT. The Dutch inventory of allied health care 
reports that it is difficult to generalise about the need for PT in chronic 
conditions and that the duration of therapy depends on the results of 
therapy, the age of the patient and the type of health problems20. Patient 
organizations have pointed out that physiotherapists have insufficient 
knowledge concerning more than half of the 74 chronic conditions for which 
PT is indicated. Also physiotherapists themselves feel that they lack expertise 
in 70% of chronic conditions. Besides, in 30% of the chronic conditions for 
which PT is indicated, the coordination of the care of different professionals 
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is considered a problem20. These findings support the need of an integrated 
multidisciplinary approach. 
There was some 'underuse' of ST when comparing the volume of ST 
recommended in the expert advice with current volume of ST. A considerable 
number of patients received information, instruction and advice on problems 
with eating and drinking and communication during a single ST consultation. 
Generally an unmet need for ST is estimated in patients with chronic 
progressive neurological conditions with voice or speech disorders, hearing 
disorders, breathing problems and generally communication problems20. It is 
remarkable that problems with swallowing or chewing (eating and drinking) 
are not reported in the Dutch inventory of allied health care. Patients with 
chronic progressive neurological conditions such as NMD regularly 
experience such problems. The speech therapists working at the 
neuromuscular centre of Nijmegen have specific expertise in the diagnosis 
and provision of advice regarding these problems2224. 
Patient organizations and speech therapists both feel that generally 
speech therapists lack knowledge about chronic conditions. Besides, patients 
are not aware of what ST has to offer and referring physicians lack insight 
into when a patient should be referred for ST20. 
Our findings and the reported problems regarding OT, PT and ST for 
chronic conditions20, support the value of a integrated multidisciplinary 
expert advice regarding appropriate allied health care for patients with NMD. 
Also, the majority of the patients rated the multidisciplinary assessments and 
advice positively. 
Obviously, the implementation of treatment recommendations could 
be improved. Reasons for poor implementation include limited awareness 
among patients and referring physicians, and problems with referral, 
availability and funding. Additionally, there may be problems with the 
feasibility of the advice, limited motivation to change routines or limited 
knowledge and skills of therapists to implement the advice. These causes 
have been explored and will be analysed and published together with 
possible ways to obtain a stronger commitment on the part of allied health 
services in primary care. 
Although the multidisciplinary assessment resulted in a decrease in 
the cost of allied health services, these savings were offset by the extra costs 
incurred by the multidisciplinary assessments. Clearly, ways need to be found 
to obtain a more favourable balance between the costs and savings of the 
multidisciplinary approach. 
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Limitations of this study include possible recall bias of the volume of 
allied health care. Still, we preferred patient questionnaires above patient 
records since the latter did not provide reliable information on this subject. 
Secondly, one could question whether service utilisation during an eight 
week period may be extrapolated to 26 weeks. However, the amount of OT, 
PT and ST measured retrospectively with a patient questionnaire did not 
differ significantly with the amount measured prospectively with a health 
care diary for eight weeks and extrapolated to six months. We therefore felt 
that it was justifiable to conclude that the amount of OT, PT and ST did not 
change in the usual care group. 
On the basis of our findings, we cannot comment on the effect of the 
intervention on patients' health status in terms of functional status or quality 
of life, because this would require a different study design and different 
outcome measures. Such studies are very much needed. 
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Abstract 
Purpose: Patients with neuromuscular diseases (NMDs) do not always receive 
appropriate allied health care. This is partially because of the large 
heterogeneity among these conditions, some of which are quite rare. 
Individual allied health care professionals, therefore, have relatively little 
opportunity to develop relevant experience with these patients. To overcome 
this problem, we developed specialist multidisciplinary advice regarding 
management of patients with NMD for occupational therapy (OT], physical 
therapy [PT] and speech therapy (ST] in a primary care or rehabilitation 
setting. The aims of the study were to explore to what extent this allied health 
care advice was implemented with a focus on the amount of therapy received 
and to explore possible barriers to implementation. 
Methods: One-hundred two patients visited the Neuromuscular Centre 
Nijmegen for OT, PT and ST consultations. Integrated allied health care advice 
was written on the basis of these consultations and a multidisciplinary 
meeting. All patients, their therapists and rehabilitation physicians received 
this advice. Following the advice, questionnaires were sent out at baseline 
and at 6 months follow up, collecting data on implementation of the amount 
of therapy suggested and on possible barriers for adherence. 
Results: Advice for ST and OT was fully implemented in primary care, but only 
partially (58%] in a rehabilitation setting. Advice to reduce the amount of PT 
was implemented in only 15% of the cases. Possible barriers were related to 
the advice itself (feasibility of treatment duration, correctness and 
completeness], the patient (motivation] and the professional (experience in 
treatment of NMDs]. Therapists expressed a desire to have the opportunity to 
discuss the treatment advice with the multidisciplinary team. 
Conclusions: The extent to which multidisciplinary advice was implemented 
differed for OT and ST compared to PT and for the setting (primary care or 
rehabilitation]. Possible barriers were identified at different levels. We 
recommend follow-up telephone calls to provide therapists opportunity for 
discussion. 
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Introduction 
At least one in 3500 individuals develops a disabling neuromuscular disease 
[NMD] at some time during childhood or later in life1. Sooner or later, these 
patients are confronted with impairments in functions, activity limitations 
and participation restrictions. When this is the case, they may benefit from 
allied health care, including occupational therapy (ΌΤ), physical therapy (PT) 
and speech therapy (ST). Unfortunately, such therapy is not always 
adequately provided to meet the complex needs of this patient population25. 
This may result from the fact that patients and referring physicians are not 
fully aware of existing treatment opportunities, the weak evidence for ΟΤ, PT 
and ST in NMD6 8, and the scarcity of therapists in primary care who have 
sufficient clinical experience with these patients4 5. These findings support 
the need for specialist services for patients with NMD. Both in the UK5 and 
the Netherlands, care for patients with NMD is concentrated in a limited 
number of specialised centres. However, because of limited capacity, it is 
impracticable to manage all patients under treatment in these centres. For 
patients to fully benefit from such services, knowledge and experience should 
be transferred to OTs, PTs and STs in primary care and rehabilitation centres, 
where their treatment can be continued. 
For this purpose, our neuromuscular centre has developed a 
consultation and advice service for OT, PT, and ST. Part of this service 
consists of the development of integrated, multidisciplinary allied health care 
treatment advice for each individual patient. This advice is based on the best 
available scientific evidence and clinical experience. For OT, scientific 
evidence consists of indications for the efficacy of hand training in muscular 
diseases7; for PT, there is weak evidence of efficacy for strengthening 
exercise in combination with aerobic training in different types of NMD and 
for breathing exercises in some specific forms of NMD6; for ST, evidence 
indicates that correction of head position in patients with OPMD improves 
swallowing8. There is no evidence of efficacy of interventions such as 
education of patients and family, practicing skills or activities, or the use of 
assistive advices. Also, lifestyle modification strategies including pace setting 
or other energy conservation techniques have not yet been studied for their 
effectiveness. For best practice though, these strategies are used in OT, PT 
and ST in order to enable participation in activities and roles which are 
meaningful to the daily life of persons. 
The OT, PT and ST consultations included assessments of body 
functions, activities and participation2. Upon completion of the assessment. 
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some patients received advice with no further treatment required. If further 
treatment was advised, the objectives, the content and the expected duration 
were explicitly stated2. An example of treatment objectives for PT was 'to 
increase stamina to be able to cycle for at least half an hour and to implement 
regular exercise in daily life'. To reach these objectives, aerobic exercise on a 
bicycle was suggested with a frequency of twice a week for 6 weeks followed 
by an evaluation. For OT, an example of an objective was 'to have enough 
energy to make dinner safely without fear of falling'. To reach this goal, 
supporting the patient in the use of energy conservation strategies and 
assistive devices was suggested. The expected duration was 5 sessions of OT 
in the home situation. Regarding ST, many patients received advice during 
the consultation and did not need further treatment. These activities involved 
for instance speaking slower, eliminating certain food or eating and drinking 
with slightly flexed head position. 
The advice was offered to the OTs, PTs or STs in primary care or to a 
rehabilitation physician. However, following such advice may require 
changes in established long standing practices in the management of these 
patients, hampering implementation9. Therefore, the aims of this study were: 
1. to investigate the extent to which the allied health care advice was 
implemented in OT, PT and ST practice in primary care and 
rehabilitation setting and 
2. to identify possible barriers for implementation, based on a conceptual 
model of implementation of changes in health care9; these barriers 
were related to the advice itself, the patient, the professional, and the 
organisation. 
Methods 
Patients 
A prospective cohort study was carried out with consecutive patients visiting 
the outpatient department of the Neuromuscular Centre Nijmegen, the 
Netherlands. Patients were asked to participate if they fulfilled the following 
inclusion criteria: age 18 years or older; a definite or probable NMD; 
sufficient command of the Dutch language and informed consent to 
participate in this study. The study was approved by the local medical ethics 
committee. 
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Procedure and questionnaires 
The procedures that were used in this study are schematically represented in 
Figure 1. Eligibility for inclusion was assessed on the basis of a medical 
record review. After receiving written informed consent, patients were 
invited to attend the Neuromuscular Centre Nijmegen twice. At the first visit 
(TO], they consulted a neurologist and completed Patient questionnaire 1, 
which asked the patient about the use of allied health care during the 
previous 6 months, their medical diagnosis and duration of the disease. 
Patients reporting to have OT, PT or ST, were asked to hand their therapist 
Professional questionnaire 1, asking information regarding frequency, 
duration and content of current therapy. These therapists were also asked to 
estimate the number of patients with NMD they treat annually, and whether 
they would appreciate advice from a centre of expertise. Within 2 weeks from 
the first visit, patients were seen by an OT, PT and ST from the centre. 
Integrated allied health care advice was developed on the basis of these 
consultations and a multidisciplinary meeting (2). The advice was sent to the 
patients together with Patient questionnaire 2 (Tl], asking for their opinion 
on the OT, PT and ST consultations and their satisfaction with the advice 
provided (2). The therapists in primary care also received this advice as well 
as Professional questionnaire 2. This questionnaire included statements about 
the advice (clarity, feasibility and credibility), about the professionals' 
appreciation of the advice and the organisation and the communication 
around the advice (see Appendix 1). Response options for each statement 
were 'agree', 'neither agree nor disagree', or 'disagree'. In case patients had 
been treated by a rehabilitation physician prior to the consultation, or if the 
advice involved a multidisciplinary approach to be coordinated by a 
rehabilitation physician, the advice was sent to the rehabilitation physician. 
After six months (T2), Patient questionnaire 3 and Professional 
questionnaire 3 were sent to the patients and their allied health care 
providers or rehabilitation physicians. Patients were questioned about the 
amount of OT, PT or ST services that they had received since the advice. 
Allied health care professionals or rehabilitation physicians were questioned 
about the advice itself (clarity, feasibility, credibility, adaptability), about the 
patient (motivation), about themselves as a professional (appreciation, 
knowledge/skills, attitudes/ habits, communication) and about the process 
(referral, practice, time, waiting list, funding and communication) (see 
Appendix 2). 
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Figure 1. Flowchart showing the inclusion, consultation and advice, and follow up of patients and 
professionals involved. 
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Implementation measure 
For OT and ST, implementation was considered successful if patients had 
indeed received OT or ST as recommended. Patients who had received advice 
for OT or ST were divided into two groups: patients who were referred 
directly to OT or ST in primary care and patients who were referred to a 
rehabilitation physician. For PT, this distinction did not apply, since most 
patients already had PT in primary care and also visited a rehabilitation 
physician. For PT, implementation was considered successful if patients 
received the recommended amount of PT as advised. The outcomes were 
divided into five categories: continued not to have PT, discontinued PT, 
reduced the amount of PT, continued the same amount of PT, or initiated PT 
as recommended. 
Statistical analysis 
Chi-square statistics were carried out as appropriate to test the significance 
of the correlation between referral procedure (primary care or rehabilitation 
setting) and successful implementation for OT and ST and the correlation 
between the category regarding the volume advised and implementation for 
PT. 
For the analysis of Professional questionnaires 2 and 3 descriptive 
statistics were used. The percentages 'agreement', 'neither agreement nor 
disagreement' and 'disagreement' were calculated for each statement. If less 
than 70% of the respondents agreed (disagreed when negatively formulated) 
with a statement, these statements were further analyzed with use of non-
parametric (Chi-square] statistical test procedures. 
Results 
Inclusion and follow up of patients 
The process of inclusion, baseline measurements, consultation, advice and 
follow up measurements are presented in Figure 1. In total, 257 medical 
records were reviewed to identify eligible patients. Eighty patients failed the 
inclusion criteria and another 64 patients did not participate for a variety of 
reasons. Informed consent was obtained from 113 patients. Eleven patients 
dropped out, leaving 102 patients who participated in the research project 
and who completed Patient questionnaire 1. The characteristics of the 
patients including age, gender, medical diagnosis and duration of disease are 
presented in Table I. 
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Table 1. Characteristics of patients Included (n=102) 
Age (years] 
Mean (standard deviation] 
range 
Gender 
Male / female ratio 
Medicai diagnosis 
Motor neuron disorders 
Motor nerve root disorders 
Peripheral nerve disorders 
Neuromuscular transmission disorders 
Muscle disorders 
muscular dystrophies 
myopathies 
myositis 
Duration of complaints 
0-6 months 
6-12 months 
>12 months 
49 (13] 
20-73 
5 1 / 5 1 
8 
4 
15 
7 
68 
39 
21 
8 
3 
4 
95 
All patients [n=102] visited the OT, PT and ST of the neuromuscular centre 
and received written integrated advice together with Patient questionnaire 2. 
The response rate for Patient questionnaire 2 was 89% (n=91]. Most patients 
(83% for OT, 90% for PT and 73% for ST] highly valued the assessments and 
appreciated the professional attention paid to their problems and needs. 
Where patients indicated they did not appreciate the assessment and advice, 
the main reasons for this were that they did not experience any problems or 
did not have any needs in this particular area. Nearly all patients agreed with 
the advice given for OT (99%], PT (95%] and ST (100%)2. The response to 
Patient questionnaire 3 was 86% (n=88] (Figure 1]. 
Implementation of advice on occupational therapy 
During the 6 months prior to the consultations, nine patients had had OT, of 
which six patients still received OT. Forty-five percent of the patients (n=46] 
received advice for OT treatment, 21 (46%] of whom were referred directly 
to primary care and 25 (54%] to a rehabilitation physician (Figure 1]. The 
percentage of successful implementation for patients referred to OT in 
primary care was 100%, versus 58% for patients referred to a rehabilitation 
physician (p<0.001]. Reasons for not implementing the advice are presented 
in Table II. The reasons from the patients' perspective generally correspond 
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with the reasons from the perspective of the rehabilitation physician and 
include barriers at the level of the advice (unclear), the patient (personal 
reasons), the professional (disagreement with advice) and the organization 
(waiting list). 
Table II. Reasons for not having had OT according to patients and rehabilitation 
physicians (n=10] 
Patient's perspective 
Did not know what to do 
Illness of partner 
Appointment in near future 
Rehabilitation physician disagreed 
No need for OT anymore 
OT advice integrated in PT 
Not specified (n=4) 
Rehabilitation physician's perspective 
Patient never made an appointment 
Patient is not motivated 
There is a waiting list for appointments 
Problems had been addressed before (n=33 
Questionnaire not completed (n=2} 
Patient is not in treatment anymore 
Rehabilitation physician does not work here 
anymore 
Missing (n=2) 
OT=occupational therapy; PT= physical therapy 
The response rate for OT questionnaire 2 was 95% (n=20) (see Figure 1). Less 
than 70% of OTs in primary care agreed that they would adopt the advice 
regarding the location where the treatment should be given. Specifically, OTs 
often preferred to treat a patient at home, when the advice recommended 
treatment in an OT department. 
The response rate for OT questionnaire 3 at 6 months follow up was 
90% (n=19) (Figure 1). Less than 70% of OTs in primary care agreed with 
feasibility of all therapy goals (59%) or with the statement that therapists 
from the neuromuscular team were easily to contact (47%). In addition, 33% 
of OTs indicated lack of waiting lists and 67% indicated problems related to 
appropriate funding. 
Implementation of advice on physical therapy 
Forty patients (39%) had PT when they participated in the study. Thirty-five 
PTs (88%) returned PT questionnaire 1 (Figure 1). The majority of the PTs 
(71%) treated patients for a duration of at least 1 year and 82% saw their 
patients at least once a week or more. Most PTs in primary care (73%) 
treated less than five patients with a NMD per year and all PTs appreciated 
receiving advice from the neuromuscular centre. 
According to the multidisciplinary team, 45% of the patients had an 
indication for PT. Of these, 70% (n=32) were, in fact, under PT treatment. 
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Among patients who were considered not to have an indication for PT 
(n=54), 15% (n=83 were under PT treatment. For 63% of the patients (n=64) 
the advice did not involve any change [continue not to have PT or continue to 
have PT as given), and the advice was almost fully implemented. In contrast, 
implementation of advice recommending a change in the amount of PT was 
significantly less [p<0.001). Implementation of advice recommending a 
reduction in the amount of PT was 15% [2 out of 13), recommendations to 
discontinue PT were implemented in 37.5% [3 out of 8) and 
recommendations to initiate PT were implemented for 29% of the patients [2 
out of 7) [Figure 2). 
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No PT before 
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Had PT before 
No PT indication 
n=54 
PT indication 
n=46 
No PT before 
n=15 
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have PT 
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Missing 
Γ n=3 
vos 
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Continue volume 
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Figure 2. Flow chart implementation physical therapy advice. PT, physical therapy. 
* For one patient there was an indication for PT only if the complaints did not disappear 
within two weeks and for another patient the advice was to discontinue PT in primary 
care and wait for the multidisciplinary rehabilitation programme. 
The response rate for PT questionnaire 2 was 76% [n=29) [Figure 1). 
Less than 70% of the PTs agreed with the six statements: clarity of treatment 
location, feasibility of therapy duration, feasibility of treatment location, 
completeness of advice, ability to provide information and opportunity for 
discussion. None of these statements correlated significantly with 
implementation of the advice. 
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The response rate for PT questionnaire 3 was 66% (n=25] (Figure 1). 
Less than 70% of the PTs agreed with the 12 statements. These were 
statements regarding feasibility of the advice (treatment goals, treatment 
duration and treatment location), credibility of the advice (correctness of 
advice, completeness of information and need for more information), patient 
motivation, experience in treatment of patients with NMD, communication 
with the neuromuscular team (therapists easily to contact, referral received 
and reporting findings to referring physician), and appropriate funding. None 
of the statements had a significant impact on implementation (Chi-square 
test statistic p>0.05). Six statements, however, did seem to be related to 
implementation of the advice, including feasibility of the treatment duration, 
correctness of the advice, completeness of information, need for more 
information, experience with treatment of patients with NMD and patient 
motivation (Appendix 2). 
Implementation of advice on speech therapy 
Two out of 102 patients had ST in the 6 months prior to the multidisciplinary 
consultation (see Figure 1). One ST returned ST questionnaire 1. This ST saw 
less than five patients with NMD per year and valued advice from the 
neuromuscular centre. Six percent of the patients (n=6) received ST advice 
for further treatment. For three patients the advice was sent to a ST in 
primary care and for three patients the advice was sent to a rehabilitation 
physician (Figure 1). Four patients (67%) responded to Patient questionnaire 
2 and 3. All STs responded to ST questionnaire 2 and 3 and all rehabilitation 
physicians had returned the Rehabilitation physician questionnaire 2 and 3. 
All ST advice was fully implemented. Because of the limited number of 
questionnaires, no further analyses were undertaken. 
Discussion 
Our main finding was a wide difference between the implementation of 
advice for OT and ST and that of PT. OT and ST advice was fully implemented 
in primary care, which is remarkable, given that passive dissemination of 
information (only sending the advice) is generally an ineffective strategy9. 
Our high rate of implementation is very likely related to the current underuse 
of OT and ST (2), which, in turn, may result from the fact that OT and ST 
services are generally less well-known to patients and physicians, and the 
scarcity of scientific evidence for their effectiveness68. 
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However, implementation was considerably less successful (58%) 
when the advice was sent to a rehabilitation physician. Barriers to 
implementation were identified at all levels [advice, patient, rehabilitation 
physician, and organisation). In most cases, the patients were known to the 
rehabilitation physician and the problems were generally more complex than 
the problems of the patients referred to primary care. 
Implementation of advice to change the amount of PT was extremely 
poor. Potential barriers for implementation included feasibility of the 
suggested treatment duration, correctness of advice, completeness of 
information, need for more information and lack of opportunity for 
discussion about the treatment advice. Other factors that may have 
contributed to poor implementation include lack of patient motivation, PT's 
lack of clinical experience and knowledge with NMD and income 
deprivation24. 
It should be noted that NMD are chronic progressive conditions, with 
increasing loss of abilities. Although there is limited evidence regarding the 
effectiveness of PT on improving bodily functions, patients may perceive a 
need to control this gradual process of deterioration and may feel reassured 
having PT. This need for continuous monitoring of their condition by PT 
might have contributed to the limited implementation of advice to reduce the 
amount of PT. Other reasons might have been that the goals had not been 
reached within the timeframe suggested or that of new goals arose. 
For an improved understanding and resolution of barriers related to 
feasibility, lack of information and correctness of information, a follow-up 
telephone contact with the professionals in primary care or rehabilitation 
setting would be a logical intervention strategy. A follow-up telephone call 
provides an opportunity to exchange experience, to provide additional 
information and available scientific evidence if needed to support the 
professionals in the decision making process. Another way to increase 
understanding of the barriers for implementation would have been a focus 
group with PTs to discuss the findings in respect to poor implementation of 
the amount of therapy advised. 
A limitation of this study is that we could not assess whether the 
content of the advice was implemented. Nor did we evaluate the advice with 
patient-centred measures. Another shortcoming is that we investigated the 
implementation and possible barriers for all NMDs together. Because of small 
numbers for the various NMD diagnoses, we could not investigate whether 
implementation differed across the various diagnoses. 
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The aim of this study was to improve allied health services for patients 
with NMD by providing advice from a neuromuscular centre. This way, 
patients can continue to have allied health care close to where they live, and 
therapists are provided with knowledge and experience from a 
neuromuscular centre. To obtain greater uniformity in content of therapy, the 
accumulative knowledge and experience should precipitate into guidelines. 
We also strongly recommend the use of more explicitly defined goals of 
therapy and the use of instruments to measure change. This would provide 
patients and therapist with opportunities to discuss continuation or 
discontinuation of therapy. 
Conclusions 
We explored the extent to which multidisciplinary advice was implemented 
in daily care. Recommendations were generally readily adopted when 
additional therapies were suggested to address patient needs and where no 
capacity problems existed. Where we recommended critically evaluating, and 
possibly reducing therapy, this was hardly implemented. To improve 
implementation of this type of knowledge transfer, we suggest improved 
communication between professionals from the centre of expertise and local 
professionals, for instance through follow-up telephone calls. Also the use of 
agreed moments to evaluate therapy may assist in deciding when to continue 
and when to discontinue therapy. 
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Appendix 1: Statements included in Professional questionnaire 2 
Clarity of the advice in general 
- The lay-out of the advice is clear 
- The language of the advice is understandable 
- The length of the advice is good 
Clarity of specific OT/PT advice 
- The OT/PT/ST advice is clear 
- The language of the OT/PT/ST advice is understandable 
- The length of the OT/PT/ST advice is good 
- The therapy goals are clearly described in the OT/PT/ST advice 
- The number of hours are clearly described in the OT/PT/ST advice 
- The therapy frequency is clearly described in the OT/PT/ST advice 
- The therapy duration is clearly described in the OT/PT/ST advice 
- The place of therapy is clearly described in the OT/PT/ST advice 
Feasibility of the advice 
- The therapy goals are applicable 
- The therapy goals are attainable 
- The therapy frequency seems feasible 
- The therapy duration seems feasible 
-1 will treat at the suggested place of therapy 
Credibility of the advice 
- The whole advice is complete 
- The OT/PT/ST part is complete 
Appreciation by the professional 
-1 appreciate the advice 
- The advice is important 
- The advice is a valuable contribution to the therapy 
Organization and communication around the advice 
-1 have received an information leaflet 
- The information leaflet was clear 
-1 was able to provide information 
- There was opportunity for discussion. 
OT= Occupational Therapy; PT= Physical Therapy; ST= Speech Therapy 
hi 
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Appendix 2; Statements included in Professional questionnaire 3 
Clarity of the advice in general 
- The advice is clearly formulated 
Feasibility of the advice 
- Certain therapy goals are not attainable 
- The treatment duration is not feasible 
- The treatment location is not feasible 
Credibility of the advice 
- Parts of the advice are incorrect 
- The advice can be used in a wrong way 
- The advice lacks important information 
-1 need additional information 
Adaptability of the advice 
- There is enough room for my own considerations 
- There is enough room for the patients' wishes 
Patient motivation 
- The patient is not motivated for this advice 
Appreciation by the professional 
-1 appreciate the advice 
-1 feel resistance towards the advice 
Knowledge/skills of the professional 
-1 have enough knowledge to implement this advice 
-1 have enough skills to implement this advice 
-1 lack experience in the treatment of neuromuscular diseases 
Attitudes/habits of the professional 
- This advice resembles my working routines 
-1 have problems changing my routines 
Communication of the professional 
-1 have discussed the advice with the patient 
-1 have reported my findings back to the referring physician 
Organization and communication 
-1 have received a referral 
-1 have received the advice 
-1 have received an information leaflet 
- Therapists were easily to contact 
- The advice costs more time than I can give 
- My practice is not suitable 
- There is a waiting list of more than a month 
- There is no appropriate financial funding. 
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Abstract 
A systematic review was conducted to assess the evidence base of 
occupational therapy for adults with neuromuscular diseases. A 
comprehensive search for controlled and uncontrolled studies was 
performed in the Cochrane, Medline, CINAHL and Embase databases. After 
screening 3,534 titles and abstracts, six articles were retrieved for more 
detailed evaluation. Only two of the studies met all of the predefined criteria 
and were subjected to methodological assessment. These studies provide 
indications for the efficacy of hand training in muscle diseases. There is a lack 
of scientific evidence regarding the question of whether patients with 
neuromuscular diseases are better capable of participating in meaningful 
activities and roles through occupational therapy. Recommendations for 
future research are given. 
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Introduction 
Neuromuscular diseases include disorders of the muscle, the neuromuscular 
transmission, the peripheral nerve, the nerve root, or the motor neuron. Most 
of these diseases have a slowly progressive course with increasing 
impairments such as muscle weakness, exercise intolerance, fatigue or pain, 
that ultimately result in limitations in activities and restrictions in 
participation. On the basis of these sequelae, it is conceivable that a 
considerable portion of these patients may benefit from occupational 
therapy. Indeed, in a cohort of 102 consecutive patients with neuromuscular 
diseases attending our outpatient clinic, 43% were considered to potentially 
benefit from occupational therapy1. However, this judgment was entirely 
based on the clinical expertise of the participating occupational therapists. 
The purpose of this article is to assess whether there is evidence for 
occupational therapy for patients with neuromuscular diseases. 
Methods 
We searched the Cochrane Database of Systematic Reviews and the Cochrane 
Central Register of Controlled Trials [The Cochrane Library 2005, Issue 3), 
Ovid Medline In-Process & Other Non-Indexed Citations and Ovid Medline 
[1966 through September 2005), WebSPIRS 5.1 CINAHL [1982 through 
September 2005} and WebSPIRS 5.03 EMBASE [Rehabilitation and Physical 
Medicine] [1995 through September 2005). The search strategy was based 
on: 1) a search of randomized controlled trials and controlled clinical trials as 
recommended by the Cochrane Neuromuscular Disease Group; 2) a search of 
other research designs; 3) a search of different types of neuromuscular 
diseases; and 4] a search of occupational therapy interventions. For all search 
strategies medical subject headings [MeSH] or indexed terms were used in 
addition to free text words. The full search strategy can be found in appendix 
A at the end of this chapter. Reference lists of selected articles and related 
articles were scanned for other potential relevant articles. 
Selection criteria 
Inclusion of articles was restricted to peer-reviewed articles with an abstract 
that were published in the English, German, French or Dutch language. 
Regarding types of studies, we included randomized controlled trials, 
controlled clinical trials and other designs such as pre-post designs. Single 
case studies were excluded. 
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Regarding the types of participants, we included studies with adults 
(individuals older than 18 years] with different types of neuromuscular 
diseases. Children or adolescents (individuals younger than 18 years) with 
Duchenne muscular dystrophy, spinal muscular atrophy or Becker muscular 
dystrophy were not included. The content and the context of occupational 
therapy in children are different from occupational therapy for adults with 
neuromuscular diseases due to aspects such as development and growth. 
Entrapment neuropathies (such as carpal tunnel syndrome or cubital 
tunnel syndrome), radiculopathies, thoracic outlet syndrome or diabetic 
neuropathies were excluded, because we were interested in the chronic 
progressive types of neuromuscular diseases. Diagnoses with impairments 
similar to those in neuromuscular diseases, such as chronic fatigue syndrome, 
spinal cord injuries, reflex sympathetic dystrophy or complex regional pain 
syndrome, forms of cancer, and acquired immunodeficiency syndrome, were 
also excluded. 
Occupational therapy interventions had to include training of activities 
of daily living (including self care, mobility, work, household tasks, or leisure) 
skills training (including fine motor skills), advice and instruction in the use 
of assistive devices, provision of splints and slings, counseling on energy 
conservation strategies, educating patient, families and caregivers, or a 
combination of the above. Studies evaluating specific assistive devices such as 
wheelchairs, robotic arms or mobile arm supports were excluded unless the 
evaluation comprised instruction and advice specifically provided by 
occupational therapists. 
Primary outcome measures had to be at the level of activities and 
participation, quality of life, or general health. Outcome measures at the level 
of pain, fatigue, muscle strength or fine motor skills (dexterity) were 
accepted as secondary outcome measures. 
Procedure for inclusion 
A preliminary screening of titles and abstracts was performed by two 
qualified occupational therapists (EHCC and 1HWMS). Full texts of studies, 
that were considered potentially eligible for inclusion, were reviewed further. 
Based on the full articles, the two reviewers independently made a final 
selection using the criteria described above. In cases of different conclusions, 
consensus was reached through discussion. 
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Methodological Quality 
The methodological quality of the studies was independently rated using a 
selection of the list with criteria recommended by van Tulder et al.2. Because 
it is not possible for the therapist or the patient to be blinded for an 
occupational therapy intervention, these criteria were discarded. Therefore, 
the adapted list consisted of nine criteria for internal validity, six descriptive 
criteria and two statistical criteria for randomized controlled trials and 
controlled clinical trials (Table 1]. All criteria were scored as yes, no, or not 
clear. Equal weight was given to all items. 
Randomized controlled trials and controlled clinical trials were 
considered high quality if at least six of nine internal validity criteria, three of 
six descriptive criteria, and one of two statistical criteria were scored 
positively3. Other research designs were considered sufficient quality if four 
of nine internal validity criteria, two of six descriptive criteria, and one of two 
statistical criteria were scored positively3. The two reviewers independently 
assessed the methodological quality and disagreements were resolved by 
discussion. 
Doto analysis 
A standardized data extraction form was used to present details of included 
studies, such as first author, year of publication, number of patients, patient 
characteristics (inclusion criteria, gender and age), description of outcome 
measures, intervention (intensity and content], and results. A best-evidence 
synthesis was presented by attributing specific levels of evidence to the 
various intervention strategies, taking into account the design of the studies, 
the methodological quality, the type of outcome measures and the statistical 
significance of the findings3. 
Results 
The initial search strategy resulted in a total of 3,534 citations. After 
screening by title and abstract, the majority of the studies (n=3,528) did not 
meet the predefined criteria for the type of study, type of participants, type of 
intervention, or type of outcome measures. Six full-text articles were 
retrieved for detailed evaluation4 9. 
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Potentially relevant citations 
identified and screened on title 
and abstract for retrieval 
(n= 3,534] 
Citations excluded [n= 3,528] 
Reasons: 
type of study did not meet criteria 
type of participants did not meet criteria 
type of intervention did not meet criteria 
• type of outcome measures did not meet criteria 
Citations retrieved for more 
detailed evaluation in full article 
(n=6] 
Citations excluded (n= 4] 
Reasons: 
- type of study did not meet criteria (Young 1989] 
- type of outcome measures did not meet criteria 
(Agre 1998; Rudanko 1995; Klein 2002] 
Selected for the systematic 
review (n= 2] 
Figure 1. Flow chart showing the selection of studies for the systematic review. 
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Table 
Code 
a 
b 
c 
d 
f 
g 
i 
j 
k 
1 
m 
η 
0 
Ρ 
q 
1. Criteria for methodological quality in the two studies selected for evaluation 
Description of the criteria 
Were the eligibility criteria specified? 
1) Was a method of randomization performed? 
2) Was the treatment allocation concealed? 
Were the groups similar at baseline regarding 
the most important prognostic indicators? 
Were the (index and control) interventions 
explicitly described? 
Were co-interventions avoided or comparable? 
Was the compliance acceptable (in all groups]? 
Was the outcome assessor blinded? 
Were the outcome measures relevant? 
Were adverse effects described? 
Was the withdrawal/drop-out rate described 
and acceptable? 
1] Was a short-term follow-up measurement 
performed? 
2] Was a long-term follow-up measurement 
performed? 
Was the timing the outcome assessment in all 
patients comparable? 
Was the sample size for each group described? 
Did the analysis include an intention-to-treat 
analysis? 
Were point estimates and measures of 
variability presented? 
Score for internal validity (criteria b,f,g,i,j,l,n,p) 
Score for descriptive quality (criteria a,c,d,k,m) 
Score for statistical quality (criteria o,q} 
Aldehag 
etal. 
(2005) 
Yes 
NA 
NA 
NA 
Yes 
Yes 
Yes 
Unknown 
Yes 
Yes 
Yes 
Yes 
No 
Yes 
Yes 
Yes 
Yes 
6 of 9 
4 of 6 
2 of 2 
Sandin-
Aldehag & 
Jonsson 
(2003) 
Yes 
NA 
NA 
NA 
Yes 
Unknown 
Yes 
Yes 
Yes 
No 
Yes 
Yes 
No 
Yes 
Yes 
No 
Yes 
5 of 9 
3 of 6 
2 of 2 
Ν A: Not Applicable. 
Four of the six studies were excluded because either the type of study9 or the 
type of outcome measures did not meet the predefined criteria4;6:7 [Figure 1). 
The article by Young (1989) reviewed the late effects of poliomyelitis and the 
abstract referred to guidelines for occupational therapy assessment and 
treatment7. The full-text article showed that these guidelines were based on 
the author's experiences as a clinician and a polio survivor and on the 
literature. The reference list was reviewed but comprised no occupational 
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therapy intervention studies. Table 2 presents characteristics of the other 
three studies that were excluded from further analysis. 
Two articles fulfilled all inclusion criteria and were subjected to the 
methodological assessment58. Both studies were both pre-post designs. The 
methodological quality of these studies was sufficient [Table 1). The study 
characteristics are described in Table 3. Both studies evaluated an 
individualized hand training program with silicone-based putty in five 
patients with myotonic dystrophy type I5 and 12 patients with Welander 
distal myopathy8, respectively. 
The first study resulted in improvements in self-rated performance 
and satisfaction with performance using the Canadian Occupational 
Performance Measure5. The second study showed significant improvements 
in activities of daily living8. Muscle strength improved significantly in both 
studies, grip force did not and the results on pinch grip were inconsistent. In 
the study by Aldehag et al. (2005), fine motor skills were assessed and 
showed significant improvements5. In the study by Sandin-Aldehag & Jonsson 
(2003), range of motion was measured and showed significant improvements 
in the extension of some finger joints8. 
Applying the best evidence synthesis to these data, we conclude that 
these studies provide some indications for the efficacy of a hand training 
program in muscle diseases (myotonic dystrophy and Welander distal 
myopathy) with initial scores of at least 3 out of 5 on manual muscle test in 
wrist and hand. 
Discussion 
Methods 
In the current review, we choose to conduct a comprehensive search in a variety 
of large databases. We did not limit our search to randomized controlled trials and 
controlled clinical trials. We included other designs because occupational therapy 
is a relatively young profession with an even younger research tradition and 
literature about the efficacy of occupational therapy was expected to be sparse. 
Also, other research designs were included because neuromuscular diseases 
generally have a low prevalence and incidence, making it difficult to use research 
designs with comparisons of more than one group. We considered searching 
specific databases such as OT seeker and PEDro, but these databases are restricted 
to clinical trials and systematic reviews and draw their articles from the other 
databases already searched in this study. 
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Table 2. Characteristics of excluded studies 
Author, 
date 
Agre et al. 
(1989) 
Klein, et 
al. 
(2002) 
Rudanko, 
1995 
Type of study 
Retrospective study 
with charts 
reviewed; 
a selection of the 
patients was 
evaluated at a 
follow-up visit 
A randomized 
parallel group study 
Uncontrolled 
clinical study 
Type of participants 
84 patients visiting a post-polio 
clinic, 79 met the criteria for 
poliomyelitis 
29 polio survivors 
(15 men, 14 women); 
inclusion criteria: 
bilateral knee-extensor and hip-
extensor strength grade 3 - 5 ; 
> 30 days of shoulder pain with 
daily activity 
20 persons with Leber's 
hereditary optic neuropathy 
Type of intervention 
Recommendations including: pacing. 
energy conservation, gentle 
stretching or strengthening exercise, 
use of orthotic devices, weight loss or 
nutritional counseling, gentle aerobic 
exercise, use of a cane and use of 
adaptive equipment 
Group 1: home exercise program 
focused on strengthening and 
stretching the hip-extensor and knee-
extensor muscles; 
Group 2: lifestyle modification 
techniques to avoid shoulder 
overuse; 
Group 3: both interventions 
Prescription of a wide variety of low 
vision aids 
Type of outcome 
measures 
Unknown 
Pain (Visual Analogue 
Scales) during 4 resistance 
tests and after performing 3 
simulated tasks; isometric 
knee-extension and hip-
extension (hand-held 
dynamometer) 
Type and frequency of 
prescription of low vision 
aids with correlation to 
World Health Organization 
categories of visual 
impairment 
Table 3. Characteristics of included studies 
Characteristic Aldehag et al. (2005)5 
No. of patients 5 
Patient characteristics 
Inclusion Myotonic dystrophy with score of at least 3 of 5 on 
criteria manual muscle testing in wrist and hand 
Male/Female 2/3 
Mean age (Y) 52.4 (range: 28 to 67) 
Outcome measures 
Primary Performance and satisfaction with performance of 
problems in daily activities (COPM) 
Secondary 1) Muscle strength of extensors and flexors of wrist 
and fingers (hand-held myometer); 2) Grip force and 
pinch grip (Grippit); 3) Fine motor control (Purdue 
Pegboard) 
Intervention 
Intensity 12 weeks, 3 times per week, 45 minutes 
Content Hand exercise program with isolated and mass 
movements with silicone-based putty and a stretching 
program 
Results 
Primary Mean performance increased with 1.7 (range; 0.4-3.8); 
Mean satisfaction increased with 2.7 (range; 0-6.3) 
Secondary 1) Muscle strength increased (p < .05); 2) Grip force 
and pinch grip did not change (p > .05); 3) Fine motor 
control improved (p < .005) 
Sandin-AIdehag & Jonsson (2003)8 
12 
Welander distal myopathy with score of 2 or 3 of 5 on manual 
muscle testing in extension of the fingers 
5/7 
62.5 (range; 39 to 83) 
Activities of daily living (interview with ADL- Taxonomy); 
Life satisfaction (modified Life Satisfaction Checklist) 
1) Muscle strength in extension of the fingers (Manual muscle 
testing); 2) Grip strength and pinch grip (peak, mean and 10-
second value) (Grippit); 3) Range of Motion (goniometer) 
12 weeks, 3 times per week, 45 minutes 
Hand exercise program with isolated and mass movements 
with silicone-based putty and a stretching program 
ADL improved (p = .01) Changes in life satisfaction were not 
significant 
1) Muscle strength increased in left hand (p =.01); 2) No 
values of grip strength changed significantly; 3) For pinch 
grip, peak value and left hand 10-second value increased (p = 
.04); 4) Range of Motion improved 
COPM = Canadian Occupational Performance Measure; ADL = Activities of Daily Living. 
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Of the 3,534 citations screened, only six studies were retrieved for 
detailed evaluation. The reason our search yielded so many citations that did 
not fulfill the predefined inclusion criteria was due to our comprehensive 
search strategy. Because we included many different study types, the search 
led to citations that included cohort studies on incidence or prevalence of 
symptoms or studies on measurement instruments. We used MeSH 
(including all subheadings) and free text words for different types of 
neuromuscular diseases, which resulted in citations with a broad a range of 
neuromuscular conditions including stroke and Parkinson's diseases and 
musculoskeletal problems, and studies with children, which we did not want 
to include. 
Our search also included broad terms such as 'rehabilitation' and 
'activities of daily living' so studies about occupational therapy not 
specifically indexed as such were not missed. This resulted in many citations 
on interventions other than occupational therapy. However, if we had 
narrowed the search terms to occupational therapy only, it would not have 
resulted in the articles retrieved. 
Main results 
The purpose of this study was to summarize the evidence for occupational 
therapy in patients with neuromuscular diseases. Based on two other 
research designs, we found indicative findings for the effectiveness of a hand 
training program to improve daily activities in patients with muscle 
disorders (Myotonic dystrophy and Welander distal myopathy]. These 
studies also suggest that training of hand function may be efficacious in 
improving hand strength and fine motor skills50. No evidence was found for 
any other occupational therapy intervention in neuromuscular diseases. 
Recommendations and conclusion 
Based on our results and clinical experience, we have made 
recommendations for the type of studies, participants, interventions and 
outcome measures in future research. 
The preferred types of studies are randomized controlled trials and 
controlled clinical trials. However, pre-post designs should be considered as 
acceptable alternatives, because of the limited number of eligible patients 
with the same neuromuscular diagnosis. Moreover, because there is little 
evidence available on occupational therapy in neuromuscular diseases, we 
recommend that future research (reviews and clinical studies) not be 
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confined to quantitative intervention studies. Descriptive studies and 
qualitative research may generate valuable information for occupational 
therapy on patient's needs and their adaptive strategies to manage their daily 
occupations and fulfill their life roles, such as the studies by Jönsson et al.10 or 
Thorén-Jönsson & Grimby11. 
Regarding the type of participants, there are indications that different 
factors affect the process of adaptation in patients with different 
neuromuscular diseases. For instance, patients with facioscapulohumeral 
muscular dystrophy and hereditary motor and sensory neuropathy may need 
a different approach to reduce fatigue than patients with myotonic 
dystrophy12. Therefore, homogenous patient samples should preferably be 
included in future occupational therapy research. 
Because the goal of occupational therapy intervention is to maintain or 
increase participation in daily occupations and life roles, research should 
focus on the efficacy of interventions with this aim. In patients with 
neuromuscular diseases, such interventions would typically include training 
of daily activities, with or without the use of assistive devices, modifying the 
work and home environments, and educating about work simplification and 
energy conservation techniques. 
Based on the findings from qualitative studies, we recommend a client-
centered approach that includes the following aspects: educating the patient 
about the disease because education plays an important role in his or her 
understanding of the need to implement adaptive strategies91013; evaluating 
the patient's perception of his or her life history, personal values, goals and 
problems310 informing the patient about the adaptive strategies available; 
and identifying the patient's adaptive strategies, which can be used in 
occupational therapy to empower the patient to make changes in his or her 
occupational performance10. 
To measure the efficacy of occupational therapy, the outcome 
measures should be in agreement with the type of intervention. We 
recommend client-centered measurement instruments at the level of 
activities and participation, such as the Canadian Occupational Performance 
Measure14 and the Impact on Participation and Autonomy questionnaire1517. 
The low yield of our search of only two pre-post designs about hand 
training programs for patients with muscle disorders demonstrates the 
limited scientific evidence for occupational therapy in patients with 
neuromuscular diseases. Although clinically there is no debate, further 
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exploration and efficacy studies are needed to provide occupational therapy 
for patients with neuromuscular diseases with a firm scientific base. 
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Appendix A 
Search strategy for systematic reviews on the effectiveness of occupational 
therapy and physical therapy for persons with neuromuscular diseases. 
Searches for controlled trials are according to the recommendations of the 
Cochrane Neuromuscular Disease Group. The search strategies for 
neuromuscular diseases, occupational therapy and physical therapy are the 
same in all databases. 
OVID Medline 
Search strategy for controlled trials [Cochrane Neuromuscular Disease Group): 
1 randomized controlled trial.pt. 
2 randomized controlled trials/ 
3 controlled clinical trial.pt. 
4 controlled clinical trials/ 
5 random allocation/ 
6 double-blind method/ 
7 single-blind method/ 
8 clinical trial.pt. 
9 exp clinical trials/ 
10 [clinS adj25 trial$].tw. 
11 ((singl$ or doubl$ or tripl$ or trebl$) adj25 (blind$ or mask$ or 
dummy]).tw. 
12 placebos/ 
13 placebo$.tw. 
14 random$.tw. 
15 research design/ 
16 (clinical trial phase i or clinical trial phase ii or clinical trial phase ili or 
clinical trial phase iv.pt. 
17 multicenterstudy.pt. 
18 meta analysis.pt. 
19 prospective studies/ 
20 intervention studies/ 
21 cross-over studies/ 
22 meta-analysis/ 
23 [meta?analys$ or systematic review$).tw. 
24 control$.tw. 
25 or/1-24 
26 limit 25 to humans 
Search strategy for neuromuscular diseases: 
27 neuromuscular diseases/ or exp *motor neuron disease/ or exp 
*muscular atrophy, spinal/ or exp *muscular disorders, atrophic/ or exp 
*neuromuscular junction diseases/ 
28 muscular diseases/ or exp *arthrogryposis/ or exp *compartment 
syndromes/ or exp *eosinophilia-myalgia syndrome/ or exp *isaacs 
syndrome/ or exp *mitochondrial myopathies/ or exp *muscle cramp/ or 
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exp *muscle weakness/ or exp *muscular disorders, atrophic/ or exp 
*myopathies, structural, congenital/ or exp *myositis/ or exp *myotonic 
disorders/ or exp *paralyses, familial periodic/ or exp *rhabdomyolysis/ 
29 peripheral nervous system diseases/ or exp *amyloid neuropathies/ or 
exp *brachial plexus neuropathies/ or exp *diabetic neuropathies/ or exp 
*guillain-barre syndrome/ or exp *isaacs syndrome/ or exp 
*mononeuropathies/ or exp *nerve compression syndromes/ or exp 
*neuralgia/ or exp *neuritis/ or exp *peripheral nervous system 
neoplasms/ or exp *polyneuropathies/ 
30 "hereditary motor and sensory neuropathies"/ or exp *charcot-marie-
tooth disease/ or exp *refsum disease/ 
31 exp *Postpoliomyelitis Syndrome/ 
32 (neuromuscular disorders or neuromuscular disease$}.mp. [mp=ti, ot, ab, 
η m, hw] 
33 (muscular disease$ or muscular disorder$].mp. [mp=ti, ot, ab, nm, hw] 
34 (muscle disease$ or muscle disorder$).mp. [mp=ti, ot, ab, nm, hw] 
35 (neuromuscular junction diseases$ or neuromuscular junction 
disorder$].mp. [mp=ti, ot, ab, nm, hw] 
36 (motor neuron disease$ or motor neuron disorder$).mp. [mp=ti, ot, ab, 
nm, hw] 
37 (peripheral nervous system disease$ or peripheral nervous system 
disorder$].mp. [mp=ti, ot, ab, nm, hw] 
38 (polyneuropathS or neuritis or neuralgia].mp. [mp=ti, ot, ab, nm, hw] 
39 (myopathS or myotoni$].mp. [mp=ti, ot, ab, nm, hw] 
40 myositis.mp. [mp=ti, ot, ab, nm, hw] 
41 muscular dystrophSmp. [mp=ti, ot, ab, nm, hw] 
42 or/27-41 
Search strategy for occupational therapy: 
43 "activities of daily living"/ or occupational therapy/ or rehabilitation, 
vocational/ 
44 "activities of daily living"/ or automobile driving/ or exercise/ or leisure 
activities/ or work/ 
45 self-help devices/ or communication aids for disabled/ or wheelchairs/ 
46 Splints/ 
47 Counseling/ 
48 Caregivers/ 
49 assistive devices.mp. [mp=ti, ot, ab, nm, hw] 
50 SplintS.mp. [mp=ti, ot, ab, nm, hw] 
51 energy conservation.mp. [mp=ti, ot, ab, nm, hw] 
52 carerS.mp. [mp=ti, ot, ab, nm, hw] 
53 Counsel?ing.mp. [mp=ti, ot, ab, nm, hw] 
54 Occupations.mp. [mp=ti, ot, ab, nm, hw] 
55 or/43-54 
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Search strategy for physical therapy: 
56 behavior control/ or clinical protocols/ or drainage/ or exercise 
movement techniques/ or musculoskeletal manipulations/ or exp 
*physical therapy techniques/ 
57 exp *"Physical Therapy [Specialty]"/ 
58 rehabilitation/ or "activities of daily living"/ or early ambulation/ or 
physical therapy techniques/ or respiratory therapy/ or self care/ 
59 breathing exercises/ or relaxation techniques/ 
60 exercise movement techniques/ or breathing exercises/ or drainage, 
postural/ or exercise/ or exercise therapy/ or relaxation/ or relaxation 
techniques/ 
61 exercise/ or physical fitness/ 
62 exercise therapy/ or motion therapy, continuous passive/ or kinesiology, 
applied/ or manipulation, spinal/ or massage/ 
63 exercise movement techniques/ or breathing exercises/ or drainage, 
postural/ or exercise/ or exercise therapy/ or relaxation/ or relaxation 
techniques/ or walking/ 
64 hand strength/ or muscle fatigue/ or muscle tonus/ or musculoskeletal 
equilibrium/ or physical endurance/ or anaerobic threshold/ or exercise 
tolerance/ or posture/ or "range of motion, articular"/ 
65 "Physical Education and Training"/ 
66 [physiotherapy or physical therapy).mp. [mp=ti, ot, ab, nm, hw] 
67 [exercise therap$ or exercise training or exercise program! or training 
program$).mp. [mp=ti, ot, ab, nm, hw] 
68 [strength training or aerobic training or aerobic exercise$).mp. [mp=ti, ot, 
ab, nm, hw] 
69 [resistive exercise! or endurance training or muscle exercise!).mp. 
[mp=ti, ot, ab, nm, hw] 
70 or/56-69 
OVID CINAHL 
Search strategy for controlled trials (Cochrane Neuromuscular Disease Group). 
1 random assignment/ or random sample/ or simple random sample/ or 
stratified random sample/ or systematic random sample/ 
2 Crossover design/ 
3 exp Clinical trials/ 
4 Double-blind studies/ or triple blind studies/ 
5 Placebos/ 
6 Quasi-experimental studies/ 
7 Solomon four-group design/ or Static group comparison/ 
8 Meta analysis/ 
9 Concurrent prospective studies/ or Prospective studies/ 
10 Factorial design/ 
11 ("clinical trial" or "systematic review").pt. 
12 random!.tw. 
13 [(singl! or doubl! or tripl! or trebl!) adj25 [blind! or mask!)).tw. 
14 (cross?over or placebo! or control! or factorial or sham? or dummy).tw. 
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15 ((clin$ or interventions or compar$ or experiments or preventive or 
therapeutic) adjlO trial$).tw. 
16ABABdesign$.tw. 
17 (meta?analys$ or systematic review$).tw. 
18 or/1-17 
19 18 and subject terms 
OVID Embase 
Search strategy for controlled trials (Cochrane Neuromuscular Disease Croup). 
1 randomized controlled trial/ 
2 clinical trial/ 
3 multicenter study/ 
4 controlled study/ 
5 crossover procedure/ 
6 double blind procedure/ 
7 single blind procedure/ 
8 randomization/ 
9 major clinical study/ 
10 placebo/ 
11 meta analysis/ 
12 phase 2 clinical trial/ or phase 3 clinical trial/ or phase 4 clinical trial/] 
13 Cclin$adj25trial$).tw. 
14 ((singl$ or doubl$ or tripl$ or trebl$) adj25 (blind$ or mask$)}.tw. 
15 placebo$.tw. 
16 random$.tw. 
17 control$.tw. 
18 [meta?analys$ or systematic review$].tw. 
19 [cross?over or factorial or sham? or dummy].tw. 
20 ABAB design$.tw. 
21 or/1-20 
22 human/ 
23 nonhuman/ 
24 22 or 23 
25 21 not 24 
26 21 and 22 
27 25 or 26 
28 27 and subject terms 
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Abstract 
Objective: to summarize and critically appraise the available evidence on 
exercise therapy and other types of physical therapies for patients with 
neuromuscular diseases (NMD], 
Data Sources: Cochrane Central Register of Controlled Trials and Cochrane 
Database of Systematic Reviews, Medline, C1NAHL, Embase (Rehabilitation 
and Physical Medicine], and reference lists of reviews and articles. 
Study Selection: Randomized clinical trials (RCTs), controlled clinical trials 
(CCTs] and other designs were included. Study participants had to have any 
of the following types of NMD: motor neuron diseases, disorders of the motor 
nerve roots or peripheral nerves, neuromuscular transmission disorders or 
muscle diseases. All types of exercise therapy and other physical therapy 
modalities were included. Outcome measures had to be at the level of body 
functions, activities, or participation according to the definitions of the 
International Classification of Functioning, Disability and Health (ICF). 
Data Extraction: Two reviewers independently decided on inclusion or 
exclusion of articles and rated the methodologie quality of the studies 
included. All RCTs, CCTs and other designs only if of sufficient methodological 
quality were included in a best evidence synthesis. A level of evidence was 
attributed for each subgroup of NMD and each type of intervention. 
Data Synthesis: Initially 58 studies were included: 12 RCTs, 5 CCTs and 41 
other designs. After methodologie assessment, 19 other designs were 
excluded from further analysis. There is level II evidence ("likely to be 
effective") for strengthening exercises in combination with aerobic exercises 
for patients with muscle disorders. Level III evidence ("indications of 
effectiveness") was found for aerobic exercises for patients with muscle 
disorders and for the combination of muscle strengthening and aerobic 
exercises in a heterogeneous group of muscle disorders. Finally, there is level 
III evidence for breathing exercises in patients with myasthenia gravis and 
for patients with myotonic muscular dystrophy. Adverse effects of exercise 
therapy were negligible. 
Conclusions: the available evidence is limited, but relevant for clinicians. 
Future studies should be preferably multicentered, and use an international 
classification of the variables of exercise therapy and an ICF core set for NMD 
in order to improve comparability of results. 
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Introduction 
Neuromuscular diseases (NMD) represent a heterogeneous group of 
disorders, including motoneuron diseases, disorders of motor nerve roots or 
peripheral nerves, neuromuscular transmission disorders and muscle 
diseases.12 The progression of the diseases varies considerably. The deficits 
can range from muscle weakness, sensory loss, pain, fatigue and autonomic 
dysfunction in varying combinations. These deficits combine to lead to 
impairments of musculoskeletal and sensory functions, limitations in 
activities and restrictions in participation.2 
There are approximately 600 different NMD with great variety in 
referral to physical therapy (PT).3 There is no consensus regarding the type 
and intensity of PT.4 PT often includes exercise therapy to improve or 
preserve muscle function (strength and endurance) and aerobic capacity to 
prevent or reduce secondary problems such as contractures, pain or 
fatigue.24 The benefits or injurious effects of exercises in NMD are unclear, 
and this uncertainty is particularly pertinent when the consideration of the 
'appropriate' level of intensity is addressed.511 
Three Cochrane systematic reviews thus far focused on one type of 
NMD or a specific type of exercise therapy and were restricted to randomized 
clinical trials (RCTs) or controlled clinical trials (CCTs). In their Cochrane 
review on muscle strength training and aerobic exercise training for patients 
with muscle diseases, van der Kooi et al12 concluded that moderate-intensity 
strength training in myotonic dystrophy and facioscapulohumeral muscular 
dystrophy appeared not to be harmful, but there was insufficient evidence to 
establish its benefit. This conclusion was based on 2 RCTs.13;14 White et al.15 
did a Cochrane review on exercise therapy for people with peripheral 
neuropathy and concluded that there is insufficient evidence to evaluate the 
effect of exercise therapy on functional ability in people with this condition. 
This was based on 1 RCT,13 which was also included in the review by van der 
Kooi.12. Ashworth et al, 16 reviewing treatment for spasticity in patients with 
amyotrophic lateral sclerosis (ALS), concluded that the available evidence 
was insufficient to determine whether individualized exercises for muscle 
endurance of the trunk and limbs with moderate intensity are beneficial or 
harmful for these patients. The conclusion was also based on 1 single RCT 
performed.17 
When RCTs are scarce, evidence from nonrandomized studies and 
other designs, such as pre-post studies or case-control studies may be 
particularly relevant.18 There are previous reviews on exercise therapy for 
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patients with NMD,910 including other designs. However, these reviews lack a 
systematic approach. 
Our aim here is to summarize and critically appraise the available 
evidence on exercise therapy and other modalities of physical therapies for 
patients with NMD to support neurologists, physicians, and physical 
therapists in their clinical decision-making for the individual patient with 
NMD. We conducted a comprehensive systematic review, including RCTs, 
CCTs, and other designs, all types of exercise and PTand all types of NMD. 
Methods 
Search strategy 
We searched in the Cochrane Central Register of Controlled Trials [The 
Cochrane Library 2005, Issue 3), Ovid Medline In-Process & Other Non-
Indexed Citations and Ovid Medline [1966 through September 2005}, 
C1NAHL WebSPIRS 5.1 [1982 through September 2005] and Embase 
WebSPIRS 5.03 [Rehabilitation and Physical Medicine] (1995 through 
September 2005]. We also searched in the Cochrane Database of Systematic 
Reviews to find articles indirectly by screening reference lists. Further, 
potentially relevant publications were searched manually through citation 
and author tracking. 
Our broad search strategy was built on the following components: 1] 
RCTs and CCTs as recommended by the Cochrane Neuromuscular Disease 
Group; 2] other designs, such as pre-post designs; 3] types of NMD; and 4] PT 
modalities. For all search strategies Medical Subject Headings [MeSH] or 
indexed terms were used as well as free-text words. The full search strategy 
can be found in Appendix A at the end of Chapter 4. 
Selection criteria 
Inclusion was restricted to articles with an abstract, and language had to be 
English, German, French, or Dutch. The following study designs were 
included: RCTs, CCTs and other designs such as pre-post studies. Case studies 
were excluded. 
Participants included adults having one of the following types of NMD: 
1] motoneuron diseases; 2] motor nerve root and peripheral nerve disorders; 
3] neuromuscular transmission disorders; or 4] muscle disorders. Excluded 
were children or adolescents [< 18 y] with Duchenne's muscular dystrophy, 
spinal muscular atrophy or Becker's muscular dystrophy. Also, patients 
having signs and symptoms of muscle weakness, pain or fatigue, not related 
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to specific NMD were excluded as well as diagnoses including chronic fatigue 
syndrome, spinal cord injuries, thoracic outlet syndrome, reflex sympathetic 
dystrophy or complex regional pain syndrome, cancer or acquired immune 
deficiency syndrome. Although often classified as NMD, diabetic neuropathies 
and entrapment neuropathies such as carpal tunnel syndrome and 
radiculopathies were not included in this review. 
Regarding the type of interventions, we included different modalities 
of PT: 1) muscle strengthening exercises; 2) aerobic exercises; 3} breathing 
exercises; 4) other interventions such as relaxation techniques, exercises to 
improve mobility including transfers and walking, functional electric 
stimulation, education of the patient, family and caregivers; or 5] a 
combination of these interventions. Comprehensive rehabilitation programs 
were excluded, since it is impossible to isolate the effectiveness of PT in such 
programs. 
Outcome measures had to be at the level of body functions, activities 
or participation according to the definitions of the International Classification 
of Functioning, Disability and Health [ICF]19. Outcome measures at the level 
of body functions included measures for muscle strength or muscle 
endurance, range of motion, aerobic capacity, pulmonary function, 
respiration, pain, or fatigue. Excluded were measures for blood pressure as 
well as blood parameters, such as lactate. Outcome measures at the level of 
activities and participation included indices for walking and moving around, 
self care, work and employment, domestic life, leisure, quality of life, or 
general health. 
Procedure for inclusion 
In all databases a preliminary selection, based on title and abstract, was 
carried out by 2 reviewers [EHC and AJP) independently. Studies that seemed 
to fit inclusion criteria were retrieved for more detailed evaluation (Figure 
1). In case of doubt, the reviewers collaboratively decided on retrieval of the 
full article. 
Another pair of reviewers (EHC and JMB-P) independently decided on 
the inclusion or exclusion based on detailed information in the full articles. If 
disagreements persisted, a third reviewer (AjP) was consulted. The 2 
reviewers (EHC and |MB-P) also independently scanned the reference lists of 
all articles and reviews for additional articles. Additional articles fulfilling the 
inclusion criteria, as well as relevant related articles and reviews found 
during the process of hand searching were retrieved for more detailed 
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evaluation. Final in- or exclusion of the articles was always based on 
independent assessments of 2 reviewers (EHC and JMB-P). 
Methodologie quality 
The methodologie quality of the RCTs, CCTs and other designs was rated 
using the list recommended by van Tulder et al.20 The quality of the internal 
validity was scored with 11 criteria [random assignment, allocation 
concealed, care provider blinded, cointerventions standardized, compliance > 
70%, patient blinded, outcome assessor blinded, outcome measures relevant, 
drop-out rate acceptable, timing of outcome assessment comparable, 
intention-to-treat analysis). Descriptive quality was scored with 8 criteria 
(eligibility criteria, similarity of groups at baseline, interventions, adverse 
effects, short-term follow-up, long-term follow-up, sample size, point 
estimates and measures of variability]. All criteria were scored as yes, no, or 
unclear. Equal weight was given to all items. For the other designs, only the 
criteria that were applicable (7 criteria for internal validity and 7 criteria for 
descriptive quality) were used. 
RCTs and CCTs were considered to be of sufficient quality if at least 6 
of 11 criteria for internal validity and 4 of 8 descriptive criteria were scored 
positively. The other designs were considered to be of sufficient quality if at 
least 4 of 7 criteria for internal validity and 4 out of 7 descriptive criteria 
were scored positively. Two reviewers [EHCC and JMCB-P) independently 
rated the methodological quality of the trials. Disagreements were resolved 
by discussion. 
We decided to exclude other designs of insufficient methodologie 
quality from further analysis because of their lack of value for the best 
evidence synthesis. 
Classification of included studies 
The studies were classified based on type of NMD and type of intervention. 
For each study, the design, the methodologie quality, the number of 
participants, the diagnosis, the exercise intensity, frequency and duration, 
and outcome was presented [Table 1). 
Studies comparing a group of patients with a reference group of 
healthy persons were categorized as other designs. Also studies in which 1 
side of the body was exercised and the contralateral side of the body served 
as control were treated as other designs. 
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The type of intervention was categorized into the different modalities 
of PT: 1] muscle strengthening exercises; 2) aerobic exercises; 3) breathing 
exercises; 4) other interventions; or 5} a combination of these modalities. For 
the different types of exercise therapy, the intensity was described, if the 
article provided enough details. 
We divided the outcome variables into 2 categories: 1 category with 
outcome variables at the level of body functions and a second category 
including outcome variables at the level of activities and participation. This is 
based on the corresponding components in the 1CF.19 Adverse effects were 
presented separately. The aim was to present primary and secondary 
outcomes for each study. However, only few studies defined primary and 
secondary outcome measures.1421 We then decided to include all outcome 
variables fulfilling the inclusion criteria and considered them of equal 
importance. Within each category (body functions or activities/participation 
respectively], the number of variables that showed a statistically significant 
(P<.05} effect in a study was divided by the total number of outcome 
variables in the study. If presented in the article, different subscales of an 
instrument were treated as different outcome variables. A study was 
considered to provide evidence of effectiveness if more than half of the 
variables showed a significant effect. 
Best evidence synthesis 
The comprehensive scope of our review and the heterogeneity in patient 
populations, interventions and outcome measures precludes quantitative 
analysis (meta-analysis) of the data. We used a best evidence synthesis based 
on a classification of the Dutch Institute for Healthcare Improvement22 The 
following levels of evidence were attributed based on the hierarchy of 
evidence. Recommendations were formulated accordingly. 
Level I evidence is based on (a systematic review of) at least 2 
independent RCTs of sufficient methodologie quality and leads to the 
conclusion: "It has been shown that...". 
Level II evidence is based on 1 good quality RCT or at least 2 independent 
controlled studies (RCTs or CCTs) of less methodologie quality and leads to 
the conclusion: "It is likely that...". Level III evidence is based on an RCT or 
CCT of low methodologie quality or at least 1 other design of sufficient 
methodologie quality. The conclusion is formulated as "There are indications 
that....". In case of inconsistent findings in studies of similar design and 
methodologie quality (studies with and without evidence), the conclusion is 
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formulated as 'There is insufficient evidence that...". If studies showed 
consistent significant findings, a level of evidence was attributed for each 
subgroup of NMD and each type of intervention. 
Results 
Selection of studies 
The search resulted in 5712 citations (see Fig 1). Of these, 5634 articles were 
excluded because the type of study, the participants, the intervention, or 
outcome measures did not meet the predefined criteria. 
The preliminary selection resulted in 62 articles and 16 reviews that 
were retrieved for more detailed evaluation. Citation tracking resulted in 19 
additional reviews and 27 additional articles to be retrieved. The final 
selection resulted in a total of 60 articles, comprising 58 different studies, 
because 2 studies were published twice.13;23-25 Among these studies were 12 
RCTs, 5 CCTs, and 41 other designs. 
Methodologie quality 
Five of 12 RCTs13·14·21^:27 and 1 of 5 CCTs28 had sufficient methodologie 
quality (a score of > 6/ 11 for internal validity and > 4 8 for descriptive 
quality). Of the other designs, 22 studies had sufficient methodologie quality 
(a score of > 4/7 for internal validity and > 4/7 for descriptive quality]. 
Nineteen other designs had insufficient methodologie quality and were 
excluded from further analysis.29'47 
Two RCTs1748 had a lower score on the validity criteria than we 
accepted from other designs. Four RCTs4851 and 4 CCTs285254 presented only 
within-groups analysis, but no between-groups comparisons. These studies 
were treated as other designs in the best evidence synthesis. 
The methodologie quality of all studies included in the best evidence 
synthesis is presented in Table 1. 
Best evidence synthesis 
The best evidence synthesis is based on the information presented in Table 1. 
For each subgroup of NMD and each type of intervention, the evidence is 
summarized. 
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Potentially relevant citations identified and 
screened on title and abstract for retrieval 
[n= 5,7121 
Reviews 
retrieved for further 
screening (n=16] 
Additional reviews 
retrieved further 
screening (n=19) 
Citations excluded (n= 5,634) 
Main reasons: 
• type of study did not meet criteria 
• type of participants did not meet criteria 
• type of intervention did not meet criteria 
• type of outcome measures did not meet 
criteria 
Citations retrieved for 
more detailed evaluation 
in full article (n=62) 
Additional citations retrieved 
for more detailed evaluation 
in full article [n=27) 
Citations excluded with reasons (n=9): 
- unable to retrieve (n=l) (Gross 1993] 
- type of study did not meet criteria 
(n=l) [Taivassalo 2003) 
- type of participants did not meet 
criteria (n=l) (Horber 1985) 
- type of intervention did not meet 
criteria (n=6) (Ahlström 2006; Heim 
1997; Janiszewski 1983; Milner Brown 
1990; Sanjak 1987; Waring 1989) 
N=42 
N=18 
Citations excluded with reasons 
(n=20): 
• unable to retrieve (n=3): Keim 
2001; 
Kriz 1992; Toedebusch 2005 
• type of study did not meet criteria 
(n=4): Agre 1989; Dean 1988; 
Escalante 1993; Hicks 1995 
- type of participants did not meet 
criteria (n=4) Koessler 2001; 
Richardson 2004; Winkler 2000; 
Zupan1995 
- type of intervention did not meet 
criteria (n=9) Agre 1991; Ashton-
Miller 1996; Bakhtiary 2000; 
Heikkilä2001; Kilmer 2001; Moon 
1996; Nitz 2002; Varelas 2002; 
Wenneberg 2004 
Selected for the systematic 
review (n= 60 comprising 58 studies) 
Other designs excluded 
because of insufficient 
methodological quality (n=19) 
Included in best evidence 
synthesis(n= 39) 
F igure 1. Flow c h a r t s h o w i n g t h e se lec t ion of s t u d i e s for physical t h e r a p y for p a t i e n t s 
wi th n e u r o m u s c u l a r d i s o r d e r s . 
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Motoneuron disorders 
Muscle strengthening exercises. Four RCTs17485035 and 4 other 
designs56 59 studied muscle strengthening exercises in NMD. None of the RCTs 
had sufficient methodologie quality. One RCT17 included patients with ALS 
and all other studies included patients with postpoliomyelitis syndrome 
(PPS). The low quality RCT17 on muscle strengthening exercises in patients 
with ALS reported significant findings in 1 of 8 variables on body functions 
and 1 of 4 variables on activities and participation. According to the criteria 
used in this review, this implies that there is insufficient evidence for the 
effectiveness of muscle strengthening exercises for patients with ALS. 
Three RCTs485055 of insufficient methodologie quality and 4 other 
designs5659 studied muscle strengthening exercises in PPS. The type and 
intensity of strengthening exercises and the outcome variables differed in all 
studies. Although 4 studies (1 RCT and 3 other designs) showed significant 
effects in most outcome variables at the level of body functions, the other 3 
studies (2 RCTs and 1 other design) resulted in insufficient evidence of 
effectiveness. Hence, according to our criteria, there is insufficient evidence 
for the effectiveness of muscle strengthening exercises for patients with PPS. 
Aerobic exercises. One RCT60 and 1 CCT53, both of limited methodologie 
quality, studied the effectiveness of aerobic exercise in PPS. The RCT showed 
a significant effect in 4 of 7 outcome variables in the category body functions. 
The CCT showed no significant results in the between-groups analysis. In the 
within-group analysis, significant results were found for 2 of 7 variables on 
body functions and in 1 of 2 variables on activities and participation level. 
Our conclusion is that there is insufficient evidence for the effectiveness of 
aerobic exercises for patients with PPS. 
A combination of muscle strengthening and aerobic exercises. One CCT61 
of insufficient methodologie quality evaluated the combination of muscle 
strengthening exercises and aerobic exercises in patients with PPS. Three out 
of 20 variables on body functions and none of the outcome variables on 
activities and participation showed a significant effect. Hence, there is 
insufficient evidence for the effectiveness of a combination of muscle 
strengthening exercises and aerobic exercises for patients with PPS. 
Lifestyle modification with or without muscle strengthening exercises. 
One study with a randomized parallel group design evaluated the 
effectiveness of lifestyle modification alone and in combination with muscle 
strengthening exercise in PPS50. The methodologie quality of the study was 
insufficient. There was a significant effect in 1 of 5 variables on body 
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functions in the group receiving the lifestyle modification. The group 
combining the 2 intervention strategies showed no significant findings. In 
conclusion, there is insufficient evidence for the effectiveness of lifestyle 
modification techniques, with or without muscle strengthening exercises for 
patients with PPS. 
Motor nerve root disorders and peripheral nerve disorders 
Muscle strengthening exercises. One RCT13 of sufficient methodologie 
quality studied the effect of muscle strengthening exercises for patients with 
hereditary motor and sensory neuropathy (HMSN]. Significant findings were 
found in 1 of 4 variables on body functions and 1 of 6 variables on activities 
and participation1325. One other design1 i ·2 4 showed significant findings in 3 of 
9 variables on body function and all 4 variables on activities and 
participation. Based on these findings, the conclusion is that there is 
insufficient evidence for the effectiveness of muscle strengthening exercises 
in patients with HMSN. 
A combination of muscle strengthening and aerobic exercises. One RCT51 
of insufficient methodologie quality studied the effectiveness of muscle 
strengthening and aerobic exercises in chronic peripheral neuropathy [CPN]. 
There were significant findings in 2 of 4 variables on body functions and in 1 
of 11 variables on activities and participation. Our conclusion is that there is 
insufficient evidence for the effectiveness of strengthening exercises in 
combination with aerobic exercises in patients with CPN. 
Neuromuscular transmission disorders 
Breathing exercises. One RCT with sufficient methodologie quality 
studied the effectiveness of inspiratory muscle training and diaphragmatic 
breathing and pursed lips breathing in patients with myasthenia gravis (MG] 
26
. Four of 19 variables on body functions and 1 of 9 variables on activities 
and participation showed a significant effect in the analysis between groups. 
The within-groups analysis showed a significant effect in 10 of 19 variables 
on body function. If we consider this study as an other design, then the 
conclusion is that there are indications for the effectiveness of breathing 
exercises in patients with MG [level HI evidence]. 
Table 1. Classification of PT studies in type of NMD 
Study Design V D Ν Diagnosis Type of intervention (type of exercises, type of muscles, 
load, number of reps, sets and progression) 
Frequency 
and duration 
Body 
functions 
Activities/ 
participation 
1. Motoneuron disorders 
Muscle strengthening exercises 
Drory et 
a l " 
Klein et 
ais» 
Prinsetal 
55 
Chan et 
al4 8 
Fillyawet 
al5" 
Einarsson 
58 
Agre et 
al« 
Agre et 
a l " 
RCTt 
RCT* 
RCTt 
RCT* 
ΟΟφ 
OD« 
OD 
OD 
3 
4 
4 
3 
4 
4 
5 
5 
7 
4 
5 
7 
5 
7 
6 
6 
25 
29 
16 
10 
17 
12 
12 
7 
ALS 
PPS 
PPS 
PPS 
PPS 
PPS 
PPS 
PPS 
AROM exercises for muscles of limbs and trunk against 
modest loads 
3-5 AROM exercises for hip and knee extensors against 
gravity. RPE 12-14, increasing number of reps 
Aquatic exercise: swimming and exercises for arms and 
legs using fins and paddles 
3 sets of eight 3-5 seconds 50% MVC of thenar muscle. If 
possible increase of 10% per week until 70% MVC level 
Full AROM exercises for knee or elbow: 3 sets of 10 reps 
with weights. 1st set weight of 50% of 10-RM; 2nd set 
75% and 3rd set 100% of 10RM. 10RM weight was 
evaluated every 2 wk 
12 sets of 8 maximal isokinetic knee extensors 
contractions at 180°/sec angular speed interposed with 
12 sets of isolated 4/s isometric contractions 
6 reps (30 s each) of knee extension with weight of 1-1,5 
kg until RPE 17 or until 10 reps. If RPE <17 weight was 
increased (.23 kg) 
Tuesday and Friday : 3 sets of 12 reps with ankle weights 
(1-1,5 kg). If RPE <19, the weight increased (0.23 kg) the 
next session. Monday and and Thursday ; 3 sets of 4 max 
effort isometric quadriceps contractions (5s) 
Twice a day 
15 min for 12 
mo 
Daily 30 min 
for 16 wk 
3x/wk45-70 
min for 8 wk 
3x/wk 
for 12 wk 
Every other day 
up to 2 y 
3 x/wk 
(96s)for6wk 
Every other day 
up to 12 wk 
4d/wkfor l2 
wk 
l /8 t 
2/5* 
7/39t 
2/2*11 
2/3« 
5/7« 
0/5 
6/611 
l/4t 
NV 
NV 
NV 
NV 
NV 
NV 
NV 
Aerobic exercises 
loneset RCTf 5 7 37 PPS 
al« 
Dean and CCT*t 4 6 20 PPS 
Ross" 
Cycle ergometer at intensity of 70-75% of HRR plus resting HR. 
Bouts of 2-5 min, 1-min rest 
Treadmill walking at comfortable speed, RPE < 5 (somewhat 
heavy] 
3 x/wk 
15-30 min 
for 16 wk 
3 x/wk 20-40 
min for 6 wk 
4/7f 
0/1 f 
2/7* 
NV 
1/2' 
Muscle strengthening and aerobic exercises 
Willen et CCTf 4 5 28 PPS 
al61 
Fitness in water: resistance and endurance activities, balance, 
stretching and relaxation, avoiding mucle fatigue 
2x/wk 40 min 
for 8 mo 
3/20f 0/4f 
Lifestyle modification 
Kleinet RCT* 4 4 29 PPS 
ais» 
Muscle strengthening exercise and lifestyle mo 
Klein et RCT* 4 4 29 PPS 
al™ 
2. Motor nerve root disorders and peripheral 
Lifestyle modification to avoid shoulder overuse 
dification 
3 - 5 AROM exercises for hip and knee extensors against 
gravity, increasing number of reps. RPE 12-14 
nerve disorders 
Monthly 
for 16 wk 
Daily 30 min 
for 16 wk 
1/5* 
0/5* 
NV 
NV 
Muscle strengthening exercises 
Lindeman RCTt 6 7 29 HMSN 
et a l ' « 5 
Chetlin2« OD 5 6 20 HMSN 
4 
Exercises of muscles of hip and knee. Wk 1-8:3 sets of 25 reps 
of 60% of 1-RM; wks 9-16: 3 sets of 15 reps of 70% of 1-RM; 
from wk 18: 10 repetitions of 80% of 1-RM 
2 sets of varying reps for flexion and extension at 40% to 50% 
MV1S for knee and 20% to 30% MV1S for elbow. Every 4 wk, 
resistance increased. Reps increased wkly from 4 to 6 to 8 to 10 
3 x/wk 
30 min 
for24wk 
Daily 
for 12 wk 
l /4 t 
3/9 
l /6 t 
4/411 
Muscle strengthening and aerobic exercises 
Ruhland 
and 
Shields^1 
RCT* 4 5 28 CPN Exercises with Theraband with no resistance and progressing 
to light and medium resistance with 10 reps. Aerobic 
conditioning at 60-70% of estimated maximal HR or'somewhat 
hard'on Borg RPE Scale 
Daily 20 min 
for 6 wk 
2/4» 1 /11 · 
3. Neuromuscular transmission disorders 
Breathing 
Fregonezi 
et al2f' 
exercises 
RCTt* 6 6 27 MG Ten minutes diaphragmatic breathing, followed by 10 min 
interval-based inspiratory muscle training and 10 min of 
pursed lips breathing. Initial load 20% of Pimax, increased to 
30% in wk 3, 45% in the fifth wk and 60% in wk 7. 
3 x/wk 
45 min 
for 8 wk 
4/19t 
10/19*1 
1 
l / 9 t 
1/9* 
4. Muscle disorders 
Muscle strengthening exercises 
Van der 
Kooi et 
al ." 
Lindeman 
et al»3«5 
Belanger 
and Noel52 
Alexander 
son et al63 
RCTf 7 7 
RCTt 6 7 
CCT* 4 5 
OD 6 6 
65 
33 
6 
11 
FSHD 
MMD 
MMD(5) 
LGD(1} 
PM(7) 
DM (4) 
Dynamic and isometric exercises for elbow flexors and ankle 
dorsiflexors, wk 1-8: 2 sets of 5-10 reps with 10-RM weights, 
interspersed with 30 sec isometric exercise with 10-RM; wk 9-
17; sets of 8 reps with 8RM weights; from wk 18; 5 reps of 5-
RM. 
Exercises of muscles of hip and knee. Wks 1-8; 3 sets of 25 reps 
of 60% of 1-RM; wks 9-16; 3 sets of 15 reps of 70% of 1-RM; 
From wk 18; 10 reps of 80% of 1-RM 
Maximal contractions of dorsiflexors and plantarflexors with 
ankle exerciser. Two sets of 10 M VC of 3-5 s for dorsiflexors 
and for plantarflexors 
Warming up. Exercises for shoulder mobility and grip strength 
with a pulley apparatus, exercises for quadriceps and hip 
muscles, sit ups and stretching. If FI score > 38 exercises with 
weights (0.25 -2 kg) were included. Also 15- min walking at 
self-selected speed 
3 x/wk 
for 52 wk 
3 x/wk 
30 min 
for 24 wk 
Daily 
for 4 mo 
5 x/wk 15 
min 
for 12 wk 
2/12t 
0/4t 
0/2* 
4/511 
0/3t 
0/6t 
0/4* 
3/8 
Arnadottir 
et al«* 
Aldehag et 
al« 
Sandin 
and 
Jonsson65 
Tollback«· 
OD 
OD 
OD 
OD* 
6 
6 
5 
4 
5 
6 
5 
6 
7 
5 
12 
9 
slBM 
MMD1 
WM 
MMD 
Exercises for shoulder mobility with a pulley apparatus, 
resistive exercises for shoulder and hip muscles, quadriceps 
and neck and trunk muscles. [10 reps of each exercise); Weight 
cuffs ( 0.25- 2 kg) depending on Fl score (> 38) and self paced 
walking (15 min) 
Hand exercises with silicone-based putty with isolated (1-2-3 
sets of 3 reps or 1-2-3 sets of 5 reps) and mass (1-2-3 sets of 10 
reps or 1-2-3 sets of 15 reps) movements, starting with 1 set of 
3-5 reps in isolated movements and 1 set of 10-15 reps in mass 
movements. Number of sets increased every 4 wks. Stretching 
was also included 
Hand exercises with silicone-based putty with isolated (1-2-3 
sets of 3 reps or 1-2-3 sets of 5 reps) and mass (1-2-3 sets of 10 
reps or 1-2-3 sets of 15 reps) movements, starting with 1 set of 
3-5 reps in isolated movements and 1 set of 10-15 reps in mass 
movements. Number of sets increased every 4 wks. Stretching 
was also included 
Maximal AROM exercises for knee extensors with weights on an 
iron shoe with increasing load. Wk 1: 60% of 1-RM; wk 2: 70% 
of 1-RM and thereafter 80% of 1- RM. 3 sets of 8 reps were 
performed 
5 x/wk 
for 12 wk 
3 x/wk 
45 min 
for 12 wk 
3 x/wk 45 
min 
for 12 wk 
3 x/wk for 12 
wk 
0/3 
7/1211 
4/14 
1/4 
NV 
3/411 
1/2 
NV 
1 Aerobic exercises 
Taivassalo 
et aP» 
Taivassalo 
etal^ 
0D§ 
OD 
4 
5 
5 
5 
24 
10 
MM (14) 
NMM(IO) 
MM 
Treadmill exercise 70 to 85% of HRR 
Treadmill exercise at 60-80% of HRR 
Exercise until reaching the RPE of 15 ("hard") 
3-4 x/wk 20-
30 min for 8 
wk 
3-4 x/wk 20-
30 min for 8 
wk 
2/211 
4/411 
1/111 
1/lli 
-
G 
-
-3 
Œ 
•< 
•s. 
r. 
> 
— 
-; 
a: 
-
-
> 
-
Taivassalo 
étal71 
Trenell et 
a l " 
Haller et 
al<·7 
Olsen et 
al6 8 
Sunnerhag 
en et al73 
OD 
ODS 
OD 
OD 
OD 
5 
5 
4 
5 
5 
5 
5 
5 
5 
5 
10 
10 
8 
8 
8 
MM 
MM 
MD 
FSHD 
HM 
Cycling at 70-80% of maximal HR 
Cycling at 70-80% of maximal HR 
Cycling at 60-70 % of maximal HR 
Cycling at 65% of VO2 max 
Cycling at 70% of maximal workload 
Subjective workload with a target of 5 (Borg category scale 
with exponential increments from 0-10) 
3-4 x/wk 30-
40 min for 14 
wk 
3 x/wk 30 
min 
for 12 wk 
4 x/wk 30-40 
min for 14 wk 
5 x/wk 35 
min 
for 12 wk 
5 x/wk 
30 min 
for 8 wk 
4/611 
2/3 
3/3 
2/211 
1/3 
NV 
1/1 
NV 
NV 
1/4 
Muscle strengthening and aerobic exercises 
Cejudo et 
al« 
RCT* 
Wiesingeret RCTt 
a l " 
4 
6 
7 
7 
20 
14 
MM 
DM/PM 
Cycling 30 min at 70% of peak work rate; 
isotonic arm weight (50% 1-RM, repeated 
and 3 dynamic 
every 2 wk) lifting 
procedures through full ROM; shoulder press (shoulder, upper 
back and arm muscles), butterfly (pectora 
curls (biceps brachii and brachialis). Wk 1 
reps; next wks: 2 -3 sets 
lis major) and biceps 
and 2: Iset of 10-15 
Cycling: 3-5 min warming up; resistance increased until 60% of 
maximal HR. Step aerobics 30 min at different rate levels 
adjusting load of exercises. Last 5 min coo ing down and 
stretching exercises. First 2 wks 2 times/wk, remaining 4 wks: 3 
x/wk 
3 x/wk 
60 min 
for l2wk 
2-3x/wk 
60 min 
for 6 wk 
13/18* 
2/2tll 
2/4*11 
1/lt" 
Wiesingeret CCT* 5 7 8 DM/PM 
al5·· 
Cycling; 3-5 min warming up; resistance increased until 60% of 
maximal HR. Step aerobics 30 min at different rate levels 
adjusting load of exercises. Last 5min cooling down and 
stretching exercises. First 2 wk 2x/wk, 4 wk:3x/wk, remaining 
18wk;lx/wk 
l-3x/week 
60 min 
for 6 mo 
6/8*11 1/1*11 
Muscle strengthening exercises, respiratory exercises and mud/massage/bath 
Varjuetal" OD 4 5 21 DM/PM 
Breathing exercises 
Ugaldeet OD§ 4 5 11 MMD 
al7 5 
Assisted bending and stretching of all joints; Isotonic muscle 
training until fatigue. Movements were repeated until 65-70% 
of max reps, then they had rest for 3min. If muscle were too 
weak a sling was used. Breathing exercises included instructions 
how to put hands on abdomen and rib cage and feeling and 
controlling movements, mud/massage/bath 
Pursed lips breathing as voluntary expiratory blowing through 
partially closed lips to create a resistance at the mouth 
compared to matched volume breathing (exhaling without 
pursing lips] and tidal breathing (comfortable breathing 
without pursing lips) 
5 x/wk 40-
60 min for 3 
wk 
120 s of each 
breathing 
condition 
9/18 
6/911 
2/4 
NV 
5. Heterogeneous neuromuscular disorders 
Strengthening exercises 
Aitkenset OD« 4 4 27 MMD (12); 
al7 6 HMSN (8); 
LCD [3); 
SMA (2); 
FSHD [2) 
Initially 3 sets of 4 reps with speed of 30/s for knee extensor 
with ankle weights of 30% of max isometric knee extension 
force; and also for elbow flexors with weight of 10% of max 
elbow flexion force. Also 3 sets of 4 reps for hand grip exercises. 
Increasing resistance and reps 
3 x/wk 
15-20 min 
for 12 wk 
7/1111 NV 
< 
χ 
η 
Τι 
O 
sa 
-
< 
> 
Η 
= 
-
PO 
> 
-
Kilmer et OD« 
a l " 
6 5 10 MMD (53; 
LGD (33; 
HMSN (23 
Knee extensors and elbow flexors with ankle and wrist cuff 
weights, 1 set of 10 reps with 12- RM, gradually increasing until 
5 sets of 10 reps during 4 d/wk After wk 5, resistance was 
increased by .45kg/wk (llb/wk3 If feasible. After wk 9, from 4 to 
5 sets 
3-4x/wk 
for 12 wk 
3/10 NV 
Aerobic exercises 
Florence CCT* 
And 
Hagberg2» 
Wright ett OD 
aP* 
6 
4 
5 
5 
12 
11 
Muscle strengthening and aerobic 
Dawes et RCTf 
al« 
7 6 18 
CCD(13; 
NM (13; 
MyM(13; 
SMA(13; 
CMD(23; 
LGD (33; 
GMT (23; 
FSHD (13 
MMD (73; 
HMSN (33; 
LGD (13 
exercises 
Becker MD 
(43; MMD 
(43; PM 
(13; FSHD 
(33; 1MB 
(13; LGD 
(43; CM (13 
Cycling on cycle ergometer 5-min exercise bouts, 2-min rest at 
70% of VOimax: Resistance was adjusted to continually elicit 
70%ofVO2max 
Walking with training at HR of 50-60% HRR 
Wk 1 and 2; 3 times per wk 15 min; week 3; 20-30 min; wk 5 - 9 
options to increase frequency to 4 x/wk 
Walking for as long as possible at light subjective exercise 
intensity up to 20 min, then Increase towards a moderate 
intensity (Borg CR-10 scale3. Two exercises for each leg muscle 
endurance and core stability increasing the number of reps and 
range until 2.5 min for each exercise. Then Increasing difficulty 
with gravity as resistance. Increasing number of reps 
3 x/wk 
for 12 wk 
3-4x/week 
15-20-30min 
12 wk 
Alternate 
days for 8 wk 
3/5*11 
1/33 
l / 7 t 
6/7*11 
0/2* 
NV 
0/6t 
0/6* 
Abbreviations: Activities/participation = number ofvariables at the level of activities or participation with significant change divided by total 
number ofvariables at the level of activities or participation; ALS = amyotrophic lateral sclerosis; AROM = active range of motion; Becker MD = 
Becker muscular dystrophy; Body functions = number of variables at the level of body functions with a significant change divided by the total 
number of variables at the level of body functions; BorgCR-10 scale = exercise symptom rating scale; CCD = central core disease; CM = Congenital 
myopathy; CMD = Congenital Muscular Dystrophy; CMT = Charcot-Marie-Tooth; CPN = Chronic Peripheral Neuropathy; D = descriptive criteria 
(maximum, 8); DM = dermatomyositis; Fi = functional index in myositis; FSHD = facioscapulohumeral muscular dystrophy; HM = hereditary 
myopathy; HMSN = hereditary motor and sensory neuropathy; HR = heart rate; HRR = heart rate reserve; IBM = inclusion body myositis; LCD = 
limb girdle dystrophy; MD = McArdle's disease; MG = myasthenia gravis; Min = minutes; MM = mitochondrial myopathy; MMD = myotonic 
muscular dystrophy; MVC = maximum voluntary contraction; MV1S = maximum voluntary isometric strength; MyM = myotubular myopathy; Ν = 
number of patients included in the study; NM = nemaline myopathy; NMM = nonmetabolic myopathy; NV = no variables in this area; OD = other 
design; PM = polymyositis; PPS = postpoliomyelitis syndrome; reps = repetitions; RPE = rating of perceived exertion; s = seconds; sIBM = 
sporadic inclusion body myositis; SMA = spinal muscular atrophy; V = criteria for internal validity [maximum, 11); VOzmax = maximum oxygen 
uptake; wk = week; WM = Welander myopathy; xRM = repeated maximum [maximum weight, which can be lifted χ repetitions). 
*Analysis within groups; 
f Analysis between groups; 
* One side of the body randomly chosen for exercise, contralateral side of the body served as control; 
5 Comparison with a reference group of healthy subjects; 
II Results significant [P<.05) for more than half of the variables. 
CHAPTER Γ. 
Muscle disorders 
Muscle strengthening exercises. Two RCTs13:14;25 of sufficient 
methodological quality, one CCT52 with insufficient methodologie quality and 
5 other designs62 6 6 studied strengthening exercises for patients with muscle 
disorders. Different types of muscle disorders and different muscle groups 
were studied. There was also much variety in type and intensity of 
strengthening exercises and in the outcome variables. The RCTs and CCT 
showed hardly significant findings, neither at the level of body functions nor 
at the level of activities and participation. The findings of the other designs 
were inconsistent. In conclusion, there is insufficient evidence for the 
effectiveness of muscle strengthening exercises for patients with muscle 
disorders. 
Aerobic exercises. Seven other designs67 7 3 studied aerobic exercises for 
patients with muscle disorders. Six other designs 67-72 showed consistent 
significant findings at the level of body functions and at the level of activities 
and participation. One other design73 showed significant findings in only 1 of 
3 outcome variables on body function. The outcome variable that showed a 
significant effect was a measure of aerobic capacity; the other 2 were 
strength measures. In conclusion, there are indications that aerobic exercises 
have a positive effect on body functions as well as activities and participation 
in patients with muscle disorders [level 111 evidence). 
A combination of muscle strengthening and aerobic exercises. Two 
RCTs2749 and 1 CCTS4 studied the combination of muscle strengthening 
exercises and aerobic exercises in patients with muscle disorders. One RCT27 
had sufficient methodologie quality, whereas the methodologie quality of the 
other RCT49 and the CCT54 was insufficient. The good quality RCT27 showed 
significant findings in all 2 variables at the level of body functions and in the 
only variable measured at the level of activities and participation. The low 
quality RCT49 and CCT™ showed significant findings consistent with the good 
quality RCT. In conclusion, it is likely that strengthening exercises in 
combination with aerobic exercises have a positive effect on body functions 
as well as on activities and participation in patients with muscle disorders 
(level II evidence]. 
A combination of muscle strengthening and breathing exercises and 
mud/massage/hath. One other design74 showed significant findings in 9 of 18 
variables at the level of body functions and 2 of 4 variables at the level of 
activities and participation. In conclusion, there is insufficient evidence for 
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the effectiveness of the combination of strengthening and respiratory 
exercises and mud/massage/bath for patients with muscle disorders. 
Breathing exercises. One other design75 on pursed lips breathing in 
myotonic muscular dystrophy [MMD] showed significant findings on 6 of 9 
variables on body functions. In conclusion: there are indications that pursed 
lips breathing is effective patients with MMD (level III evidence). 
Heterogeneous group of patients with NMD 
Muscle strengthening exercises. Two other designs7677 studied muscle 
strengthening exercises in a heterogeneous group of patients with NMD. The 
findings were inconsistent. In conclusion, there is insufficient evidence for 
the effectiveness of muscle strengthening exercises for a heterogeneous 
group of NMD. 
Aerobic exercises. One CCT28 and other design78 studied aerobic 
exercises in a heterogeneous group of patients with NMD. The CCT was of 
sufficient methodologie quality and presented significant findings in 3 of 5 
variables on body function28. There were no significant findings at the level of 
activities and participation. Only within-groups findings were presented, 
which means that we cannot consider this study to be a truly controlled trial. 
The other design78 showed a significant effect in only 1 of 33 variables on 
body functions. In conclusion, there is insufficient evidence for the 
effectiveness of aerobic exercises for a heterogeneous group of NMD. 
Muscle strengthening and aerobic exercises. One RCT21 of sufficient 
methodologie quality studied muscle strengthening and aerobic exercises in a 
heterogeneous group of NMD. The between-groups analysis showed a 
significant effect in lof 7 variables on body functions and none of the 
variables at the level of activities and participation. The within-group 
analysis showed a significant effect in 6 of 7 strength measures in the 
intervention group. If we consider this study as an other design, then the best 
evidence synthesis leads to the conclusion that there are indications that a 
combination of muscle strengthening and aerobic exercises is effective in 
increasing muscle strength (level III evidence). 
Adverse effects 
Thirty-three studies reported absent or negligible adverse effects. Chetlin et 
al.24 reported that 3 of 20 patients decreased their training for 1 or 2 sessions 
due to delayed-onset soreness. Six studies did not report whether exercise 
therapy resulted in adverse effects. 
1 ( 1 1 
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Other PT modalities 
No studies were found on the application of functional electrical stimulation 
or interventions to improve mobility including transfers and walking or 
education of the patient, family and caregivers. 
Discussion 
Methodology 
The extensive search used in this review with MeSH terms exploded without 
restrictions and free text words such as activities of daily living or physical 
activity, resulted in a large database of citations. However, 90% of the 
citations did not fulfill our predefined inclusion criteria regarding the study 
design, the participants, the intervention, or the outcome measures. 
Surprisingly, hand searching of the reference lists of the articles and reviews 
revealed a substantial number of additional citations. Hopewell et al.79 
compared hand searches versus Medline searching and found that 25 % of 
reports of randomized trials with a Medline record were missed by the 
electronic search, because they did not have either of the publication type 
terms randomized controlled trial or controlled clinical trial. This was 
especially the case for reports of RCTs published prior to 1991. It shows the 
limitations of electronic searches and suggests the need to combine 
electronic searches and manual searches.18 Another explanation is that the 
indexing of other designs is less precise and reliable compared with RCTs.18 
We included all RCTs and CCTs in our best evidence synthesis, 
regardless of their methodologie quality and only the other designs of 
sufficient methodologie quality. Although RCTs are usually cited as the 
highest level of evidence for judging the efficacy of therapeutic interventions, 
randomization should not be seen as a reliable proxy for overall quality.18 
Well-conducted nonrandomized studies may be more valid than poorly 
conducted RCTs. In this review we found 2 RCTs17;48 with a lower score on 
the criteria for internal validity than we accepted from other designs. 
Another unexpected finding was that 4 RCTs4851 and 4 CCTs285254 did not 
present between-groups comparisons. We recommend the presentation of 
between-group comparisons to be an additional criterion in the future rating 
of methodologie quality. 
The various types of NMD and PT interventions in combination with 
the use of a variety of outcome measures required that decisions were made 
on classifications and cutoff points. We decided that more than half of the 
outcome variables in a given study had to show a significant effect in order to 
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provide evidence. We presumed that all outcome variables were of similar 
importance, but this is arbitrary. It may have resulted in loss of evidence 
when effects of important variables were overruled by other variables 
without an effect. However, when we checked the actual variables, they were 
generally in agreement with our assumptions. 
Finally, in our method, a study that provided evidence of effectiveness, 
could be neutralized by studies without substantial evidence. One can argue 
that this is too strict, considering the fact that a study could only provide 
evidence if more than half of the variables showed a significant effect. On the 
other hand, we were not strict in including all RCTs and CCTs regardless their 
methodologie quality and other designs of sufficient methodologie quality. 
Exercise intensity 
Most studies evaluated muscle strengthening exercises, aerobic exercises, or 
a combination of these. The intensity of strengtening exercises can be 
manipulated by varying the resistance or weight, the number of repetitions, 
the length of the rest interval, or the number of sets of exercises completed. 
The American College of Sports Medicine (ACSM) formulated minimal 
requirements to evaluate the quality of training programs for effective 
muscle strength training in healthy adults80. The ACSM recommends a 
progressive individualized program, for all major muscle groups with at least 
1 set of 8 to 12 repetitions and a frequency of 2 to 3 days a week. Obviously, 
these requirements for healthy individuals cannot simply be applied to 
persons with NMD, because of lack of evidence regarding the effect of 
physical exertion on the diseased neuromuscular system. Overexerting 
muscles might accelerate disease progression12. Still, the intervention should 
be of enough intensity in order to provide a training stimulus. 
Nearly all studies on muscle strengthening exercises included in this 
review met the requirements of an individualized and progressive program. 
However, there was considerable variation in the muscles exercised, type of 
exercises given, and type of resistance, number of repetitions, and number of 
sets. Most investigators used a moderate level of intensity in order to prevent 
adverse effects. Indeed, a very important finding was the absence of adverse 
effects. If, however, the intensity is too low, one cannot expect an effect of 
training other than physiologic adaptations due to activation of muscles that 
might have been inactive before. 
For aerobic exercises, the ACSM recommends the use of large muscle 
groups in a rhythmic, aerobic and continuous manner18"1. For most people. 
CHAPTER S 
intensities within the range of 70% to 85% of maximum heart rate, or 60 to 
80% of oxygen uptake reserve or heart rate reserve are sufficient to achieve 
improvements in cardiorespiratory fitness, when combined with an optimal 
frequency of 3 to 5 days a week B1. This review has shown that these 
intensities can be recommended for patients with NMD without adverse 
effects. Most of the included studies used cycling or treadmill exercise with a 
frequency of at least 3 times a week and exercise intensity around 70% of 
heart rate reserve or estimated maximum heart rate. 
For both muscle strengthening and aerobic exercises the entire 
program should last at least 10 weeks and regular supervision optimizes the 
effect of training and improves safety and compliance12. Yet, in only 30% of 
all studies on muscle strengthening and aerobic exercises, the duration of the 
interventions was less than 10 weeks and in approximately 50% of the 
studies, the training was under regular supervision. 
Uniformity 
In order to facilitate meaningful comparisons among studies and statistical 
power by effective pooling of study results, more uniformity is needed in type 
of interventions, intensity of exercise therapy and type of outcome measures. 
To achieve more uniform terminology, we recommend the development of an 
international classification for PT modalities. In the Netherlands, such a 
classification has been developed for allied health care professionals82. In 
this study, the 1CF19 was used to make a distinction between outcome 
variables at the level of body functions and at the level of activities and 
participation. We recommend to develop 1CF core sets specifically for NMD, 
like ICF core sets developed for other chronic diseases8385. This would 
provide professionals and researchers with a framework for the selection of 
assessment and outcome measures on body functions, activities and 
participation and on environmental factors for research as well as for clinical 
purposes. 
Conclusions 
Our best evidence synthesis resulted in level II evidence (likely to be 
effective) for strengthening exercises in combination with aerobic exercises 
for patients with muscle disorders. Level 111 evidence (indications of 
effectiveness] was found for aerobic exercises in patients with muscle 
disorders and for the combination of muscle strengthening and aerobic 
exercises in a heterogeneous group of muscle disorders. Finally, there is level 
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III evidence for breathing exercises for patients with MG and for patients 
with MMD. There was insufficient evidence for strengthening exercises due to 
insignificant or inconsistent effects. Most studies reported the absence of 
adverse effects. 
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Abstract 
Purpose: A systematic review was conducted to summarize and evaluate the 
literature on the effectiveness of speech pathology interventions in adults 
with neuromuscular diseases. 
Method: Databases searched included the Cochrane Database of Systematic 
Reviews, the Cochrane Central Register of Controlled Trials, Medline, 
C1NAHL, Embase, PsyclNFO and PubMed. A total of 1,772 articles were 
independently screened on title and abstract by 2 reviewers. 
Results: No randomized controlled trials or clinical controlled trials were 
found. Four other designs were included. Only one study on oculopharyngeal 
muscle dystrophy [OPMD] appeared to have sufficient methodological 
quality. There is evidence indicating that correction of head position in 
patients with OPMD improves swallowing efficiency [level 111 evidence). 
Conclusion: Despite 1,772 studies, there is only evidence of level 111 regarding 
the effectiveness of speech pathology interventions in patients with OPMD. 
Recommendations for future research are given. 
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Introduction 
Neuromuscular diseases [NMD) represent a subfield of neurology, including 
heterogeneous groups of patients with approximately 600 diseases of the 
muscle, neuromuscular transmission, peripheral nerve and nerve root or 
motor neuron. NMD can lead to dysarthria and dysphagia, which are both 
diagnosed and treated by speech pathologists [SP]. 
Both dysarthria and dysphagia are not only relatively prevalent, but 
also clinically relevant symptoms in NMD. The impact of dysarthria on 
quality of life is obvious, since communication is generally considered to be a 
critical determinant of quality of life. Dysphagia can lead to aspiration 
pneumonia and therefore to serious health problems. Dysphagia and 
concomitant pneumonia may even be life-threatening in otherwise weakened 
NMD patients. 
In a sample of 102 NMD patients, we found that 45% of the patients 
had an indication for SP advice, regarding dysarthria or dysphagia1. However, 
this judgement was based on the expertise of the participating SP. The aim of 
this article is to assess whether there is evidence for the efficacy of 
treatments administered by SP in patients with NMD. 
Methods 
Search strategy 
We searched the Cochrane Database of Systematic Reviews and the Cochrane 
Central Register of Controlled Trials (The Cochrane Library November 2007, 
Issue 3), Medline (1966 through November 2007), C1NAHL (1982 through 
November 2007], Embase (1980 through November 2007], PsycINFO (1806 
through November 2007] and PubMed (1950 through November 2007]. 
The search strategy was built on different types of NMD and different 
types of SP interventions. For all search strategies Medical Subject Headings 
(MeSH] or indexed terms were used as well as free text words. The full search 
strategy is shown in Table 1. Reference lists of reviews and selected articles 
were scanned for further potentially relevant articles. 
Selection criteria 
Inclusion was restricted to peer-reviewed articles published in English, 
German, French or Dutch. Randomized controlled trials (RCTs], clinical 
controlled trials (CCTs] and other designs (ODs) were included. Single case 
studies were excluded. 
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Table 1, Free text words and MeSH terms used in search strategy to find evidence for 
the effectiveness of speech pathology in NMD 
Free text words 
Speech pathology 
Speech pathology, speech therapy, speech and language therapy, speech disorder, 
communication disorder, articulation disorder, swallow disorder, deglutition disorder, 
dysphagia, dysarthria, dietary modification, swallow, intelligibility, alternative 
communication 
NMD 
Neuromuscular disease, neuromuscular disorder, muscle disease, muscle disorder, 
neuromuscular junction disease, neuromuscular junction disorder, motor neuron 
disease, motor neuron disorder, motoneuron disease, motoneuron disorder, 
neuropathy, polyneuropathy, peripheral nervous system disease, peripheral nervous 
system disorder, neuralgia, neuritis, myopathy, dystrophy, myotony, myositis 
MeSH terms 
Speech pathology 
Dysarthria, speech disorder(s], speech therapy, speech pathology, communication 
disorders, communication aids, speech intelligibility, facilitated communication, 
communication aid, alternative and augmentative communication, communication aids 
for the disabled, dysphagia, deglutition disorders 
iVMD 
Neuromuscular disease(s), neuromuscular disorders 
Participants included adults (>18 years} with various types of NMD 
[disorders of the muscle, neuromuscular transmission, peripheral nerve and 
nerve root or motor neuron). SP interventions included information and 
advice or teaching compensatory strategies. Information and advice 
incorporated (1] dietary modification, [2] augmentative and alternative 
communication, or (3) instruction of the patient and relatives. Compensatory 
strategies included teaching swallowing maneuvers and/or strategies to 
improve intelligibility. Brain computer communication devices such as 
thought translation devices were excluded, as this is not considered a regular 
SP intervention. For the same reason, we also excluded medical interventions 
related to dysphagia, such as myotomy of the cricopharyngeal muscle. 
The outcome measures included swallowing at the level of body 
functions and intelligibility, communication and eating and drinking at the 
level of activities and participation, according to the definitions of 
International Classification of Functioning, Disability and Health (ICF)2. 
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Procedure for inclusion 
Two reviewers [SK and EHCC} independently carried out a preliminary 
selection based on title and abstract of articles. Full texts of articles that 
seemed to fit the inclusion criteria were retrieved for further evaluation. A 
final selection was made independently by the 2 reviewers on the basis of full 
texts. When different conclusions were drawn, consensus was reached 
through discussion. 
Methodological quality 
Methodological quality of studies was independently rated using criteria 
recommended by Van Tulder et al.3. The 2 reviewers independently assessed 
the methodological quality. Disagreements were resolved by discussion 
between the reviewers. 
For RCTs and CCTs, the quality of reporting was scored on 6 criteria 
(eligibility criteria, comparability of groups, explicit description of 
interventions, adverse effects, short-term and long-term follow-up 
measurements). Methodological quality was scored on 9 criteria 
[randomization, concealed allocation, avoidance of co-interventions, 
compliance, blinding of outcome assessor, relevance of outcome measures, 
acceptable dropout rate, comparable timing of outcome assessment and 
intention-to-treat analysis). Statistical quality was scored using 2 criteria 
(description of sample size and presentation of point estimates/measures of 
variability). One criterion regarding statistical quality [between-group 
statistical comparison) of the PEDro scale was added4. 
Methodological quality of articles was considered sufficient when 3 out 
of 6 reporting criteria, 6 out of 9 methodological criteria, and 2 out of 3 
statistical criteria were scored positively3. For ODs, the criteria of 
comparability of groups, randomization, allocation, and between-group 
comparison were not applicable. For these designs, 2 out of 5 reporting 
criteria, 4 out of 7 methodological criteria, and 1 of 2 statistical criteria had to 
be scored positively to be of sufficient quality5. 
Best evidence synthesis 
A best-evidence synthesis was performed according to the classification of 
the Dutch Institute for Health Care Quality Improvement6. Three levels of 
evidence and conclusions were formulated. Level I evidence refers to at least 
2 RCTs of sufficient quality. Conclusions are formulated as 'it has been shown 
that....'. Level II evidence refers to 1 good quality RCT or at least 2 
independent controlled studies (RCTs or CCTs) of less methodological 
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quality. Conclusions are formulated as 'it is likely that....'. Level 111 evidence 
refers to an RCT or CCT of low methodological quality or at least 1 OD of 
sufficient methodological quality. Conclusions are formulated as 'there are 
indications that....'. When inconsistent findings were found in studies of 
similar design and methodological quality, conclusions are formulated as 
'there is insufficient evidence that....'. 
Results 
Selection 
The search strategy identified 1,772 articles, duplicates excluded (Figure 1). 
After screening on title and abstract, 1,723 articles were excluded because 
they did not meet predefined criteria for study design, type of participants, 
type of intervention, type of outcome measures, or English, French, German 
or Dutch language. In 42 articles there was discussion between the 2 
reviewers, leading eventually to retrieval of 17 full-text articles that seemed 
to fit the inclusion criteria. In addition, 7 review articles were retrieved and 
screened for additional articles. Another 15 articles from reference lists were 
retrieved in full text. Following evaluation of the full-text articles, 4 fulfilled 
all inclusion criteria710. These studies were subjected to assessment of 
methodological quality. 
Methodological assessment 
The 4 studies included were all ODs. The methodological quality of 3 studies 
was insufficient (8-10] and the methodological quality of 1 study was found 
sufficient7 (Table 2). 
De Swart et al.7 found a negative influence of ptosis on swallowing 
function in patients with oculopharyngeal muscle dystrophy. The instruction 
'head position slightly flexed', i.e. head not adapted to the ptosis, significantly 
increased swallowing efficiency. This was objectively evaluated with 
videofluoroscopy (with 20 ml of thin and thick liquid] and maximum 
swallowing volume. 
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PubMed 
N=468 
PsycINFO 
N=71 
CINAHL 
N=177 
Embase 
N=981 
Medline 
N=1.055 
Reviews retrieved for 
further screening {n=7) 
(Hill 2004. Yorkston 1996 
Yorkston 2007, Morris 2006 
Langmore 2006. Roche 2005. 
Gilardeau 1995) 
1,053 duplicates 
excluded 
Excluded (n=1,723) with reasons 
Type of study not and intervention study 
Participants not (only) patients with NMD 
Intervention not a (current) ST ntervention 
Type of outcome measures 
Case study 
Potentially relevant articles 
identified and screened on title 
and abstract for retrieval (n=42) 
Retrieved from reference lists 
for more detailed information in 
full article {n=15) 
Excluded (n=14) with reasons 
Type of study not and intervention study 
Chetney 2004, Doyle 2001, Turner 1995: 
Weismer 2000. Yorkston 2001 
Casestudy Carcia 1998 
Participants not (only) patients with NMD 
Ertekm 2001. Light 1992: Enderby 1981. 
Shanahan. 1993, Ekberg 1986, Glennen 
1985, Gulp 1986 
Intervention study not a (current) ST 
intervention Esposito 2000 
Excluded (n=25) with reasons 
Type of study not an intervention study 
Blackstone 2002 Chernousov 1989, 
Clark 2005, Cook 1999, Cup 2007. 
Danon1992. Goodenough-Trepagmer 1981, 
Han 2003. Hudspeth 2006. Kahnlas 
2003 Kirker2003. Krefting 1990, Lind 
2003, Logemann 2000: Mc Naughton 
2001 Murphy 2004 Silverman 1979: 
Somes 1997. Squires 2006 Williams 2003 
Casestudy Darrow1992 
Participants not (only) patients with NMD 
Kays 2006: Lasker 2001. Logemann 
1996 Yoshida 2007 
Retrieved for more detailed 
information in full article 
(n=17) 
Excluded (n=14) with reasons 
Type of study not an intervention study 
Ball 2004a, Ball 2004b. Carter 1998, 
Fried 2006, Kazandiian 1995 
Type of outcome measures De Swart, 
2007 
Participants not (only) patients with NMD, 
Draizar 1984, Η ι rd 2007, Kotler 2002: 
Martens 1990. Schmidt 2007, Soderholm 
2001 
Intervention not a (current) ST 
intervention Birbaumer 2000, Perry 1981 
| Selected for systematic review (n=4) 
I De Swart. 2006, Oh 2007, Scott 1994. 
Silberglett 1991 
Figure 1. Process for identification of included studies. 
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Table 2: Methodological quality of included studies showing 3 studies of insufficient 
methodological quality (8-10) and 1 study of sufficient methodological quality7 
Criteria Silbergleit 
et al.«» Oh et al.» 
Scott & 
Austin9 
De 
Swart 
et al.7 
Reporting criteria 
Eligibility criteria specified? 
Intervention explicitly described? 
Adverse effects described? 
Short-term follow-up measurement 
performed? 
Long-term measurement performed? 
Total descriptive criteria (at least 2/5) 
Yes 
Yes 
No 
No 
Yes 
3/5 
Yes 
Yes 
Yes 
No 
Yes 
4/5 
Yes 
No 
Yes 
Unknown 
Yes 
3/5 
Yes 
Yes 
No 
Yes 
No 
3/5 
Methodological criteria 
Co-interventions avoided? 
Compliance acceptable? 
Outcome assessor not involved in the 
treatment? 
Outcome measures relevant? 
Withdrawal/drop-out rate described 
and acceptable? 
Timing of the outcome assessment in 
all patients comparable? 
Analysis including an intention-to-treat 
analysis? 
Total internal validity (at least 4/7) 
Unknown 
Yes 
Unknown 
Yes 
Yes 
No 
No 
3/7 
No 
Unknown 
Unknown 
Unknown 
No 
No 
No 
0/7 
No 
Yes 
No 
No 
Yes 
Unknown 
Unknown 
2/7 
Yes 
Yes 
N.A. 
Yes 
Yes 
Yes 
No 
5/7 
Statistical criteria 
Was the sample size of the group 
described? 
Were point estimates and measures of 
variablility presented for the primary 
outcome measures? 
Yes 
Yes 
Yes 
No 
Yes 
No 
Yes 
Yes 
Total statistical criteria (at least 1/2) 2/2 1/2 1/2 2/2 
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Best-evidence synthesis 
The study by de Swart et al.7 is an OD of sufficient methodological quality. 
Therefore the evidence-based conclusion was that there are indications (level 
111 evidence) that when head position is slightly flexed and not adapted to the 
ptosis, swallowing efficiency improves in patients with oculopharyngeal 
muscle dystrophy. 
Discussion 
The main conclusion of this study is that the published evidence for 
effectiveness of SP in adults with NMD is very limited, as our search strategy 
did not identify RCTs or CCTs on this topic. There was only 1 OD 
(uncontrolled pre-post study] that was of sufficient methodological quality. 
Regarding dysphagia, the only available evidence (level 111] found was 
based on an uncontrolled study7. As we know from normal swallowing, 
extension of the neck leads to ineffective swallowing1113. Therefore, basic 
instructions about the influence of posture of head and neck on swallowing 
seem valuable in NMD in general - particularly when the disease leads to 
changes in posture or weakness in the head-neck-shoulder region or when 
the disease leads to weakness in muscles involved in speech or swallowing. 
Regarding dysarthria, despite the extensive amount of articles, no 
evidence was found for the effectiveness of SP in NMD. We only found 2 
articles in which one-time manipulations of speaking rate led to a slower 
speaking rate, but this technique did not have a positive effect on 
intelligibility.14:15. 
All 4 studies included a homogeneous patient population with regard 
to the medical diagnosis. This may limit generalization of the results to other 
groups of patients with NMD. However, many NMD patients suffer from 
weakness in speech and swallowing muscles. Therefore, we hypothesize that 
the SP interventions are applicable to different groups of NMD patients with 
comparable impairments and disabilities. The comparison between studies is 
also difficult because of the different outcome measures used. Finally, 
considering the small number of patients, there might be a type 11 error in the 
included studies. This problem can be solved by including different groups of 
NMD patients with comparable impairments in one study. 
Exclusion of studies 
Our extensive search resulted in a large number of articles, most of which 
were excluded. Many studies did not evaluate the effectiveness of an SP 
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interventions but were descriptive studies, for instance on dysarthria and 
dysphagia in patients with NMD. The use of MeSH and free text words for 
different types of NMD resulted in many studies concerning other 
neurological conditions, such as Parkinson's disease or stroke, which did not 
fulfill our inclusion criteria. 
Recommendations for future research 
Despite their potential limiting effect on quality of life and general health 
condition, there are hardly any studies focusing on the effects of dysarthria 
and dysphagia. We would like to propose that both dysarthria and dysphagia 
are of utmost importance in NMD patients and treatment strategies with 
respect to these impairments should be the topic of well-designed RCTs. 
Preferably, these trials should be performed in homogenous patient samples, 
with comparable levels of impairments. Conclusions of those trials might be 
used in other groups of NMD patients, with similar impairments at the bulbar 
level. However, these remarks should not discourage researchers to perform 
less ambitious research, for example observational cohort studies or 
controlled trials. Results of such trials also add to the required level of 
evidence of SP. 
As for the interventions, it is important that all patients are given 
standardized interventions and that SP interventions are being properly 
described. It should be noted that the feasibility of interventions depends on 
the type of intervention. Swallowing techniques are internationally uniform 
and well described in the literature16. However, there is less uniformity 
regarding techniques to improve intelligibility, although interventions like 
decreasing speaking rate or producing a louder voice can be objectively 
described in syllables per second or by measuring sound levels. Interventions 
regarding augmentative and alternative communication and instruction of 
the patient and relatives are tailor-made to such an extent that they cannot 
be standardized. 
With regard to the type of outcome measures, we recommend using 
videofluoroscopy or flexible endoscopic evaluation of swallowing to 
objectively evaluate swallowing. Also, other quantitative measurements like 
the timed test17 and the dysphagia limit18 can be easily used as objective 
outcome measures. Secondary outcome measures like body weight, 
percentage of oral intake and quality of life can be valuable. For evaluating 
speech at the level of activities, we recommend using a speech intelligibility 
test1921. At the level of participation, a scale of communicative participation is 
being developed22. Acoustic measurements are the most objective 
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measurements to evaluate speech at the level of body functions. It should be 
kept in mind, however, that acoustic measurements have limited predictive 
value with regard to communication effectiveness2325. Therefore we 
recommend using the acoustic measurements only in combination with 
measurements at the level of activities or participation. 
A consensus meeting with experts on speech pathology, neurology and 
methodology is recommended to further discuss and agree on the outlines of 
future trials. Previous meetings along these lines and covering various 
neuromuscular topics, such as myotonic dystrophy, have been very 
succesful26. 
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Abstract 
To Increase understanding of how myotonic dystrophy type 1 (MDl) affects 
the lives of couples and how they manage individually and together, a 
qualitative study was carried out. Fifteen in-depth interviews with five 
couples took place in their homes. People with MDl associate this 
neuromuscular disease with decreasing abilities, describing physical, 
cognitive and psychosocial barriers to everyday activities and social 
participation. Partners highlighted the increasing care giving burden, giving 
directions and using reminders to compensate for the lack of initiative and 
avoidant behaviour due to MDl. Couples portrayed the dilemmas and 
frustrations of renegotiating roles and responsibilities; stressing the 
importance of achieving a balance between individual and shared activities. 
All participants experienced a lack of understanding from relatives, friends, 
and society, including health care, leading to withdrawal and isolation. 
Couple management, supporting the self-management skills of both partners 
is proposed as a way to better match health services and needs. 
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Introduction 
"Every time 1 ask her to come shopping with me, she says you better go without me". 
This quote is typical for a partner of someone with myotonic dystrophy type 
1 (MD1). It may raise questions like why this person with MD1 chooses to 
stay at home? What does it mean for her and her partner? Is it considered a 
problem or not and if so by whom? These questions address the impact of 
MD1 on daily life of couples and are related to their health and well-being. 
How often are such issues addressed by health care professionals? 
MD1, also known as Steinert disease, is the most frequent of the adult 
neuromuscular diseases with a prevalence estimated at 1/20,000 
inhabitants1. MD1 is a hereditary chronic systemic disease with wide 
variability in clinical expression, both within and between families. MD1 is 
characterized by the involvement of many organs, including impairments in 
the muscular, respiratory, cardiac, central nervous, endocrine and ocular 
functions and structures24. Typical symptoms of the disease include 
myotonia and progressive loss of muscle strength, usually distal to proximal, 
and weakness of facial and anterior neck muscles. Other symptoms include 
cataracts, frontal baldness, dysarthria, fatigue and daytime somnolence. Also 
cognitive decline including lack of initiative and specific personality traits 
such as an avoidant personality are related to MD158. Compared to other 
neuromuscular diseases, persons with MD1 have among the gravest 
functional disabilities and the greatest dependence on others for activities of 
daily living9. They also have the lowest social participation, most psychosocial 
problems and poorest psychosocial well-being10. This not only has huge 
impact on persons having the disease81011, as well as on their partners n · 1 3 
and surely on their lives together as a couple. As far as we know, this is the 
first study to explore the impact of MD1 on the daily lives of couples. 
Despite the huge impact of MD1 on daily life, individuals with MD1 
tend to play down or avoid expressing their problems when attending 
physicians or other health care professionals and adherence to rehabilitation 
services is generally poor 14. Reasons for this are not well understood. 
Difficulties managing their own health has been attributed to personality 
features such as diminished persistence and increased avoidance51516. It may 
also be that persons with MD1 perceive their limitations as normal, since the 
slowly progressive nature of the deterioration gives them time to adapt and 
live more by what they can do than by what they cannot do 10 or they might 
have received the message that the disease is progressive and that there is no 
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cure8. Finally, they may believe that professionals cannot help and have little 
knowledge and understanding of the disease8. Indeed, although MDl is one of 
the most prevalent neuromuscular diseases, the disease is relatively 
unknown among medical and allied health professionals and scientific 
evidence of the effectiveness of allied health care is limited as shown in the 
various systematic reviews1719. Very little is known about how couples cope 
in daily life with this complex, progressive disease. It is important to 
understand their perspective of living with this hereditary, systemic disease 
in order to better match health care to their problems, concerns and needs. 
Persons with MDl and their partners both live with the disease and become 
experts through their experience. They are more knowledgeable than 
professionals regarding the consequences of the disease for their lives and 
how treatment effects their daily lives20:21. 
The purpose of this study is to increase our understanding of what 
MDl means for persons having the disease, for their partners and for both as 
a couple, and how they manage in daily life individually and together. The 
research questions are: 
How do persons with MDl and their partners reflect on living with this 
hereditary chronic progressive disease? 
- How do persons with MDl and their partners experience their lives 
together as a couple? 
Methodology 
Design 
As we aim to study personal experiences, make sense of these and interpret 
these in terms of the meanings the persons themselves bring to them, a 
qualitative method is most appropriate22. Couples were visited in their 
homes. In 2009, 15 in-depth interviews were carried out with persons with 
MDl and their partners separately and simultaneously at two different 
moments in time to obtain insights in the meaning of MDl on the lives of 
couples. 
This study followed a hermeneutic approach according to the method 
of'verstehen', which is based on three principles22: 
1) Human experience has a historical nature and is context bound. This was 
addressed by asking the participants about present and past experiences 
and the context of these and by conducting the interviews in the homes of 
the couples, their naturalistic setting. 
2) Understanding requires imaginative participation in the lives of those 
being studied to not impose foreign meanings on their thoughts and 
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actions. This was addressed by listening to the couples and observing how 
they live and manage in their home situation. 
3) The researchers' professional perspectives and experiences are used 
when interpreting the findings to gain better insight and understanding of 
the meaning of living with MD1. 
Data collection and procedure 
The researcher [EC] approached all couples by telephone. All agreed to 
receive written information about the study. When contacted a week later, all 
couples agreed to participate in the study. The first couple served as a pilot 
couple to test the interview guide [Box 1]. As lack of understanding was a 
major issue raised spontaneously by this couple, this topic was added to the 
interview guide. 
Data collection was iterative and consisted of four phases for each 
couple: 
1] Interview with the person having the MD1; 
2] Interview with the partner; 
3] Verbatim transcription of interviews and selection of meaningful 
expressions or topics by the researcher [EC]; 
4] Interview with couple about three weeks later. The goal was to elaborate 
on previous topics and to get more in depth information on how MD1 affects 
the lives of couples and how they manage together. 
Preceding the interviews, informed consent forms were signed and all 
participants gave permission to record the interviews. Small talk and an 
explanation of the purpose and format of the interview enabled the 
interviewer and interviewees to become acquainted with each other. The 
interview guide comprised one main question and follow-up topics. Each 
interview proceeded in an informal conversational style, lasting between 60 
and 90 minutes. Following the interviews, the researcher wrote memos on 
the impressions and reflections of the interview and field notes about the 
home situation. 
Ethical considerations 
At all visits the researcher emphasized that participation was entirely 
voluntary and that the participants could withdraw at any time without 
consequences for their treatment. Permission to audiotape the interview was 
confirmed at every visit as was reassurance of confidentiality. Following the 
interviews, the researcher gave participants an opportunity to reflect on the 
experiences and checked the need for formal after care from a social worker. 
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None of the participants indicated they needed this. All data and quotes used 
were anonymized. Approval from the local medical ethics committee (CMO 
number 2008/261 NL26868.091.09] was obtained. 
Box 1. Interview guide 
Main question: 
"How has myotonic dystrophy influenced your 
manage?" 
Topics: 
daily life and how do you 
Current daily activities, roles and relations and their meaning 
Activities, roles and relations and their meaning ir 
Changes in activities roles and relations 
Management strategies to deal with changes 
Topic added following the pilot interview: 
Understanding from others 
the past 
Participants 
Ten persons, five with MDl [adult or classical type] and their partners, were 
included. Purposive sampling 23 was used, identifying couples with MDl from 
the Dutch neuromuscular database, CRAMP [Computer Registry of All 
Myopathies and Polyneuropathies] which contains about 300 persons with 
MDl. All participants with MDl had been admitted to the medical centre in 
the past for the purpose of multidisciplinary [medical and allied health] 
assessment and advice. Criteria for inclusion were: 1] the person with MDl 
was restricted in activities of daily living and social participation; and 2] the 
couples had been living together for at least ten years. Difficulties in 
communication such as dysarthria, which had been an exclusion criterion in 
other qualitative studies with persons having MDl only, was not an exclusion 
criterion in the current study. 
Three men and two women with MDl and their partners, all 
Caucasian, representing the majority of couples with MDl in the Netherlands, 
were willing to participate. They lived in different villages in the south of the 
Netherlands. The mean age of the persons with MDl was 58 years [range 53 
- 65]. There was variation in socio-economic background and work status. 
One of the persons with MDl still worked part-time in a sheltered work 
facility, two were retired and two were housewives. One partner worked 
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fulltime, one part-time, one worked on occasions and one partner had taken 
early retirement. Two couples had one or more children with MD. 
Data analysis 
Analysis started following initial interviews with each couple. In depth 
analysis took place after completing all 15 interviews. Analysis involved a 
constant comparison method24 including the following steps: 
1) Familiarization with the interviews and understanding of the experiences 
and meaning of living with MD1 by listening and multiple readings of the 
transcripts, the production of summaries and reading the reflexive memos 
and field notes; 
2] Assignment of codes to meaningful text units (statements) related to the 
research questions. ln-vivo codes were assigned to stay close to the original 
voices of the interviewees; 
3] Categorization of meaning units from the combination of all codes, 
reorganization and interpretation, resulting in the formulation of themes and 
subthemes; 
4) Interpretation of relations between themes and subthemes with use of 
other sources including literature, field notes and own experiences leading to 
new insights and better understanding of the meaning of MD1 for couples. 
The researcher (EC) performed all steps and two co-authors (TS, AK) 
served as peer-reviewers during the process of coding and the formulation of 
themes and subthemes. The codes, themes and subthemes were discussed 
with the whole research group at three meetings. MaxQDA 2007 computer 
software was used to assist in organizing the data (www.MAXQDA.com). The 
analysis was carried out in the Dutch language to minimize bias and preserve 
meaning. Only the quotations used in this article were translated into English. 
Reflection on the role of researcher and research group 
The research group included researchers with different medical, 
philosophical, allied health care and methodology background. Three 
members were experienced researchers and lecturers in the field of 
qualitative research (AK, TS, G|W). The researcher (EC) also worked as an 
occupational therapist (OT) in a multidisciplinary team of clinicians and 
researchers. Previously, she had seen three of the participants with MD1 for 
a single assessment and advice in the neuromuscular centre. In the restricted 
time allocated in a clinical setting, she had felt it was impossible to 
understand what it is like for couples living with MD1. The fact that the 
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researcher was known to three people with MDl did not seem to influence 
the participants in sharing their personal experiences. 
7ri/siwort/7;>)ess 
To further enhance the trustworthiness or rigor of the study2S, several 
triangulation methods were used2'1, including the use of different 
perspectives [persons with MDl, their partners and as a couple] generating 
richer understanding than single perspectives27; and investigator 
triangulation within the research group. Credibility25 of the study was further 
ensured by member checking and the use of participants' quotes and in-vivo 
[sub] themes. All couples had received summaries of the interviews including 
meaningful quotes and had confirmed content. 
Box 2. The four themes resulting from the analysis 
Impact for persons with MDl (35% of codes): 
1) Decreasing abilities 
• Many barriers; "no power, no pep, no guts" 
• Avoiding barriers; "1 don't do that much" 
Impact for partners [15% of codes): 
2] Increasing burden 
• "If I did not do it, nothing happened" 
• "I am in charge; 1 give directions" 
Impact for couples f25% of codes): 
3) Finding a mode together 
• Doing or leaving; renegotiation of tasks 
• Individual and shared activities; give each other freedom 
Impact for persons with MDl, for partners and for couples [20% of codes). 
4) Lack of understanding 
• Even the family does not understand 
• We manage ourselves 
• Health care: many islands focused on part of the disease 
Results 
In total 1070 codes were assigned to meaningful text units in the transcribed 
interviews. Of these, most codes [433] came out of the interviews with the 
partners and 339 codes were from the interviews with persons with MDl. 
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The couple interviews yielded another 298 codes. Four themes emerged 
representing the impact for persons with MD1 (35% of the codes), for their 
partners (15% of the codes), for couples (25% of the codes), and the last 
theme represented an overall impact (20% of all codes) (Box 2). The 
subthemes reflect the impact of living with MD1 and the main self-
management strategy used. To capture the essence of a (sub) theme, in vivo 
codes were used. 
Theme 1: Decreasing abilities 
Participants with MD1 all experienced progressively more limitations in an 
increasing number of daily activities and roles which were important for 
them. These activities were enjoyable, made them independent, gave a sense 
of belonging or made them feel valued by others. For some participants the 
decrease in abilities felt like "I cannot do anything anymore". 
"1 have always helped my brothers a lot. Those were good times. 1 could do it 
all. But that's history. 1 cannot do anything anymore. Now they no longer 
need me. They have sort of forgotten me." 
Many barriers; no power, no pep, no guts 
Participants experienced obstacles to everyday activities and social 
participation. Some referred to barriers; others said it was too much trouble, 
too much hassle, too difficult, or too complicated. When someone said that he 
or she lacked pep or guts, it could mean that he or she lacked energy or 
vitality (physical barrier), experienced difficulty initiating or planning tasks 
(cognitive barrier), or lacked courage (psychosocial barrier) or a combination 
thereof. 
"For a lot of things I just don't have the guts. Then it takes ages before I get 
dressed, simply because 1 don't feel like it." 
Participants reported physical limitations such as reduced strength in hands 
and legs, decreased balance, reduced fitness and fatigue. These limitations led 
to safety risks, fear of falling, inability or a disproportionate amount of time 
or effort was needed to perform tasks. 
"I used to make the table. But I cannot do this anymore. Because, when I take 
the plates and 1 fall, then we have no plates anymore ..." 
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"My condition is nearly nothing. 1 cannot walk anymore, at least, not what it 
should be. When I walk, I'm dead tired. 1 walk as little as possible." 
Several participants mentioned problems with their bowels or continence 
which restricted participation in daily activities. 
"I used to sit on the toilet the whole morning. Now I notice with my bladder 
sometimes 1 cannot do much, otherwise I may lose control" 
Few participants described lack of initiative or mentioned that thinking what 
to do or how to do it was difficult for them. Instead, many regarded 
themselves as 'easy' and some wondered whether they might be too easy 
going. 
"Deciding what we are going to eat is terribly difficult for me". 
"Persons with my muscle disease don't have much initiative. If my wife 
suggests shall we go on holiday? Then I say okay, you say where, because I 
don't care. She does not like that. She says you can think of what you like. 
Then 1 say I enjoy everything, I am very easy." 
In social situations, persons with MD1 found it hard to take initiative and 
usually waited for invitations from others. They described barriers associated 
with feelings of shame or insecurity. The reduced intelligibility or clumsiness 
made them feel anxious and led to fear of being looked at or being made a 
fool of. 
"On a birthday, I'll quietly sit in a corner. I dare not say anything. There are 
also strange people that might not understand me or make me feel foolish." 
Avoiding barriers; I don't do that much 
Persons with MD1 mentioned that they increasingly give up, postpone or 
avoid activities and roles, like stopping work or sports and going out less. 
Even the daily shopping is often left to the partner. The result is that their 
world becomes smaller and social contacts decline. Although this is perceived 
as a difficult and painful process, the participants felt that there is no use in 
complaining and tried to stay positive. 
"I get very annoyed when I'm in a shop and I cannot open a bag to put 
tomatoes in it or something. Then I have to ask to keep the bag open. It may 
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be false modesty or shame, but 1 find that terrible. That's why I have quitted 
doing the shopping." 
"Because you are at home most of the time, your world becomes smaller, 
which is very annoying for me But 1 am not going to sit and be sad. 1 still 
do things, but not that much." 
Participants also adjusted their expectations and demands, making life more 
manageable. Sedentary or spectator activities were mentioned like enjoying 
the presence of grandchildren or sitting in the garden or at the camping site. 
They described adapting activities or doing less complicated activities in 
order to participate with less effort. 
"I'm short of breath. When I sing, I occasionally cheat, 1 call it playback. We 
have performances, which is nice and it is also good for social contacts. " 
Participants found alternatives like playing bridge instead of tennis or joining 
a book club instead of the quilt club. Being a member of a club or a group of 
friends with regular appointments appeared very helpful to stay in touch 
with others and have fun. Participants mentioned that they perceived no 
barriers when doing sedentary activities such as reading or watching 
television and experienced much pleasure doing this. 
"Television is important to me. Especially since I've always been a sports fan, 
I like to watch sports. Soon Wimbledon and Tour de France are on television. 
Then I watch television in the afternoon. For me it's an important thing to 
relax." 
Theme 2: Increasing burden 
Partners expressed how they gradually had taken over more activities or 
even the entire organization of their lives as a couple. Because it happens 
gradually, it is experienced as an ordinary natural process, but also as a 
burden. 
"You feel that you are on your own and have to do it all. The idea that it will 
never change, can be an enormous burden", [partner] 
All partners mentioned how the disease effected their employment. Most 
partners had been able to adapt their working hours to their home 
circumstances, combining home and work tasks to support their partner. 
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If I did not do it, nothing happened 
Partners experienced that they had to do it all: the household, the 
administration as well as initiating social events and keep in touch with 
friends and family. They noticed the difficulties their partners with MDl had 
in initiating action. The inactivity and deferral of duties often was a 
frustrating experience for partners. 
"What can be postponed was postponed. It completely irritated me. Then I 
thought come on, do something!" [partner] 
/ am in charge; I give directions 
Partners found themselves completely in charge of what needs to be done, 
whereas in the past they had shared responsibilities. Several partners used 
reminders such as writing down duties or making a telephone call from work 
to prompt actions. Partners noted the willingness of the person with MDl to 
act, but the need for an extra stimulus to actually get going. 
"1 am often the one who plans everything. He usually agrees. Sometimes he is 
too tired for things. Then 1 have to say well come on. 1 write down the things 
he can do. I say you're at home all day, so you can also do something, stay 
busy, we must do it together." [partner] 
Some partners deliberately gave directions based on their knowledge and 
understanding of the cognitive consequences of MDl. However, not all 
partners were aware of these. One partner felt that her partner's brain did 
not work well, as if there was some kind of dementia. She felt that she 
constantly had to say something, otherwise nothing would be done. 
Theme 3: Finding a mode together 
Couples experienced living with MDl as a process with dilemmas and 
frustrations, but compared it to the give and take required in every marriage. 
They felt ambivalence whether to do tasks themselves or encourage their 
partner to do it. Giving each other freedom and respecting differences in pace 
and interests were seen as important ways of managing together. 
"1 think it is important that you do it together. The one with the disease 
should not give up too easily, but should try to do what is possible. You have 
to find a good mode together." [partner] 
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MD1 leads to changes in roles and the marital relationship. Several partners 
indicated that they can imagine that marriages fail. A partner told how she 
had been jealous on other couples who happily did things together, while her 
husband always fell asleep. When she was 40, she felt being married to a man 
of 80. Couples also had to deal with changes in sexuality and intimacy in the 
relationship, which both experienced as difficult. 
"You become a carer", [partner] 
"We pretty much live like brother and sister." 
Doing or leaving: renegotiation of tasks 
Participants with MD1 said they want to do things themselves for as long as 
possible. They experienced that their partner sometimes gets impatient when 
performance of tasks takes much time. On the other hand they welcomed 
partner assistance when efforts became disproportionate for them or 
associated with safety risks. Partners faced dilemmas when to encourage 
their partner to do activities themselves and when to take over. Couples 
indicated the importance for the person with MD1 remaining active even 
though doing so, demanded more time, effort or was clumsy. 
"If it is difficult to rise from your chair because you have pain in your legs and 
your arms and you want to put on the potatoes. Then it is much easier to ask 
the other to do it For things I know that she cannot do it, I have no 
problems to take over. I get annoyed when I think if you try a little harder, 
you can do it yourself', [partner] 
The balance between encouraging and taking over seemed to be variable and 
context-specific. A partner mentioned how she enjoyed watching her 
husband playing with their granddaughter. She knew this cost him energy, so 
she took over other activities for him. Previous roles and personal interests 
influenced this balance. In some couples there was consciously renegotiating 
of tasks, but there were also couples whereby nearly all tasks were gradually 
taken over by the partner. 
Individual and shared activities; give each other freedom 
Couples experienced an increasing difference between each other's 
capacities, pace and interests. They thought about what they could do 
together and what they could not. If they choose 'together', they adjusted the 
pace and enjoyed being engaged in shared activities. 
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"If we go shopping together, we do this leisurely at a snail's pace. Then it is 
not that I run to the supermarket after work, toss something in the car and 
fly home. No, we take the time and enjoy shopping together. We have chosen 
to do it this way." [partner] 
All couples commented that going out was important for them. However, 
spontaneous outings or holidays had led to disappointment due to 
inaccessible public buildings. This meant that outings increasingly needed 
planning and preparation, usually done by the partners. Limited stamina, 
fatigue and sleepiness of persons with MDl also influenced going out 
together because of the rest needed during the day. 
"If we go away together, we are often confronted with a lot of problems. If 
you go to a museum, you might have to take six flights of stairs before 
reaching the entrance, then the game is over for us. ... It means that you 
cannot go anywhere spontaneously." [partner] 
Couples found solutions to engage in shared activities, like cycling with 
electric bikes in the surroundings, visiting accessible restaurants or taking a 
wheelchair to go out. Several spoke about enjoying just sitting together in 
their garden. Couples emphasised the importance of giving each other 
freedom. Persons with MDl were usually quite happy for their partner to do 
things for themselves. Partners learned that doing things for themselves is a 
way to re-energise and was experienced as taking good care of one self. 
"I give my wife a lot of freedom. If she wants to go away with friends, that's 
fine with me. You go and have fun, I don't feel the need to go." 
"Freedom is important, because at times it is quite heavy. A source of energy, 
whether it is sports or something else, gives you new energy, as long as you 
have something for yourself." [partner] 
Theme 4: Lack of understanding 
Persons with MDl reported feeling misunderstood and judged as silly or 
sulky, due to their facial weakness. Couples described a lack of understanding 
within their family, among relatives and friends and in the health care system 
and society at large. They speculated that was this was due to invisible 
problems like fatigue, but felt hesitant to ask for understanding, tending to 
withdraw from situations and hide their problems. 
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"Previously, 1 was the centre of attention. That is no longer the case and I 
have to get used to that. Now 1 am being looked at as if 1 am 'not quite in line'. 
I notice this and it annoys me." 
"You constantly have to defend yourself and explain and 1 do not always feel 
like it. There are people who don't understand me and say 'yes' when it 
should be 'no'. That annoys me. 1 rather have them ask me to repeat myself 
than an answer that makes no sense ... then 1 withdraw..." 
Even the family does not understand 
Couples felt misunderstood by their own family. They experienced that 
relatives with the disease sometimes denied having MDl and did not want to 
have anything to do with it. Partners even noted that the parent with MDl 
showed little understanding for their own child(ren] with an even more 
severe form of the disease. 
"When it was discovered by her mother, we told everyone to do a DNA test, 
then you know where you stand. If you see them walking, you can see it. Her 
own brothers do not know, because they did not do a test." [partner] 
From relatives and friends they experienced lack of understanding of what it 
means to live with MDl. This led to hurtful reactions from others when for 
instance an appointment had to be cancelled due to ill-health or when they 
experienced that family members did not make efforts to understand their 
relative with less intelligible speech. 
"When he takes the phone, they always ask for me, because they cannot 
understand him. And these are his own brothers. Or when they sit next to 
him, they don't have the patience to let him tell what he wants to say, that 
sort of things. He talks slowly and it gets worse." [partner] 
We manage ourselves 
Couples experienced that people are busy with their own lives and forget 
about them. They preferred to manage themselves and found it difficult to 
ask for support. Becoming dependent on others or receiving the 'wrong' 
assistance was a reason for giving up activities and withdrawing. 
"We play 'jeu-de-boule' nearby. I cannot pick up a ball, but 1 have magnets to 
do that. Then there are people that pick up the ball for me, all with the best 
intentions, but I hate that so much". 
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However, when support was given in the 'right' manner, it was highly 
appreciated. When friends showed understanding and consideration for their 
restrictions, this was treasured. One participant with MDl mentioned that 
their group of friends had asked her to explain about her illness. When she 
had done so, she experienced better understanding. 
"Last weekend we went to dinner with some good friends. We would have 
had dinner in a restaurant where the toilet was downstairs, but they then 
choose a different restaurant. They had thought about that which was 
fantastic." [partner] 
Health care: many islands focused on part of the disease 
Participants reported that they often visit many specialists. They felt little 
attention was paid to the consequences of the disease for their daily life. A 
couple described the hospital as 'many islands', each looking at one part of 
the disease. Couples said they visited the hospital together, because that way 
you hear more. One partner said that she did not mind doing personal care 
tasks but that she needed proper instructions and support. This couple 
expressed concerns about coping with a catheter. They wondered whether 
cycling, attending the choir or swimming was still possible. These questions 
had not been addressed in the consulting room with healthcare professionals, 
so they had tried to manage and find solutions themselves. 
"You expect that they tell you these things [how to cope with a catheter] in 
hospital. Now ! need to go to the drugstore. They have something for men 
who are incontinent. I have thought of it yesterday. You have to do some 
doctoring yourself. If they had only said how to do it, but they had not." 
[partner] 
Some couples experienced understanding, recognition and support by fellow 
patients during meetings from the muscular disease association or group 
medical appointments, a 2 hour medical consultation together with 6 or 7 
other patients with the same disease and their partners. 
Discussion 
This is the first study exploring how couples live and cope with MDl. As such, 
it offers new insights into the self-management strategies used by couples 
from the perspective of persons with MDl, their partner and as a couple. 
Persons with MDl experienced physical, cognitive and social barriers in daily 
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life. Their self-management strategies included postponing, avoiding or 
giving up activities, but also adjusting expectations and finding alternative 
ways to engage in less demanding activities. Partners reported an increasing 
burden and felt that if they did not do things, nothing happened. Strategies 
used by partners included taking over activities, giving directions with 
written or verbal instructions or prompts. As a couple they faced challenges 
in finding a mode together with renegotiation of tasks and individual and 
shared activities. Giving each other freedom, respecting each other's 
differences in pace and giving scope for their own interests were ways in 
which couples managed together. Couples experienced lack of understanding 
from family, friends, society and health care. This lack of understanding 
contributed to further withdrawal and avoidance of social situations. Couples 
said they preferred to help each other, rather than asking for help or 
understanding. Health care was experienced as many islands, with each 
speciality looking at one part of the disease. Little attention was paid to the 
consequences of this systemic, neuromuscular disease for their daily life and 
marital relationship. 
Strengths and weaknesses of the study 
Although a small, purposive sample [three men and two women with MDl), 
the strength of the study was that three in depth interviews, lasting between 
60-90 minutes, were held with each couple. This resulted in 15 interviews 
with rich information from three perspectives: persons with MDl, their 
partners and as a couple. The 1070 codes saturated the four themes and 
resulted in "theme saturation" as well as "theoretical saturation"28. There 
were no obvious deviant or negative cases, but categories were saturated 
with a variety of positive and negative experiences. The trustworthiness of 
the study credibility was promoted through triangulation strategies and 
other strategies to enhance credibility2^29. 
There was homogeneity in age and the type of MD with the onset of 
symptoms in adulthood. All participants were Caucasian. There is no 
information on how MDl affects the lives of persons from other than western 
cultures. Younger persons with MDl might have different experiences, 
especially since this disease has the characteristic of anticipation, meaning 
that children of couples with MDl may have a more severe type of MD 
revealing problems at an earlier age. The findings give an impression of the 
lives of middle aged couples with one partner having MDl. However, it is to 
be expected that there is a considerable group of men with MDl without a 
partner. Men with MDl appear to have a decline in marriage eligibility 
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whereas women continue to marry at a young age and in a proportion almost 
equal to that of the unaffected population30. In a study of personality patterns 
of 15 people with MDl, 11 lived alone after divorce or were unmarried5. Our 
research shows the support needs of individuals with MDl and support 
strategies provided by their partners. This information may be of value for 
single persons with MDl who might be in need of support. 
This study also included participants with communication difficulties 
due to dysarthria in contrast to a previous qualitative study8. In some 
participants intelligibility was limited. The researcher repeated the 
participants' answers in order to make sure she understood; this repetition 
also facilitated the transcription. 
Although MDl is the most prevalent adult type of neuromuscular 
disease, the incidence is approximately 1 in 20.000; these findings may be 
relevant for couples with other complex chronic illnesses facing physical, 
cognitive and social impairments which limit everyday activities and social 
participation. 
Meaning of the study: possible explanations and comparison with other studies 
Previous studies aiming to get insight in the consequences of MDl used 
quantitative approaches9^1-3·', interviewed a heterogeneous group of persons 
with muscular dystrophies or their partners separately01234 or focused on 
living with the hereditary aspect of a muscular disease13. This study is the 
first to combine clients' and partners' perspectives on their daily life 
experiences and how they cope as couple with MDl. 
Lack of understanding of family, friends, society and health care was a 
major theme which was described in other studies in muscular 
dystrophy811 ;12:35:36. The following factors may be possible explanations: lack 
of communication, wrong expectations, ignorance and avoidance. 
Communication was not only an issue because of dysarthria, decreased 
intelligibility and limited facial expression in persons with MDl. More crucial 
is the lack of communication about the illness experience of persons living 
with MDl. How can friends, family and health care professionals understand 
if they do not communicate about the impact of the disease on daily life? 
Although patient-centred care is being promoted37, participants in current 
study experienced illness-centred care with many health care professionals 
focusing on part of the disease and its management and not on the 
consequences for their daily life. A recent review on the management of MDl 
confirmed the concentration on impaired functions and structures in medical 
subsystems38. Our study shows that during consultations, doctors [and other 
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health and social care professionals) would do well to explore the impact of 
the disease on the couple, rather than focusing on the subsystems of the 
disease. 
Other factors contributing to lack of understanding include wrong 
expectations and ignorance of other people regarding the potential or 
limitations of persons with MD1. As MD1 is classified as a neuromuscular 
disease, muscle weakness and fatigue are expected and treatment is aimed at 
improving body functions like aerobic capacity, breathing or hand 
function14;17;18;39;40. However, if cognitive problems and social barriers are 
ignored, efforts to improve physical functions are likely to fail. These barriers 
may explain why adherence to exercise programs is limited14. Current study 
showed the large impact of cognitive and psychosocial barriers such as lack 
of initiative and avoidant behaviour for the daily lives of couples. Although 
these features are well-described characteristics of MD15;7:41, they are less 
obvious and often ignored, leading to wrong interpretations and 
misjudgements by other people. 
From the interviews we have learned that persons with MD1 
experienced; 1) being stared at due to their appearance; 2) misunderstanding 
because of the decreased intelligibility; and 3) being judged as silly or sulky. 
All of these experiences contributed to avoidance of or withdrawal from 
social situations. Other social barriers include the inaccessibility of public 
buildings restricting spontaneous visits to places like museum, cinema or 
theatre, which was also described by Boström et al.34. Although participants 
tried to hide their disabilities and tended to avoid social situations, they all 
valued going out and meeting others. Many persons with MD1 experienced 
difficulties keeping in touch with others leading to feelings of being alone, 
forlorn and forgotten8134. Breaking down disabling social practices against 
people with MD1 might be as important, if not more so, than seeking 
treatment for physical impairments42. This is in accordance with Boström 
and Ahlström who state that: many issues in the management of long-term 
chronic illness can better be interpreted from a social perspective rather than 
a biomedical perspective34. 
The self-management strategies of persons with MD1, including 
adjusting expectations and finding alternative ways to participate with less 
demands on physical performance, have been described before34. These self-
management strategies are in contrast with the main rehabilitation 
interventions which tend to focus on improving physical abilities14:17:18-39;40. 
What can be learned from these self- and couple management strategies is 
that it is necessary to understand the barriers perceived in daily life, and also 
147 
CHAPTER 7 
how people adapt their lives to retain their social roles and participate. To 
support self-management, it is essential to understand the meaning of social 
participation. Especially when self-management is seen as comprising of 
three tasks: medical management such as taking medication or doing 
exercises; role management which involves maintaining, changing and 
creating meaningful behaviours or life roles, and emotional management 
including the management of emotions such as fear, frustration and 
depression, commonly experienced by persons with a chronic disease. 43. 
Most health care programmes only deal with medical management. Role-
management and emotional management are often being neglected43. This 
study provides insight into how couples themselves fulfilled these different 
self-management tasks. 
Professionals and others primarily focus on the needs of the person 
with MD1 and overlook the support needs of partners or other family 
members12. Health professionals perceive partners as caregivers rather than 
care recipients. Also partners do not express their need for support, although 
they might experience a large caregiver burden, feeling no scope for own 
interests outside the home which can be a source of despair12. This study 
showed how frustrating and annoying the lack of initiative and avoidant 
behaviour can be for partners. Previous studies report the difficulties 
encountered by partners in interpreting whether the need for support is 
related to MD1 or to lack of will or laziness12. Partners are often faced with 
dilemma's whether to take over and when to encourage their partner with 
MD1 to do things. Not all partners knew that this so-called lack of will is part 
of MD1. What can be learned from partners in current study is that knowing 
that the lack of initiative and avoidant behaviour are related to MDl helped 
partners to more consciously apply compensation strategies like prompts or 
reminders. 
Current study showed the resilience of couples to manage together. 
Supporting each other and giving each other freedom were described as vital 
couple management strategies. This finding replicates the management 
strategies used by couples facing other multiple chronic illnesses44. Two life 
philosophies were found: 1] staying positive; and 2) being married means 
supporting each other whatever happens and coping with what comes along. 
The combination of individual and shared coping strategies was considered 
indicative of a healthy balance44. A continuum was described between 
positive support like a helpful reminder and problematic support like 
nagging or pushing a partner44. A balance was promoted in which the person 
with the disease manages themselves and the partner provides support to 
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this managing. How assistance is given and received as well as marital 
interactions that accompany this support, appeared to impact both marital 
quality and health44. These findings support a couple-centred approach for 
the self-management of couples with complex chronic diseases like MD1 
which includes medical management, role management and emotional 
management for both partners43. 
A couple management approach has shown to be effective for patients 
with dementia and their caregivers4546. The problems experienced by these 
couples in relation to coping with loss of abilities, initiative and participation 
in social activities, decreased quality of life and pressure on family relations 
and friendships45 are strikingly similar to the problems experienced in MD1. 
The consequences of MD1 have been described as comparable to those of the 
aging population15. This is in line with insights that MDl is considered a 
progeroid syndrome with accelerated emergence of features of senescence 
including symptoms of dementia47. There is evidence that a community 
approach aimed at increasing abilities of older people with dementia to 
engage in meaningful daily occupations and interventions to increase support 
giving skills of partners increases participation of the person with dementia 
and reduces caregiver burden4546. Further studies evaluating couple 
management for couples with other progressive, complex diseases are 
warranted. 
Finally, some participants valued peer support to exchange 
experiences and learn from fellow patients; whilst others avoided peer 
support. Boström et al. (2004) stressed the importance of the disability 
movement with its fellowship for social connections, providing opportunities 
to meet others and also as an organizer of suitable leisure activities34. 
Another way to meet fellow patients is participation in group consultations 
with persons having MDl, their partners and their physician in which the 
topics are often chosen by the participants. During such visits, participants 
learn from each other and physicians learn from the experiences of patients 
and their partners48. This approach has been promoted as a way for medical 
students to gain understanding of what it is like to live with a chronic disease 
and how couples adjust and cope40. 
Implications for clinicians and policymakers 
Although there is mounting evidence for effective system changes that 
improve chronic care, such as the Chronic Care Model4951, health care often 
remains with basic structures and practices designed for acute diseases48. 
The traditional medical care model mainly focuses on treatment of 
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impairments6, ignoring the illness experience and its impact on the system, 
including partners. Our recommendations for clinicians therefore include: 
1. A shift from the focus on physical functions to a person-, or even a couple-
centred approach aiming to understand not only the disease, but also the 
illness experience of persons with a complex chronic illness and their 
partners. This shift involves; 
- A more narrative approach besides the traditional biomedical analytical 
approach; and 
- Referral of patients and their partners to appropriate interdisciplinary 
medical, rehabilitation and community services to address barriers from 
medical as well as psychological and social perspectives. 
2. A shift from self-management to couple management in complex chronic 
conditions, in which self-management skills of both partners are 
supported in order to: 
- Maximize participation for persons with a complex chronic disease such 
as MDl; 
- Reduce caregiver burden by enhancing support giving skills; 
- Find a healthy balance together in shared and individual activities. 
This study showed how important it is that clinicians use an integrated 
medical and social approach for persons with MDl in which couple 
management is the starting point. 
Future research 
Challenges for the future include further development and evaluation of the 
acceptability and effectiveness of a couple-centred approach for complex 
chronic illnesses. A couple-centred approach includes the three aspects of 
self-management: medical management, role management and emotional 
management43 and should also address disabling social practices. As this can 
be considered a complex intervention including several components52:53, it is 
recommended to use a stepwise approach as described in the framework for 
design and evaluation of complex interventions52. 
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General discussion 
CHAPTER H 
Part I: Professional perspective 
Part 1 of this thesis was based on the premise that utilization of physical 
therapy (PT), occupational therapy (OT) and speech therapy [ST] in persons 
with neuromuscular diseases (NMD] was inefficient. It was hypothesized that 
a multidisciplinary approach with single consultations and advice would 
result in more efficient referral to and utilization of OT, PT and ST for persons 
with NMD. In the absence of evidence based guidelines, the content of the 
consultations and advices was merely based on professional opinion from the 
OT, PT and ST from the neuromuscular expert centre. These advices were 
sent to colleagues in primary care and rehabilitation settings. Utilization of 
OT, PT and ST based on these advices was compared with usual care 
regarding volume of therapy and costs in Chapter 2. Implementation of the 
advices and possible barriers for implementation were explored in Chapter 3. 
Overuse and underuse of allied health care 
According to our comparative cohort study, in current practice there was 
overuse as well as underuse regarding PT and underuse regarding OT and ST. 
Compared to current practice, the PT advices suggested more short periods 
(boosts] of PT addressing and evaluating specific goals and supporting self-
management regarding physical exercises in daily life. The advices also 
suggested more short periods of OT compared to current practice with goals 
aimed at enabling valued occupations by means of giving instruction and 
advice regarding aids and adaptations or education regarding energy 
conservation strategies. For ST, 40% of the persons received advice during 
single consultations, which might include slowing down speaking rate to 
improve intelligibility or postural and dietary advice to improve eating and 
drinking abilities. 
The rationale behind the advices was to increase self-management of 
persons with NMD and to become a coach for persons with NMD instead of 
providing ongoing therapy. It was expected that such approach would 
improve efficient utilization of PT, OT and ST for persons with NMD and to 
decrease health care costs. This approach is in agreement with current views 
on the management of chronic diseases14, in which self-management is 
promoted. Self-management support however requires changes in 
professional thinking and behavior3. It also requires a change for persons 
with a chronic disease who are encouraged to gain the information, skills and 
confidence to manage and live with their condition4. 
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In current practice less than 10% of the persons with NMD had OT 
whereas there appeared to be an indication for short term OT in 45% of the 
persons assessed. This difference is most likely due to lack of knowledge and 
insight of what OT has to offer for persons with NMD. The lack of evidence for 
OT in NMD adds to this lack of knowledge, which calls for actions to increase 
the evidence base and provide insight into the benefits of OT to support 
persons with NMD in their abilities to carry out valued tasks and life roles. 
In current practice 70% of the PTs saw their patients with NMD at 
least once weekly for a year or more. Despite lack of scientific evidence to 
support this need for ongoing PT, advice to reduce the volume of PT was 
implemented in only 15% of the cases. Many different factors may have 
contributed to this, including the difficulties persons with NMD may 
experience difficulties in implementing physical exercise in daily life without 
support of a therapist and outside the therapy practice. 
Persons with NMD hardly make use of ST services, although a 
considerable number of persons has problems with communication or 
swallowing. Although the impairments cannot be cured, compensatory 
strategies are explained and instructions given often withinin a single 
consultation. Compared to the many advices for short term PT and OT 
interventions, further ST interventions were advised in only a very limited 
number of persons with NMD. 
Implementation of the advices and possible barriers for implementation 
Our comparative cohort study concluded that there was limited 
implementation of the advices. In this study the amount of therapy before 
and following the advices was compared. Further analyses showed a different 
picture. Implementation of the OT advices in primary care was excellent 
(100%, n=21}, whereas the OT advices (n=10) referred to a rehabilitation 
physician were implemented in 58% of the persons. There were various 
reasons for this lack of implementation and these reasons were at the level of 
the advice, the patient, the professional and the organization. 
Implementation of PT advice was also excellent (100%, n= 58] when it did 
not involve a change in volume of PT. When the advice suggested a change in 
volume (reduction, discontinuation or initiation of PT), the advice was 
implemented in 25% (7 of 28 persons). Possible factors influencing 
implementation were found at the level of the advice, the patient, the 
professional and the organization of practice. This showed that we are 
dealing with complex interventions comprising many different components. 
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To gain insight into components from the perspective of the professionals, 
follow-up telephone calls were recommended between colleagues from the 
neuromuscular centre and colleagues in community or rehabilitation setting 
to discuss the advice and possible barriers for implementation. 
Insights from the perspective of quality of health care improvements 
have indicated that implementing changes requires a whole systems 
approach engaging the patient, professionals and service organization3. An 
example of a change is when persons with NMD are encouraged to do 
physical exercises or sports in daily life themselves without the ongoing 
support of a therapist. Studies from the perspective of persons with chronic 
neurological conditions and from the perspective of PTs showed that many 
different barriers and facilitators are involved regarding participation in 
physical activities and exercise or sport in a public facility56. The presence of 
professionals that are knowledgeable about the neurological conditions is 
perceived as a facilitator, whereas a sports or exercise facility without such 
staff is perceived as a barrier for participation. Other barriers included 
accessibility of facilities, transport, costs or fees and feelings of shame or 
discomfort to sport among healthy persons. These findings support the 
complexity of various components involved when the aim is to support self-
management in for instance physical activities and exercise. The costs 
involved in medical fitness in the Netherlands generally are for the persons 
themselves, even when there is a medical indication. Individual exercise 
therapy by a PT however, is often fully reimbursed by the health insurances. 
This might have been one of the components influencing implementation of 
advice to reduce PT and instead participate in physical exercise in for 
instance medical fitness. 
Limitations 
Our studies on professional advice from a neuromuscular centre had several 
limitations. At first, the use of different types of questionnaires regarding 
therapy volume from different perspectives resulting in different outcomes; 
In the first study comparing usual practice with allied health care advices 
from a neuromuscular centre, we used data from the patient health care 
diaries and patient questionnaires at six months follow up. In the research on 
implementation of the advice, we also used professional questionnaires at six 
months follow up. This sometimes resulted in contradictory information 
showing the presence of recall bias. At six months follow up some patients 
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recalled not to have had OT, whereas they had had OT based on the 
professional questionnaires. 
Another reason for different results regarding implementation 
between the two chapters (2 and 3) was related to the criteria used for 
successful implementation. In Chapter 2, the number of treatment sessions 
advised was compared with the number of treatment sessions recorded by 
patients. In C/?opter 3 implementation was considered successful for OT when 
persons who had been advised OT, actually had received OT, regardless the 
number of therapy sessions. For PT, five categories were used (continue 
same volume, continue no PT, reduce volume, initiate volume or discontinue 
PT altogether] to determine whether implementation had been successful. 
This showed a different picture of the extent of implementation in Chapters. 
Another limitation of the study involved the lack of patient oriented 
outcomes to explore the effectiveness of the multidisciplinary advice on 
health and well-being of persons with NMD. Current exploratory study 
focused solely on allied health utilization and implementation of the 
suggested volume of therapy. If future studies aim to measure patient-
oriented outcomes, further research is needed regarding the most 
appropriate measures at the level of body functions, activities and 
participation, personal and contextual factors as well as registration of the 
content of therapies and the volume of therapy provided to be able to explore 
the outcome thereof. 
Lack of scientific evidence to support the treatment advices was also 
experienced as a limitation and showed the need for additional literature 
searches (Chapters 4, 5 and 6) and studies to be undertaken in the field. And 
finally, it was felt that single consultations provided limited insight into the 
daily lives of persons with NMD in the community and how they managed to 
live with the disease. Although the OT, PT and ST professionals aimed to 
apply a client-centered approach, by asking the persons to tell about the 
impact of the disease for their daily lives, it was felt that the client 
perspective could not be fully understood in the restricted time allocated for 
the consultations which took place in the clinical context of a hospital. To 
address this, a qualitative study was conducted aiming to gain in-depth 
insight and understanding of how persons with myotonic dystrophy type 1 
[MD1], the most prevalent neuromuscular disease among adults and their 
partners experience living with this disease and how they manage 
themselves in their own context (Chapter 7). 
CHAPTER 8 
Part II: The scientific perspective 
To address the problem of limited scientific evidence for OT, PT and ST for 
persons with NMD, three systematic reviews were conducted [Chapters 4, 5 
and 6). These reviews not only included evidence from RCTs and CCTs, but 
also from uncontrolled pre-post designs. The findings from the systematic 
reviews have shown that the evidence base for OT and ST for persons with 
NMD is weak and based on only one (ST) or two (OT) small uncontrolled 
studies7*. The highest level of evidence [level II evidence) was found for PT 
for persons with NMD, specifically for aerobic exercise in combination with 
strengthening exercises9. 
Occupational therapy 
For OT, there are indications that training of hand function is effective in 
persons with Welander muscular dystrophy (n=12)10 and myotonic 
dystrophy [MD) (n=5)11. The first diagnosis is extremely rare in the 
Netherlands with only a few people having the disease12. MD on the other 
hand is one of the most prevalent NMD13. The evidence from the study with 
persons having MD has already been applied in neuromuscular teams in the 
Netherlands, which has resulted in a description of two cases, showing 
improvements in strength and ability to use the hand in daily occupations 14. 
These findings also resulted in increased advice for training of hand function 
in persons with MD who had been admitted in the neuromuscular expertise 
and consultation centre in Nijmegen. Previously, interventions were merely 
aimed at compensation for the loss of hand function instead of training. The 
training studies have shown that there are still possibilities to train and 
improve hand function in persons with MD. However, our own experiences 
and results applying this hand function training in practice varied. Some were 
in agreement with the positive research findings and case descriptions, but 
others were not, which was due to difficulties with adherence to such 
program. Problems with adherence is a well-known problem in rehabilitation 
of persons with MD11415. In practice, additional monitoring and 
encouragement is often needed. Evidence for long-term efficacy of this 
intervention is still lacking. 
Currently, most OT interventions in NMD include advice and training 
in adaptive strategies to compensate for the loss of functions and to promote 
participation in activities and life roles. These adaptive strategies involve the 
use of aids and adaptations, the use of compensatory movements or postures, 
and simplifying or eliminating tasks to save energy for participation in 
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meaningful activities. Although these interventions have not been the focus in 
studies on OT for persons with NMD, studies in other chronic conditions have 
shown the effectiveness of OT. For instance, energy conservation strategies 
have been effective in MS to decrease the impact of fatigue1617. Severe fatigue 
is also present in the majority (61-74%] of patients with NMD18. Energy 
conservation strategies are therefore regularly advised in OT practice in 
persons with NMD19 and research in this area is recommended. 
Other fields providing evidence for the efficacy of OT include 
interventions aimed at decreasing the incidence of falls in elderly people 
living at home with high risk of falling20. The interventions included advice 
on assistive devices as part of a home hazards assessment or training of skills 
combined with a home hazard assessment. Because falling is a clinically 
important problem in NMD 21, such interventions might also be efficacious for 
the treatment of persons with NMD at risk of falling. 
There is also evidence for the efficacy of comprehensive OT on 
functional ability, social participation and quality of life in community 
dwelling elderly20. Community based OT has shown to be effective in 
improving daily functioning of older people with dementia and to reduce care 
giver burden2224. As some neuromuscular diseases like myotonic dystrophy 
are considered progeroid syndromes with accelerated emergence of features 
of senescence including symptoms of dementia25 evidence for the 
effectiveness of OT in the elderly with dementia may be applicable to some 
persons with NMD. And although clinically there is no debate regarding the 
benefits of OT in NMD, further studies are needed to provide OT in NMD with 
a firm scientific base. 
Physical therapy 
Regarding PT, aerobic exercise in combination with strengthening exercises 
is likely to be effective for persons with muscle diseases (level 11 evidence]. 
There are indications that it is also effective in a heterogeneous group of 
NMD (level 111 evidence]. Besides, level 111 evidence was found for aerobic 
exercises in persons with muscle disorder and for breathing exercises for 
persons with myasthenia gravis (MG] and MD. Adverse effects were 
negligible. 
This level 11 evidence for the combination of muscle strengthening and 
aerobic exercises found in current review was discarded in a Cochrane 
review on strength training and aerobic exercise training for muscle disease 
26
. Reason was the exclusion of training programs with duration of less than 
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10 weeks or studies that were not randomised. The only study included in 
the Cochrane review was the low quality RCT resulting in the conclusion that 
aerobic exercise in combination with strength training appears to be safe and 
may be effective in increasing submaximal endurance capacity in people with 
mitochondrial myopathy. This Cochrane review concluded that more 
research is needed before exercise programmes are generally prescribed in 
muscle diseases26. 
Another Cochrane review on Rehabilitation interventions for foot drop 
in NMD27 included an RCT which was also included in the review in current 
thesis. In this RCT28 strength training had a significant beneficial effect on 
walking ability in people with Charcot-Marie-Tooth disease (hereditary 
motor and sensory neuropathy, HMSN), but no significant effect on walking 
ability in people with MD. 
The conclusions in both Cochrane reviews were based on studies also 
included in the review in current thesis. However, the conclusions differed 
due to other in- and exclusion criteria of studies or different criteria for 
providing evidence for effectiveness. The review in current thesis considered 
studies to provide evidence when at least half of the variables in the domain 
body functions or activities/participation showed a significant effect instead 
of only one out of six, which was the case in the study on strength training in 
HMSN2728. The use of primary outcome measures is recommended instead of 
using many different outcomes, which had been the case in most studies in 
our systematic review. 
Two more recent Cochrane reviews in the field of PT in NMD were 
found. One reported no evidence for interventions for increasing ankle range 
of motion in Charcot-Marie-Tooth disease type 1A or Duchenne muscular 
dystrophy29. Another Cochrane review on therapeutic exercise for people 
with amyotrophic lateral sclerosis (ALS) or motor neuron disease concluded 
that the studies detected were too small to determine to what extent 
strengthening exercises for people with ALS are beneficial, or whether 
exercise is harmful30. 
Other reviews focusing on exercise therapy in adult persons with 
inflammatory myopathies, concluded that exercise therapy in adults with 
polymyositis and dermatomyositis was safe and efficacious and can be 
recommended J1J2. Regarding the combination of strengthening and aerobic 
exercises, this conclusion was in agreement with the findings from our 
review in this thesis. Regarding muscle strengthening exercises, the 
conclusions differed. This also could be explained by differences in studies 
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included and in criteria for effectiveness. Remarkable was the presence of 
adverse effects in a recent study in two of eight participants [increased joint 
swelling and tenderness and diffuse tendinitis pain influencing exercise 
capacity^3. However, in the conclusions this study emphasized lack of muscle 
inflammation based on muscle biopsies. The absence of adverse effects so far 
legitimated the use of exercise therapy. This study showed that although 
exercise therapy did not show muscle inflammation, other adverse effects 
were present. 
At the time of the review, there were no studies on interventions to 
improve mobility including transfers and walking. A recent study evaluated 
posture and gait abilities in patients with MD following a rehabilitation 
program34. However, this retrospective analysis of medical files of 20 
patients, showing improvements in five of six outcome measures at the level 
of strength and one of six outcome measures at the level of gait, would have 
been discarded due to lack of methodological quality. 
In conclusion, lack of uniformity in type of interventions, intensity of 
exercise therapy and type of outcome measures hamper comparison between 
studies. Clearly more uniformity is recommended. Also research designs 
other than RCTs and CCTs, such as observational studies, should be 
recognized as very valuable alternatives to provide evidence for the course of 
PT interventions and the possible effectiveness in persons with NMD. 
Speech therapy 
For ST, there were indications for the efficacy of correcting head position in 
persons with OPMD835. In clinical practice, many persons with an NMD other 
than OPMD have ptosis. Instructions regarding the influence of posture of 
head and neck on swallowing might therefore be applicable to many persons 
with NMD, particularly when the disease leads to changes in posture or 
weakness in the head-neck-shoulder region or when the disease leads to 
weakness in muscles involved in speech or swallowing. This was confirmed 
in a study showing better swallowing in persons with spinal muscular 
atrophy [SMA] type II, when the head was positioned more forward36. 
Dysphagia and dysarthria diagnosed and treated by ST, are relatively 
prevalent and clinically relevant symptoms in persons with NMD. Dysarthria 
negatively influences communication and social participation, it has large 
impact on quality of life of persons37. The aim of ST interventions is to 
improve the intelligibility of persons with dysarthria due to NMD. Even if the 
dysarthria itself continues to deteriorate, compensational strategies such as 
CHAPTKR H 
slowing speaking rate, speaking face to face, using alternative words, 
concentration on speaking only and energy conservation may prolong the 
time of successful communication 37. Studies have shown that it is possible 
for persons with amyotrophic lateral sclerosis (ALS) to alter speaking rate, 
although there is lack of evidence that it has effect on intelligibility38^9. 
Van Nuffelen et al.39 recently have studied seven rate control methods 
on speech intelligibility, speaking rate, and articulation rate and pause 
characteristics in various types and severity of dysarthria. They found that 
each rate control method decreased both speaking rate and articulation rate, 
although the decrease was not significant for the strategy 'speaking slower on 
demand'. The results showed that each rate control method had the potential 
to establish a significant improvement in speech intelligibility for various 
types of dysarthria. The most effective methods were hand tapping, pacing 
board and alphabet board. It was therefore recommended that clinicians 
judge the effect of rate control for an individual with dysarthria during a trial 
session, trying out different methods at different rates. However, they also 
mentioned that although rate control may improve intelligibility in 
dysarthria, it may also have the opposite effect on intelligibility in some 
cases39. 
Obviously, there is a need for studies to research the effectiveness of 
ST advice on successful communication. This cannot be assessed by 
measuring speech intelligibility in a clinic room, but warrants assessment in 
the individual's actual life situations. It is a challenge to use assessments that 
represent the perspective of the persons experiencing problems in 
communication, who is ultimately the best person to judge whether 
participation is adequate and successful40. A Communicative Participation 
Item Bank is being developed, rating the extent to which a condition 
interferes with participation in various speaking communication situations41. 
Although the ultimate goal of ST is to improve communication and 
eating and drinking in daily life, which is the level of activities and 
participation in terms of the International Classification of Functioning, 
Disability and Health (1CF)42, assessment and management are also aimed at 
the level of body functions influencing communication and eating and 
drinking. A recent study on lip strengthening exercises in children and 
adolescents [7-19 years) with MD1, provided indications for possible 
effectiveness on maximal lip force and lip force endurance in a group of 
persons having moderate to severe impairments in lip force43. It is suggested 
that lip strengthening exercises can be a complement to other ST 
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interventions to improve articulation, saliva control, or eating and drinking 
ability, all of which are problematic in MD144. It should be noted however 
that these findings are based on studies with children. The effectiveness of 
such interventions in adults may not have the same effect. 
Other ST interventions such as the provision of information and advice 
on dietary modification and augmentative and alternative communication 
have not been studied in persons with NMD. Further research in this area is 
therefore recommended. 
Part III: Client perspective 
Our qualitative study showed that health care for persons with MD1 is mainly 
focused on the disease and body functions, rather than on the persons having 
the disease. There is lack of understanding of the experiences and 
consequences of MD1 for the lives of persons with the disease and their 
partners. In addition to the most obvious barriers of reduced mobility, poor 
physical fitness and fatigue, persons with MDl experience several other 
disabling barriers which are less obvious and not always adequately 
addressed. These include the cognitive barriers, psychosocial barriers, and 
societal barriers. Addressing these barriers and breaking down disabling 
social practices against people with MDl might be as important, if not more 
so, than seeking treatment for physical impairments45 46. Here lies a challenge 
for OT, PT and ST for MDl in providing support to overcome the different 
types of barriers perceived. 
Another important finding from our qualitative study is the large 
impact of a complex chronic disorder like MDl on the lives of partners and on 
the lives of both as a couple. Partners may experience an enormous burden as 
the decrease in abilities and initiative of the person with MDl leads to an 
increase in demands, tasks and responsibilities of partners. They described 
this as a gradual and natural process, but also as frustrating and annoying 
experiences. Due to the differences in interests, physical and cognitive 
abilities, couples regularly have to renegotiate tasks and roles and find a 
balance between shared and individual activities. So far health care is mainly 
focused of persons with the disease. Our findings however, suggest a couple-
centred approach aiming to maximize participation for persons with MDl, 
reduce caregiver burden by enhancing support giving skills, and find a 
healthy balance together in shared and individual activities. Such couple 
management approach has shown to be effective in couples living in the 
community and in which one of the partners has dementia2224. 
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Traditionally the focus of health care is on medical management of a 
condition, whereas self-management of a chronic condition like MDl 
comprises of two other tasks: role management (maintaining, changing, and 
creating new meaningful behaviors or life roles) and emotional management 
(learning to manage emotions such as anger, fear, frustration, and 
depression) 47. Role-management and emotional management have often 
been neglected in health care and here lies a role for allied health 
professionals including OT, PT and ST as part of a coordinated 
multidisciplinary team providing appropriate services and support when 
needed. To support persons in these types of self-management, it is essential 
to understand the meaning of social participation for persons, the barriers 
perceived and how persons adapt their lives to retain their social roles and 
participation. 
In client-centered practice, the expertise of clients is considered as 
important as the expertise of professionals and in practice they share this 
knowledge and share decision making. This partnership paradigm implies 
that while professionals are experts about diseases, patients are experts 
about their own lives. Our study showed how persons with MDl and their 
partners manage their lives together, which involved adjusting expectations 
and participation in activities and roles with less demands on physical 
performance and renegotiation of (marital) roles (role management). In this 
process persons with MDl and their partners had to cope with frustrations, 
dilemmas and caregiver burden (emotional management). 
A client-centred approach or the partnership paradigm is increasingly 
being implemented in health care for chronically ill persons. Moreover, also 
in research the client-perspective is increasingly being incorporated. This has 
led to priority setting in research from the perspective of persons with 
NMD48. Four main research themes were distinguished as well as priorities 
within these themes: 1) Health status with emphasis on finding a cure or 
prevention of deterioration. This includes research into fatigue, pain and 
other specific complaints; 2) Quality of life with emphasis on partner relation, 
family life and social contacts. Also mobility, work education and leisure were 
topics considered important research topics; 3) Quality of health care with 
emphasis on mobility and training followed by aids and adaptations and 
professional support; 4) General issues with the main issue of independence 
and other issues like understanding, information provision48. 
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Perspective of effective service delivery: Chronic Care Model 
Studies in current thesis have presented the state of the art regarding the 
components of evidence based OT, PT and ST for persons with NMD. There 
are still gaps to bridge regarding: 1] professional expertise; 2) scientific 
evidence; 3] patient-centered care, including next of kin. In identifying areas 
for development to bridge these gaps, the Chronic Care Model (CCM] 
appeared useful4. The key-elements of evidence based practice in the context 
(Figure 1] can be compared with the key-elements of the CCM (Figure 2). 
Shared decision 
making 
SocietaT 
context 
Professional 
expertise 
Figure 1. Elements of evidence based practice (EBP) in a practice context and societal 
context. 
In the CCM the professional expertise is congruent with a proactive prepared 
practice team and the client expertise with the informed activated patient 
(and families]. Together they have productive interactions (including shared 
decision making] leading to improved outcomes. To support and enable these 
productive interactions, developments in the health care system are 
promoted, which include self-management support, delivery system design, 
decision support and clinical information systems. Self-management support 
is provided within health care context and in community. 
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The CCM has its roots in evidence based medicine and is a visual 
compilation of evidence about the determinants of effective chronic illness 
care and the nature of practice systems that facilitate good care and good 
patient outcomes4. Therefore, elements of CCM may assist in improving 
efficient service delivery of OT, PT and ST in persons with NMD. Specifically, 
the elements self-management support, delivery system design, decision 
support, clinical information systems and outcomes are areas for 
development and improvement. 
Self-management support 
Self-management support involves assisting and coaching persons with a 
chronic condition and their families to acquire skills and confidence to 
manage the challenges of living with a chronic condition like NMD. In the 
past, persons with a chronic condition passively received treatment to 
restore or maintain body functions. Self-management support aims to 
activate persons to be informed and able to manage their condition 
themselves. For persons with a chronic condition and for professionals such 
as OT, PT and ST, this requires a different way of thinking and working 
requiring different skills like motivational interviewing to support patients in 
their self-management349. 
Self-management support requires a systems approach including the 
patient, the professionals and service organisation (health care and 
community resources)3. An example of a self-management approach is the 
Project Shake-lt-Up, promoting health and empowerment of persons with 
different neurological disability and also building the capacity of community 
organisations that provide services to this population4546. Other initiatives 
include our own multidisciplinary program for peers with chronic 
neurological conditions such as NMD50. This program includes several 
aspects of self-management support: physical training and education on 
training and on energy conservation strategies50 as well as support to enable 
participation in sports or physical activities at home and in community. This 
program is currently being piloted. Further development and testing of these 
self-management programs is needed for which the use of the framework of 
developing and testing complex interventions is recommended51. 
Delivery system design 
As visualized in the CCM, self-management support is on the edge of health 
care system and community resources. This is where professionals from 
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health care settings and community resources collaborate. This can be within 
the same profession, but also between professionals and organizations. The 
use of internet communities may provide opportunities to share experiences 
and discuss treatment options52. Expert teams in specialized centers are 
recommended for diagnostic purposes and treatment advice, whereas for 
continuity of care, support in the home situation and in community is 
recommended with respect for the social context and autonomy of the 
persons with chronic illness49. This is in agreement with the promotion of an 
integrated multidisciplinary approach for the management of NMD involving 
all members of the patients' environment including family, clinicians, 
decision-makers and community organizations to move out of the spiral of 
disease and handicap and toward optimal citizenship and quality of life15;53;54. 
Figure 2. Elements of chronic care model (CCM) by Wagner et al.4. 
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Decision support and clinical information systems 
When persons with NMD are admitted to the neuromuscular centre for 
diagnostic purposes and treatment advice, they complete a questionnaire 
regarding perceived problems in activities and participation and the need for 
support in different areas [PLANQ3S5"57. The PLAN-Q is developed to be used 
as a decision support to guide referral to OT, PT and ST. The questionnaire 
also provides valuable information for the preparation of the consultations. 
Reports from the consultations are registered in a database accessible for 
members of the team. During a multidisciplinary meeting the findings are 
discussed within the team and results in advice for medical and rehabilitation 
interventions. 
Such standardized and organized approaches to collect, summarize 
and review individual or aggregate patient data are recommended to 
facilitate care4. A computerized disease registry that includes critical 
information about each patient and results of important aspects of care 
enable care teams to call in patients with specific needs, deliver planned care, 
receive feedback, and implement reminder systems4. Such systems will also 
assist in the development of clinical guidelines and will provide information 
which can lead to practice based evidence. 
Outcomes 
When evaluating OT, PT and ST interventions and also to guide referral to OT, 
PT and ST, valid outcome measures are required. From the perspective of 
persons with NMD4" the following themes need to be addressed and assessed 
using different levels of the International Classification of Functioning, 
Disability and Health (ICF)42: 
1) At the level of body functions and general health condition; muscle 
strength, fatigue, pain and other specific complaints such as balance 
problems; 
2) At the level of activities, participation and quality of life: mobility, work, 
education, leisure, partner relation, family life and social contacts; 
3] At the level of personal and environmental factors: self-efficacy, coping, 
provision of support, information, aids and adaptations and psychosocial 
support. 
Further systematic reviews and/or consensus meetings with researchers, 
professionals and patients with NMD are recommended to agree on outcome 
measures for clinical and research purposes regarding the rehabilitation of 
persons with NMD. 
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Conclusions and recommendations for future service delivery and 
research 
To promote efficient service delivery of OT, PT and ST for persons with NMD 
at the level of increasing professional expertise, building the scientific 
evidence base and using client expertise, recommendations regarding future 
service delivery and research include: 
- Exchange of knowledge and experience with the use of on-line internet 
communities, which will increase expertise of professionals in 
neuromuscular centers as well as professionals in community; 
- Observational studies with the use of clinical information registries in 
which patient data are systematically recorded. A practice based evidence 
approach is recommended5860 collecting comprehensive patient, 
treatment and outcome data to uncover best practices, which can be 
subject for further research; 
- For this purpose there is a need for a selection of standardized and 
individualized patient-oriented outcome measures at the level of 
diseases, body functions and structure, activities and participation, 
personal factors and contextual factors to be administered by patients and 
professionals before and during consultations using questionnaires, 
interviews, tests and observations; 
- Development and implementation of decision support tools such as 
referral guidelines5557 and clinical guidelines for OT, PT and ST in 
different types of NMD; 
- Development, testing and implementing self-management programs 
aiming at supporting persons with NMD and their next of kin in 
meaningful social participation. To achieve this, the use of the MRC 
framework for developing and testing complex interventions is 
recommended51. 
In conclusion, it is suggested to make use of practice informing research as 
well as research informing practice60 using different qualitative and 
quantitative research designs to increase the evidence base for OT, PT and ST 
in persons with NMD. 
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Chapter 9 
Summary 
CHAPTER 9 
In this thesis the state of the art regarding occupational therapy (OT], 
physical therapy [PT] and speech therapy (ST) for persons with 
neuromuscular diseases (NMD) is presented from three perspectives: 1] 
professional perspective; 2) scientific perspective; and 3) client perspective. 
These perspectives comprise the elements of evidence based practice and 
clinical decision making [Chapter 1). 
Current allied health care (OT, PT and ST) for persons with NMD is 
characterized by large variation in referral, content, duration, and knowledge 
among referring physicians, professionals, and clients. This thesis aims to 
increase and integrate knowledge and insights from the perspectives above 
regarding OT, PT, and ST for persons with NMD. 
Part I of this thesis represents the professional perspective. In a cohort 
study the volume of OT, PT and ST as currently received by persons with 
NMD (reference group n=106) was compared to the volume of OT, PT and ST 
based on an integrated advice recommended by a multidisciphnary team 
from a neuromuscular expert centre (intervention group n=102). These 
advices were composed following single OT, PT and ST consultations and a 
multidisciphnary meeting. The volume (frequency and duration) of OT, PT 
and ST for the reference group was studied retrospectively and prospectively 
with the use of patient questionnaires at baseline and a health care diary 
during 8 weeks follow up. In the intervention group, questionnaires were 
completed by patients and professionals (OT, PT, and ST or rehabilitation 
physician) at baseline, following the consultations and advice, and at 6 
months follow up. 
In a cost analysis [Chapter 2), outcome variables included volume of 
therapy, relative over- and underuse of therapy, and costs of therapy and 
intervention (consults and multidisciphnary meeting resulting in advice). 
When current service utilization was compared to the multidisciphnary 
advice given, there was 40% underuse of OT among persons with NMD. For 
PT, there was 32% overuse and 22% underuse; for ST, there was neither 
over- nor underuse. Forty percent of persons with NMD received ST advice 
during single consultations with no indication for further ST interventions. 
For OT, 27% received advice during single consultations and for PT this was 
the case for 19% of the persons with NMD. If fully implemented, the 
multidisciphnary approach would result in a mean cost savings of € 85,- per 
person (costs of the multidisciphnary advice €245,- excluded). The 
recommended therapy had, however, been implemented only partially at 6 
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months follow up. It is concluded that some persons with a NMD did not 
receive any form of OT, PT or ST, where they might need it. Among persons 
with NMD who received allied health care, quite a few received these 
treatments for too long periods of time. Ways need to be developed to 
improve implementation of the multidisciplinary advice to obtain a more 
favorable balance between its costs and benefits. 
At 6 months follow up, implementation of the advice was evaluated for 
OT, PT and ST and possible barriers to implementation were explored at the 
level of the advice itself, the person with NMD, the professional or the health 
care organization (Chapter 3]. The criterion for successful implementation for 
OT and ST was defined as having had therapy when advised so. This was 
evaluated for advice sent to primary care and to rehabilitation setting 
separately. For PT we used different criteria for implementation because a 
considerable number of persons with NMD already had PT. Five categories 
for advice were distinguished: continue not to have PT, discontinue PT, 
reduce the amount of PT, continue the same amount of PT, or initiate PT. For 
each category, the percentage in which the advice was successfully 
implemented was calculated. 
Results showed that advice for OT and ST was fully implemented in 
primary care. However, advice for OT was only partially (58%) implemented 
in a rehabilitation setting. For PT, advice to continue PT (n=64) was almost 
fully implemented. In contrast, implementation of advice recommending a 
change in the amount of PT was significantly less [p<0.001]. Advice to reduce 
the amount of PT was implemented in 15%, advice to discontinue PT was 
implemented in 37.5%, and advice to initiate PT was implemented in 29% of 
the persons with NMD. Possible barriers for implementation were related to 
the advice itself [feasibility of treatment duration, correctness and 
completeness), the person with NMD (motivation], and the professional 
(experience in treatment of NMDs]. Therapists expressed a desire to discuss 
the treatment advice with the multidisciplinary team. Follow-up telephone 
calls have been recommended to provide therapists an opportunity for 
discussion. 
Part II represents the scientific perspective with three systematic reviews 
on respectively the scientific evidence for OT, PT and ST for adults with NMD. 
Comprehensive searches were performed for controlled and uncontrolled 
studies in the Cochrane Library, Medline, CINAHL and Embase databases. 
Search strategies included a search for different types of NMD, a search for 
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different research designs in combination with searches for OT [Chapter 4), 
PT (Chapter 5) and ST (Chapter 6). A best-evidence synthesis was performed 
using three levels of evidence. Level 1 evidence refers to at least 2 RCTs 
(Randomized Controlled Trials) of sufficient quality. Level 11 evidence refers 
to 1 good quality RCT or at least 2 independent controlled studies (RCTs or 
Controlled Clinical Trials, CCTs] of less methodological quality, and level III 
evidence refers to an RCT or CCT of low methodological quality or at least 1 
other design of sufficient methodological quality. When inconsistent findings 
were found in studies of similar design and methodological quality, 
conclusions were formulated as 'there is insufficient evidence that....'. 
For OT, only two other designs were found which provided level III 
evidence for the efficacy of hand training in muscle diseases. There is a lack of 
scientific evidence regarding the question whether, through occupational 
therapy, persons with NMD are better capable of participating in meaningful 
activities and roles. For PT, there was level 11 evidence for aerobic exercises 
in combination with strengthening exercises for persons with muscle 
disorders. There was level 111 evidence that aerobic exercises with or without 
strengthening exercises were also effective in other NMD. Other studies 
provided level III evidence for the efficacy of breathing exercises in persons 
with myasthenia and myotonic dystrophy. For ST, only one study provided 
level III evidence that correction of head position in persons with 
oculopharyngeal muscular dystrophy improves swallowing efficiency. 
Part III represents the client perspective. A qualitative study was carried 
out with five couples, including three men and two women with myotonic 
dystrophy type 1 (MD1] and their partners [Chapter 7). The aim was to 
increase understanding of how MD1 affects the lives of couples and how they 
themselves manage individually and together to better match health care to 
their needs. Each couple was visited twice at home. During the first visit 
individual in-depth interviews were held, and during the second visit a 
couple interview was carried out. Findings were described from the 
perspective of persons with MD1, their partners and from both as a couple. 
People with MD1 associate this progressive, neuromuscular condition 
with decreasing abilities, describing physical, cognitive and psychosocial 
barriers to everyday activities and social participation. Partners highlighted 
the increasing burden of care giving, giving directions and using reminders to 
compensate for the lack of initiative and avoidant behaviour due to MD1. 
Couples portrayed the dilemmas and frustrations of renegotiating marital 
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roles and responsibilities; stressing the importance of achieving a balance 
between individual and shared activities. All participants experienced a lack 
of understanding from relatives, friends, and society, leading to withdrawal 
and isolation. Health care was perceived as fragmentary, with specialists 
focusing on specific parts of the body rather than seeking to understand the 
implications of the systemic disorder on daily life. 
This study indicates that people with MDl and their partners 
experience a host of problems, some of which are unexpected, 
underestimated and neglected, such as the cognitive problems and social 
barriers, which affect their quality of life and relationship. Couples felt 
misunderstood, perceiving deterioration as inevitable and that nothing could 
be done. Learning from these five couples has produced some practical 
recommendations that challenge the tendency to treat MDl as a condition 
with primarily physical impairments. It is vital to listen to couples, to elicit 
the impact of MDl, as a multisystem disorder that influences every aspect of 
their life together. Couple management, supporting the self-management 
skills of both partners is proposed as a way of reducing the mismatch 
between health services and health needs. 
In Chapter 8 all findings are discussed and the Chronic Care Model [CCM] is 
introduced as a useful model, comprising of elements to improve efficient 
service delivery of OT, PT and ST in persons with NMD. Specifically, the 
elements self-management support, delivery system design, decision support, 
clinical information systems and outcomes are areas for development and 
improvement. 
Conclusions and recommendations 
Current service delivery of OT, PT and ST for persons with NMD is not 
efficient and advice from a neuromuscular team to increase the efficiency is 
partially implemented. Besides, the evidence base for OT, PT and ST is 
limited. Finally, couples with MDl experience far more problems in daily life 
than are addressed in health care. Therefore, recommendations regarding 
future service delivery and research include: 
- Further exchange of knowledge and experience among professionals; 
- Use of standardized and patient-oriented outcome measures at the level 
of diseases, body functions and structure, activities and participation, 
personal factors and contextual factors to be administered by patients and 
professionals; 
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- Development and implementation of decision support tools such as 
referral guidelines and clinical guidelines for OT, PT and ST in different 
types of NMD; 
- Performance of observational studies with the use of clinical information 
registries in which patient data are systematically recorded; 
- Development, testing and implementing self-management programs 
aiming at supporting persons with NMD and their next of kin in 
meaningful social participation; to achieve this, the use of the Medical 
Research Council framework for developing and testing complex 
interventions is recommended. 
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CHAPTER 10 
In dit proefschrift wordt de 'state of the art' ten aanzien van ergotherapie 
[ET], fysiotherapie [FT] en logopedie [LO] voor mensen met een 
neuromusculaire aandoening [NMA] gepresenteerd vanuit verschillende 
perspectieven: 1] professioneel perspectief; 2] wetenschappelijk perspectief; 
en 3] cliëntperspectief. Samen vormen deze perspectieven de elementen van 
evidence based practice en professioneel redeneren [Hoofdstuk 1). 
De huidige paramedische zorg [ET, FT en LO] voor mensen met een 
NMA wordt gekenmerkt door grote variatie in verwijzing, kennis en ervaring 
bij verwijzers, bij professionals en bij cliënten. Dit proefschrift beoogt kennis 
en inzicht vanuit de eerdergenoemde perspectieven te vergroten. 
Deel I van dit proefschrift representeert het professionele perspectief. In 
een cohort studie werd het gebruikelijke volume ET, FT en LO voor mensen 
met een NMA [referentiegroep n=106] vergeleken met het volume op basis 
van paramedisch advies vanuit een neuromusculair expertise centrum 
[interventiegroep n=102]. Dit paramedisch advies was gebaseerd op 
eenmalige consulten ET, FT en LO en multidisciplinair overleg. In de 
referentiegroep werd bij aanvang het volume ET, FT en LO zowel 
retrospectief als prospectief vastgesteld met behulp van vragenlijsten. 
Daarnaast hielden patiënten gedurende acht weken in een zorgdagboek het 
volume ET, PT en LO bij. In de interventiegroep werden bij aanvang, na de 
consulten en na zes maanden vragenlijsten ingevuld door patiënten en 
professionals [ET, FT, LO en revalidatieartsen]. 
Bij de kostenanalyse [Hoofdstuk 2] werd gebruik gemaakt van de 
volumina en bijbehorende kosten van ET, FT en LO en de interventie 
[consulten en multidisciplinair overleg resulterend in een paramedisch 
advies]. Bij vergelijking tussen de gebruikelijke zorg en geadviseerde zorg 
was sprake van een relatief ondergebruik van ET van 40% ten opzichte van 
de geadviseerde zorg. Bij FT was zowel overgebruik [32%] als ondergebruik 
[22%] en bij LO was geen ondergebruik, noch overgebruik. Bij 40% van de 
mensen werd tijdens het eenmalige LO consult advies gegeven zonder dat er 
een indicatie was voor verdere behandeling. Bij ET was dit bij 27% en bij FT 
bij 19% van de mensen. Wanneer de adviezen volledig werden opgevolgd zou 
de multidisciplinaire aanpak €85,- per persoon besparen [exclusief de kosten 
van de interventie €245,-]. Het geadviseerde volume therapie was slechts 
gedeeltelijk geïmplementeerd na zes maanden. De conclusie is dat er 
enerzijds mensen met een NMA zijn die geen paramedische zorg krijgen, 
terwijl hier wel een indicatie voor is. Anderzijds zijn er mensen met een NMA 
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die continu therapie krijgen waarbij het de vraag is of deze behandeling 
verminderd dan wel volledig afgebouwd kan worden. Een aanbeveling is om 
de implementatie van de adviezen te bevorderen ten behoeve van een betere 
balans tussen kosten en baten. 
Na zes maanden werd implementatie van de adviezen geëvalueerd 
voor ET, FT en LO. Ook werden factoren die mogelijk van invloed kunnen zijn 
nader geëxploreerd op niveau van het advies, de cliënt, de professional en de 
zorgorganisatie (Hoofdstuk 3). Het criterium voor succesvolle implementatie 
voor ET en LO was dat mensen ook daadwerkelijk therapie hadden gekregen 
wanneer dit was geadviseerd. Hierbij werd onderscheid gemaakt tussen 
adviezen voor ET en LO in de eerstelijn en in een revalidatiesetting. Voor PT 
werden andere criteria voor succesvolle implementatie toegepast, aangezien 
een aanzienlijk aantal mensen al FT had. Er werd onderscheid gemaakt 
tussen vijf categorieën: doorgaan zonder FT, doorgaan met huidige volume 
FT, stoppen met FT, volume FT verminderen, of starten met FT. Per categorie 
werd het percentage succesvolle implementatie berekend. 
De resultaten lieten zien dat ET en LO adviezen volledig werden 
geïmplementeerd in de eerstelijn. De ET adviezen werden echter slechts 
gedeeltelijk (58%) geïmplementeerd in een revalidatiesetting. Bij FT werden 
de adviezen om met de huidige therapie door te gaan (n=64) volledig 
geïmplementeerd. Implementatie van de adviezen die een verandering van 
het therapievolume voorstelden was echter significant minder (p < 0.001]. 
Van de adviezen om het volume te verminderen werd slechts 15% 
geïmplementeerd, van de adviezen om met de FT te stoppen 37.5% en van de 
adviezen om met FT te starten werd 29% geïmplementeerd. Mogelijke 
factoren die de implementatie hebben beïnvloed, waren gerelateerd aan het 
advies zelf (haalbaarheid van de therapieduur, correctheid en volledigheid], 
de persoon met NMD (motivatie] of de professional (ervaring in de 
behandeling van NMA]. De therapeuten gaven de behoefte aan om het 
behandeladvies te bespreken met het multidisciplinaire team. Daarom werd 
aanbevolen voortaan contact op te nemen met de therapeuten om het advies 
te bespreken. 
Deel II representeert het wetenschappelijk perspectief met drie 
systematische reviews naar respectievelijk de effectiviteit van ET, FT en LO 
bij volwassenen met NMA. Uitgebreide zoekstrategieën werden uitgevoerd 
voor zowel gecontroleerde als ongecontroleerde studies in de Cochrane 
Library, Medline, CINAHL en Embase databases. De zoekstrategieën bevatten 
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een zoekstrategie voor verschillende vormen van NMA, een zoekstrategie 
voor verschillende onderzoeksdesigns en zoekstrategieën voor ET (Hoofdstuk 
4), FT (Hoofdstuk 5) en LO (Hoofdstuk 6). 
Een best-evidence synthese werd toegepast waarbij drie niveaus van 
bewijsvoering werden onderscheiden: Niveau I bewijs verwijst naar 
tenminste twee RCTs (Randomized Controlled Trials] van voldoende 
methodologische kwaliteit. Niveau II bewijs verwijst naar één RCT van goede 
kwaliteit of tenminste twee onafhankelijke gecontroleerde studies (RCTs of 
controlled clinical trials , CCTs) van minder goede kwaliteit. Niveau III bewijs 
verwijst naar een RCT of CCT van minder goede methodologische kwaliteit of 
tenminste één studie met andere onderzoeksopzet van voldoende 
methodologische kwaliteit. Wanneer de studies van vergelijkbare opzet en 
methodologische kwaliteit leidden tot inconsistente bevindingen, werden de 
conlusies geformuleerd als "er is onvoldoende bewijs dat....". 
Voor ET bij NMA werd niveau III bewijs gevonden dat training van de 
handfunctie bij spieraandoeningen effectief is. Er is geen bewijs gevonden 
voor de effectiviteit van ergotherapie interventies om de participatie van 
mensen met een NMA in betekenisvolle activiteiten en rollen te bevorderen. 
Voor PT is niveau II bewijs gevonden dat aerobe training in combinatie met 
krachttraining effectief is bij mensen met een spieraandoening. Er was niveau 
III bewijs dat aerobe training met of zonder krachttraining effectief is bij 
andere NMA. Ongecontroleerde studies resulteerden in niveau III bewijs voor 
de effectiviteit van ademhalingsoefeningen bij mensen met myasthenia gravis 
en myotone dystrofie. Voor LO bij NMA is slechts één ongecontroleerde 
studie gevonden op basis waarvan geconcludeerd wordt dat er niveau III 
bewijs is dat correctie van de hoofdhouding de efficiëntie van het slikken 
verbetert bij mensen met oculopharyngeal musculaire dystrofie (OPMD). 
Deel III representeert het cliëntperspectief. Een kwalitatief onderzoek 
werd uitgevoerd met vijf echtparen waarvan drie mannen en drie vrouwen 
met de ziekte myotone dystrofie type 1 (MDl) en hun partners (Hoofdstuk 7). 
Het doel was beter inzicht en begrip te krijgen hoe de ziekte MDl het leven 
van echtparen beïnvloedt en hoe zij zich individueel en als echtpaar redden. 
Alle echtparen werden tweemaal in de thuissituatie bezocht. Tijdens 
het eerste bezoek werden individuele diepte-interviews uitgevoerd en tijdens 
het tweede bezoek werd het echtpaar gezamenlijk geïnterviewd. De 
bevindingen zijn beschreven vanuit het perspectief van de persoon met MDl, 
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vanuit het perspectief van de partners en vanuit het perspectief van beiden 
als echtpaar. 
De mensen met de ziekte ervaren het leven met de MD1 als het steeds 
opnieuw moeten inleveren van mogelijkheden. Hierbij beschrijven ze fysieke, 
cognitieve en psychosociale barrières bij de uitvoering van dagelijkse 
handelingen en sociale participatie. De partners benadrukten de toenemende 
belasting als mantelzorger. Verschillende partners gaven extra instructies, 
aanmoedigingen en geheugensteuntjes als strategie om te compenseren voor 
de verminderde initiatiefname en neiging om situaties te ontwijken. Als 
echtpaar werden ze geconfronteerd met de dilemma's en frustraties van het 
zoeken en aanpassen van een goede rolverdeling en het vinden van een 
balans tussen individuele en gezamenlijke activiteiten. Alle echtparen 
ervoeren onbegrip van familie, vrienden en de maatschappij met als gevolg 
dat mensen zich verder terugtrekken en in een isolement geraken. De 
gezondheidszorg werd ervaren als losse eilanden waarbij specialisten zich 
focussen op een stukje van de ziekte en niet begrijpen wat dit betekent voor 
het dagelijks leven van de mensen. 
Deze studie laat zien dat mensen met MD1 en hun partners vele 
problemen ervaren waar in de gezondheidszorg onvoldoende aandacht aan 
wordt besteed. Vooral de impact van de cognitieve problemen en de sociale 
beperkingen wordt vaak onderschat. Echtparen ervaren achteruitgang als 
onvermijdelijk en als iets waar niets aan te doen is. De ervaren problemen 
worden vaak niet benoemd en er wordt vaak ook niet naar gevraagd. 
Communicatie met echtparen is dan ook essentieel om te achterhalen wat de 
impact van deze multisysteemziekte voor beiden is. Begeleiding van 
echtparen wordt aanbevolen waarbij beiden worden ondersteund in het 
omgaan met de gevolgen van de ziekte individueel en gezamenlijk als 
echtpaar. 
In Hoofdstuk 8 worden alle bevindingen bediscussieerd en wordt het Chronic 
Care Model (CCM) geïntroduceerd als bruikbaar model met elementen die de 
efficiëntie van paramedische zorg voor volwassenen met NMA kunnen 
verbeteren. Vooral verdere ontwikkeling en verbetering van de elementen 
zelfmanagement ondersteuning, optimaliseren van zorgprocessen, 
instrumenten voor besluitvorming en klinische informatiesystemen is 
wenselijk. 
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Conclusies en aanbevelingen 
De huidige ET, FT en LO voor mensen met een NMA is niet efficiënt en 
paramedisch advies vanuit een neuromusculair centrum wordt gedeeltelijk 
geïmplementeerd. Daarnaast is de wetenschappelijke basis voor ET, PT en LO 
voor volwassenen met NMA beperkt. Tot slot blijken echtparen met MDl veel 
meer beperkingen te ervaren in het dagelijks leven, dan wordt onderkend in 
de zorg. Daarom worden de volgende aanbevelingen gedaan voor de 
toekomstige paramedische zorg en onderzoek: 
Meer onderlinge uitwisseling van kennis en ervaring door professionals; 
- Gebruik van gestandaardiseerde uitkomstmaten op het niveau van 
ziekten, lichaamsfuncties en structuren, activiteiten en participatie en 
persoonlijke en omgevingsfactoren; 
Ontwikkeling en implementatie van hulpmiddelen voor de klinische 
besluitvorming zoals richtlijnen voor verwijzing en voor ET, PT en LO 
voor mensen met NMA; 
Observationen studies met gebruik van klinische informatiesystemen 
waarin gegevens systematisch worden bijgehouden; 
Ontwikkeling, testen en implementatie van zelf-management 
programma's met als doel mensen met NMA en hun naasten te 
ondersteunen bij optimale participatie in betekenisvolle activiteiten en 
rollen; om dit te bereiken wordt het gebruik van het MRC raamwerk 
(vanuit de Medical Research Council] aanbevolen voor het ontwikkelen en 
testen van complexe interventies. 
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Dankwoord 
Velen hebben vanuit hun perspectief een belangrijke bijdrage geleverd aan 
dit proefschrift. 
Cliëntperspectief 
Alle mensen met een neuromusculaire aandoening die bereid waren om deel 
te nemen aan de studies in dit proefschrift, bedankt! In het bijzonder dank ik 
de vijf echtparen die openhartig hun ervaringen hebben gedeeld over het 
leven met de ziekte myotone dystrofie. 
Wetenschappelijk perspectief 
Dit proefschrift zou er nooit zijn geweest zonder mijn promotoren prof. dr. 
Rob Oostendorp, prof. dr. Baziel van Engelen, prof. dr. Gert Jan van der Wilt 
en co-promotor dr. Henk Hendricks. 
Beste Rob, dank voor alle inbreng vanuit jouw perspectief als 
paramedisch hoogleraar, voor het steeds aanleveren van nieuwe inzichten en 
wetenschappelijke publicaties die konden bijdragen aan de verschillende 
studies, voor je nauwgezette feedback op alle stukken en voor je bereidheid 
om te allen tijde te overleggen. Ook bedankt voor de gastvrijheid op de 
avonden dat we met de projectgroep overleg hadden bij jou en Ank thuis. 
Beste Baziel, deze traditie van het vergaderen in huiselijke sfeer is 
destijds door jou geïnitieerd. Dank voor je steun, je enthousiasme voor het 
paramedisch onderzoek en de prettige samenwerking. Ook het in contact 
brengen met diverse mede-onderzoekers heb ik erg gewaardeerd. Jouw 
relativerende opmerking 'so what?'... blijf ik gebruiken om me af te vragen 
'wat doet dit er toe en waarom?' 
Beste Gert Jan, ik heb bijzonder veel geleerd van alle kritische vragen, 
discussies, feedback en de 'finishing touch' bij de laatste versies van artikelen. 
De vraag 'geef eens in één zin weer waar dit onderzoek over gaat?' gaat ook 
mee 'in mijn rugzak'. Bedankt! 
Beste Henk, dank voor je positieve betrokkenheid en inbreng bij alle 
studies. Aanvankelijk in de rol van revalidatiearts, later als zeer 
gewaardeerde co-promotor. Het was voor mij een groot compliment dat jouw 
aanvankelijke scepsis over de kwalitatieve studie is omgeslagen in 
enthousiasme hiervoor. 
Met veel plezier kijk ik terug op de samenwerking met mede-
onderzoeker, fysiotherapeut en hoofd fysiotherapie Allan Pieterse en 
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logopediste en spraak-/taalpathologe Simone Knuijt. Gezamenlijk startten we 
het onderzoek getiteld 'gerichte verwijzing van mensen met een 
neuromusculaire aandoening naar paramedische zorg'. Dit onderzoek werd 
het SPADE onderzoek (Spierziekten Paramedisch Advies en Doelmatigheid in 
de Eerste lijn]. Allan, we hadden de onderzoekstaken en aandachtsgebieden 
mooi verdeeld. Dankzij jou liep de logistiek gesmeerd en maakten we gebruik 
van de testorganiser voor alle vragenlijsten. Hartelijk dank! Simone, ook jij 
heel veel dank voor jouw grote aandeel bij alle studies evenals de logopedie 
review. Allan en Simone, geweldig dat jullie mijn paranymfen zijn. 
Verschillende collega's hebben bijgedragen aan de studies in dit 
proefschrift. Dank aan Hans Groenewoud (MTA) voor de statische 
ondersteuning en dank aan Sylvia van den Heuvel van het Nederlands 
Paramedisch Instituut (NP1) voor de hulp bij de zoekstrategieën bij de 
systematische reviews. 
Ingrid Sturkenboom, bedankt voor de bijdrage aan de ergotherapie 
review; Jessica ten Broek en Marten Munneke voor de bijdrage aan de 
fysiotherapie review. De kwalitatieve studie zou nooit zo goed zijn geworden 
zonder de deskundige begeleiding van Astrid Kinébanian en Ton Satink. 
Bedankt! Ik koester de herinneringen aan het werken in de prachtige 
ambiance in Sterksel. Also thanks to Irene Illot, president of the European 
masters in OT for her valuable support and feedback on the qualitative study. 
Mijn collega ergotherapeuten en onderzoekers Margo van 
Hartingsveldt, Maud Graff, Lucelle van de Ven, Ingrid Sturkenboom, Liesbeth 
de Vries en Yvonne Veenhuizen, evenals de leden van het Netwerk 
Ergotherapie Onderzoekers Nijmegen (NEON) dank ik voor het meedenken 
vanuit wetenschappelijk perspectief. Margo, niet alleen als mede-
onderzoeker gaf je heel waardevolle feedback, ook als hoofd van de afdeling 
heb ik altijd kunnen rekenen op jouw steun! Ook dank aan de 
revalidatieonderzoekers, in het bijzonder Nicole Voet en Joyce Kootker, 
waarmee ik werkkamer, onderzoeksperikelen en andere zaken heb gedeeld. 
Professioneel perspectief 
Voor de bijdrage aan het professioneel perspectief dank ik de 
ergotherapeuten, fysiotherapeuten en logopedisten voor het samen 
ontwikkelen en uitvoeren van alle consulten en het schrijven van de 
adviezen. In het bijzonder dank aan Yolanda van den Elzen en Mabel van Esch 
(ergotherapeuten), Allan Pieterse en Jessica ten Broek (fysiotherapeuten) en 
190 
DANKWOORD 
Simone Knuijt, Hanneke Kalf, Janneke Weikamp en Bert de Swart 
(logopedisten). 
Ook dank aan de neurologen en revalidatieartsen in het UMC St 
Radboud voor hun medewerking aan de klinische studies. Tot slot dank ik 
alle ergotherapeuten, fysiotherapeuten, logopedisten en revalidatieartsen 
buiten het UMC St Radboud die meegewerkt hebben en bereid waren om de 
vragenlijsten in te vullen en terug te sturen. 
Dank aan de collega's van de afdeling revalidatie en het 
neuromusculair expertise en consultatiecentrum [NECC] voor de plezierige 
en inspirerende samenwerking. Bovenal dank aan mijn collega's van de 
afdeling ergotherapie voor de interesse, steun en inspiratie elke dag weer! 
Andere perspectieven 
Voor de secretariële ondersteuning dank aan Jessica Berenbroek (IQ 
healthcare), Tilly Pouwels en Fokkelien Westerweel (MTA) en Margina 
Draaisma, Noor Nuijten en Marjan Brandwijk (voormalig paramedisch 
secretariaat) en alle medewerkers van het huidige secretariaat van de 
afdeling revalidatie. Voor de hulp bij het uittypen van de interviews dank ik 
Annika en Jozet Aerts en Femke Seesing. 
Also thanks to my friend Bernie Rocheford for her willingness to 
comment on the English language. 
Lieve vrienden en familie, allemaal bedankt voor de belangstelling en 
steun, in het bijzonder dank aan mijn ouders, en schoonouders. Helaas kan 
pap deze mijlpaal niet meer meemaken. 
Lieve Cees, mijn grootste steun en toeverlaat, en lieve Els en Wies, 
vooral dankzij jullie was er altijd heel veel leven naast het promotietraject. Ik 
verheug me op al onze plannen na de promotie. Het boek is af! 
I'M 
CURRICULUM VITAE 
Curriculum Vitae 
Edith Cup is op 6 mei 1966 geboren te Venray. Na de middelbare school 
(gymnasium β scholengemeenschap Jerusalem te Venray) volgde ze van 1984 
tot 1988 de opleiding ergotherapie in Hoensbroek. Na deze opleiding werkte 
ze als ergotherapeut in Engeland in verschillende instellingen in en rondom 
Coventry. In 1990 ging ze in het UMC St Radboud werken als ergotherapeut 
en in 1994 startte ze met een deeltijdstudie bewegingswetenschappen aan de 
VU in Amsterdam. Na de propedeuse maakte ze in 1995 de overstap naar de 
deeltijdstudie gezondheidswetenschappen, afstudeerrichting bewegings­
wetenschappen aan de Universiteit Maastricht. In 1998 studeerde ze cum 
laude af. Sindsdien combineert ze patiëntenzorg, onderzoek en onderwijs 
met als belangrijkste aandachtsgebied de ergotherapie bij volwassenen met 
chronisch neurologische aandoeningen, in het bijzonder CVA en 
neuromusculaire aandoeningen. Ze is auteur van meer dan 40 nationale en 
internationale publicaties op het gebied van de ergotherapie. Edith is 
getrouwd met Cees Kreulen en samen hebben ze twee dochters. Els [7] en 
Wies [5). 
Stellingen 
Behorend bij het proefschrift 
Occupational therapy, physical therapy and speech therapy 
for persons with neuromuscular diseases 
An evidence based orientation 
1. Meer mensen met een neuromusculaire aandoening hebben veelal 
m/nder langdurig paramedische zorg nodig, (dit proefschrift) 
2. Voor de implementatie van een paramedisch advies is meer nodig dan 
alleen het versturen ervan, (dit proefschrift) 
3. In tegenstelling tot eerdere opvattingen is matig intensieve 
spierkrachttraining bij de meeste spierziekten niet schadelijk, maar 
veel sterker word je er niet van. (dit proefschrift) 
4. De 'kracht' die doorgaans wordt gemeten, zegt niets over de 'kracht' die 
mensen hebben om met hun beperkingen om te gaan. 
5. Om de effectiviteit te bepalen van paramedische zorg bij mensen met 
een neuromusculaire aandoening kan niet alleen worden volstaan met 
een RCT. (dit proefschrift) 
6. Onbegrip en miscommunicatie zijn niet altijd het gevolg van dysartrie; 
vaak is het een kwestie van goed luisteren, (dit proefschrift) 
7. Bij myotone dystrofie wordt de impact van de psychosociale problemen 
voor mensen met de ziekte, hun partners en voor beiden als echtpaar 
vaak zwaar onderschat, (dit proefschrift) 
8. Niet alles wat geteld kan worden telt, en niet alles wat telt kan geteld 
worden. (Albert Einstein) 
9. Fietsen door Heumensoord (omslag) helpt om door het bos de bomen 
te zien. 
10. The quality of a life can best be appraised by the person whose life it is. 
(Karen Whalley Hammel) 
11. Met geluk is het net als met gezondheid; als je er niets van merkt, 
betekent dit dat het er is. (Iwan Toergenjew; ter nagedachtenis aan 
Anjorieke Richt) 
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